Adhesion promoter compositions for cyclic olefin resin compositions

ABSTRACT

This invention relates to compositions and methods for improving the adhesion of resin compositions to substrate materials. More particularly, the invention relates to compositions and methods for improving the adhesion of ROMP compositions to substrate materials using an adhesion promoter composition, where the adhesion promoter composition comprises a pre-reacted mixture comprising at least one compound containing at least two isocyanate groups and at least one compound comprising a heteroatom-containing functional group and a metathesis active olefin, where the adhesion promoter composition is storage stable and/or possesses in-resin storage stability when added to a resin composition, particularly a cyclic olefin resin composition, such as a ROMP composition. The polymer products produced via ROMP reactions of the invention may be utilized for a wide range of materials and composite applications. The invention has utility in the fields of polymer and materials chemistry and manufacture.

RELATED APPLICATIONS

This application is a Divisional of U.S. application Ser. No.15/120,554, filed Aug. 22, 2016; which is a 371 National PhaseApplication of PCT/US2015/017548, filed Feb. 25, 2015; which claims thebenefit of U.S. Provisional Patent Application No. 61/945,473, filedFeb. 27, 2014, the contents of which is incorporated herein byreference.

TECHNICAL FIELD

The present invention relates to methods and compositions for improvingthe adhesion of olefin metathesis compositions to substrate materials.More particularly, the invention relates to methods and compositions forimproving the adhesion of ring opening metathesis polymerization (ROMP)compositions to substrate materials and the manufacture of polymerarticles (e.g., polymer composite articles) via ROMP. Polymer productsproduced via the metathesis reactions of the invention may be utilizedfor a wide range of materials and composite applications. The inventionhas utility in the fields of polymer and materials chemistry andmanufacture.

BACKGROUND

Polymer-matrix composites offer unique combinations of properties andare useful in a wide range of applications. Such composites may befabricated utilizing either thermosetting or thermoplastic polymermatrix materials with a variety of particulate or fibrous fillers orreinforcements. It is generally advantageous to have strong adhesionbetween the polymer matrix material and the surfaces of the variousparticulate or fibrous substrates and there is considerable art relatedto substrate finishes and other treatments to optimize adhesion topolymer matrices. For example, in the production of long-fiberreinforced composites, improved adhesion between the polymer matrix andthe fiber reinforcement leads to increased material performance. Goodadhesion is particularly important where failures are likely to occur bydelamination or by other adhesive failure modes.

As described in, for example, U.S. Pat. Nos. 5,840,238, 6,310,121, and6,525,125, the disclosures of each of which are incorporated herein byreference, polymers generated by olefin metathesis processes areattractive as composite matrix materials. Of particularly beneficial useare the polymers generated by the ROMP of cyclic olefins. The lowviscosity of cyclic olefin resin formulations and the ability to controlROMP kinetics (e.g., U.S. Pat. Nos. 4,708,969 and 5,939,504, thedisclosures of both of which are incorporated herein by reference)facilitate composite processing and manufacture, and the corrosionresistance and high toughness of ROMP polymers leads to good compositedurability. Additionally, certain properties of ROMP polymers, e.g.,mechanical strength and stiffness, heat distortion temperature andsolvent resistance, can be further enhanced by crosslinking induced viathermal treatment (e.g., U.S. Pat. No. 4,902,560, the disclosure ofwhich is incorporated herein by reference) or chemically by addition ofperoxides (e.g., U.S. Pat. No. 5,728,785, the disclosure of which isincorporated herein by reference).

Commercially important ROMP resin formulations are generally based onreadily available and inexpensive cyclic olefins such asdicyclopentadiene (DCPD), norbornenes, cyclooctadiene (COD), and variouscycloalkenes. However, in contrast to traditional resin systems (e.g.,epoxy, acrylate, urethane, and polyester resins) based on polarfunctional group chemistries, these nonpolar ROMP resins have poorintrinsic adhesion to the relatively polar surfaces of common carbon,glass, or mineral fillers and reinforcements. The addition of varioussilanes to such resin formulations for improvement of electrical andmechanical properties of ROMP polymers is described in U.S. Pat. Nos.5,840,238, 6,001,909, and 7,339,006, the disclosures of each of whichare incorporated herein by reference. Many widely used commercialsilanes do not give optimal properties with ROMP polymers, however, andthe greatest enhancements are only obtained when the silanes comprisegroups with high metathesis activity (the relative reactivity of variousmetathesis active groups is described in J. Am. Chem. Soc., 2003, 125,11360-11370).

As described in International Patent Application NumberPCT/US2012/042850, the disclosure of which is incorporated herein byreference, it was discovered that the addition of an adhesion promotercomprising a compound containing at least two isocyanate groups to acyclic olefin resin formulation (e.g., ROMP resin formulation) providesbeneficial improvements in the adhesion of a cyclic olefin resinformulation to substrate materials, such as, for example carbon andglass reinforcement materials.

According to International Patent Application Number PCT/US2012/042850,addition of an adhesion promoter comprising a compound containing atleast two isocyanate groups to a cyclic olefin resin formulation, wherethe resin formulation comprising the adhesion promoter was contactedwith an olefin metathesis catalyst and used to manufacture ROMPpolymer-matrix composites, provided improved adhesion of ROMP polymermatrices to composite substrate materials compared to ROMP polymermatrices without such adhesion promoters. Adhesion of the ROMPpolymer-matrices to substrate materials was measured by the short beamshear method according to ASTM D2344. Interlaminar shear strength (ILSS)is a measure of the adhesion and/or compatibility between the polymermatrix and the substrate material in a composite.

In addition, International Patent Application Number PCT/US2012/042850also demonstrated that the addition of at least one compound comprisinga heteroatom-containing functional group and a metathesis active olefin(e.g., 2-hydroxyethyl bicyclo[2.2.1]hept-2-ene-5-carboxylate (HENB)) toa cyclic olefin resin formulation (e.g., ROMP resin formulation)comprising at least one cyclic olefin and an adhesion promotercomprising at least one compound containing at least two isocyanategroups, where the resin formulation comprising the adhesion promoter wascontacted with an olefin metathesis catalyst and used to manufactureROMP polymer-matrix composites, further improved the efficacy of theadhesion promoter to effectuate adhesion between the ROMP polymer-matrixand the composite substrate material.

While International Patent Application Number PCT/US2012/042850demonstrated that compounds containing at least two isocyanate groupsare effective to improve the adhesion of cyclic olefin resinformulations to substrate materials (e.g., carbon and/or glass substratematerials), the in-resin storage stability of adhesion promoterscomprising at least one compound containing at least two isocyanategroups was not addressed. Furthermore, the in-resin storage stability ofadhesion promoters comprising at least one compound containing at leasttwo isocyanate groups, where the cyclic olefin resin formulation (e.g.,ROMP resin formulation) further comprises at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin was also not addressed.

The importance of using additives in resin formulations, particularlycyclic olefin resin formulations, where the additives are storage stableand/or possess in-resin storage stability is known in the art. Forexample, U.S. Pat. No. 4,943,621 discloses the importance of usingstorage stable additives possessing in-resin storage stability,particularly storage stable co-catalysts, as components in cyclic olefinresin formulations. Moreover, preparing cyclic olefin resin formulationswhich comprise additives having in-resin storage stability is ofparticular importance in the commercial manufacturing of polymerarticles and/or polymer-matrix composites manufactured from such cyclicolefin resin formulations. For example, for a manufacturer of cyclicolefin resin formulations to successfully commercialize such resinformulations it is often necessary to be able transport and store theresin formulations prior to use, which further necessitates the need forthe use of in-resin storage stable additives and components.Furthermore, it is often preferable, particularly from a commercialperspective, that the cyclic olefin resin formulations be provided tocustomers, molders, and other end-users with all of the necessaryadditives and components contained in the cyclic olefin resinformulation so that these individuals can avoid additional processingand therefore use the resin formulations as received to manufacturearticles comprising ROMP polymers and/or ROMP polymer-matrix composites.

After further investigation into the in-resin storage stability ofadhesion promoters comprising compounds containing at least twoisocyanate groups, the inventors have discovered that such adhesionpromoters do possess in-resin storage stability, particularly where theresin is a cyclic olefin resin. This in-resin storage stability isobserved by little or no decrease in the ILSS over time ofpolymer-matrix composites prepared using resin compositions comprisingat least one adhesion promoter, where the at least one adhesion promotercomprises at least one compound containing at least two isocyanategroups. The in-resin storage stability of adhesion promoters comprisingcompounds containing at least two isocyanate groups, particularly wherethe resin is a cyclic olefin resin is demonstrated and discussed infra.

Surprisingly, however, the inventors have discovered that when acompound comprising a heteroatom-containing functional group and ametathesis active olefin (e.g., 2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate (HENB)) is independently orseparately added to the cyclic olefin resin formulation containing anadhesion promoter comprising a compound containing at least twoisocyanate groups, the in-resin storage stability of the adhesionpromoter is adversely affected as observed by a decrease in the ILSSover time of polymer-matrix composites prepared using such resinformulations, the results of which are demonstrated and discussed infra.

Despite the advances achieved in the art, particularly in the propertiesof olefin metathesis polymers (e.g., ROMP polymers and ROMPpolymer-matrix composites) and their associated applications, acontinuing need therefore exists for further improvement in a number ofareas, including the manufacture of cyclic olefin resin formulations, inparticular ROMP resin formulations, for use in the manufacture of ROMPpolymer-matrix composites, where such composites possess strong adhesionbetween the polymer matrix and substrate material (e.g., carbon and/orglass reinforcement materials) Furthermore, there also exists a need forfurther improvement in the manufacture of cyclic olefin resinformulations, in particular ROMP resin formulations, where theformulation additives and components, particularly adhesion promoters,are storage stable and/or possess in-resin storage stability.

SUMMARY OF INVENTION

The present invention is directed to addressing one or more of theaforementioned concerns and relates to the use of an adhesion promotercomposition in a resin composition, such as a ROMP composition, or as asubstrate material pre-treatment to provide useful improvements in theadhesion of a metathesis catalyzed composition to the substratematerial.

More particularly, the inventors have discovered that addition of anadhesion promoter composition according to the invention to a resincomposition, particularly a ROMP composition, allows for improvements inthe adhesion of the polymerized (resin) composition to the substratematerial, without adversely affecting the mechanical properties of thepolymerized resin and/or polymer-matrix composite. Alternatively, asubstrate material may be pre-treated with an adhesion promotercomposition according to the invention in order to improve the adhesionof the polymerized (resin) composition to the substrate material,without adversely affecting the mechanical properties of the polymerizedresin and/or polymer-matrix composite. In addition, the inventors havediscovered that adhesion promoter compositions according to theinvention possess in-resin storage stability when added to a resincomposition, particularly a cyclic olefin resin composition, such as aROMP composition.

Adhesion promoter compositions according to the present invention,discussed infra, are generally comprised of a pre-reacted mixturecomprising at least one compound containing at least two isocyanategroups and at least one compound comprising a heteroatom-containingfunctional group and a metathesis active olefin. Adhesion promotercompositions of the invention possess in-resin storage stability whencombined with, contacted with, or added to a cyclic olefin resincomposition (e.g., ROMP resin composition). Furthermore, adhesionpromoter compositions of the invention may also be storage stable.

In one embodiment, the invention provides a composition for improvingthe adhesion of a resin composition, for example a ROMP composition, toa substrate material (e.g., carbon and/or glass reinforcement material),in which an adhesion promoter composition of the invention is combinedwith at least one cyclic olefin, and at least one olefin metathesiscatalyst (e.g., a cyclic olefin metathesis catalyst), thereby forming acomposition with improved mechanical properties.

In another embodiment, the invention provides a composition forimproving the adhesion of a resin composition, for example a ROMPcomposition, to a substrate material (e.g., carbon and/or glassreinforcement material), in which an adhesion promoter composition ofthe invention is combined with at least one cyclic olefin, at least oneolefin metathesis catalyst (e.g., a cyclic olefin metathesis catalyst),and a substrate material, thereby forming a composition with improvedmechanical properties.

In another embodiment, the invention provides an adhesion promotercomposition comprising a pre-reacted mixture of at least one compoundcontaining at least two isocyanate groups, and at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin.

In another embodiment, the invention provides a storage stable adhesionpromoter composition comprising a pre-reacted mixture of at least onecompound containing at least two isocyanate groups, and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin.

In another embodiment, the invention provides an adhesion promotercomposition comprising a pre-reacted mixture of at least one compoundcontaining at least two isocyanate groups, and at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin, wherein the adhesion promoter composition possessesin-resin storage stability when added to a resin composition, whereinthe resin composition comprises at least one cyclic olefin.

In another embodiment, the invention provides a storage stable adhesionpromoter composition comprising a pre-reacted mixture of at least onecompound containing at least two isocyanate groups, and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, wherein the storage stable adhesion promotercomposition possesses in-resin storage stability when added to a resincomposition, wherein the resin composition comprises at least one cyclicolefin.

In another embodiment, the invention provides an adhesion promotercomposition comprising a pre-reacted mixture of at least one compoundcomprising at least two isocyanate groups, and at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin.

In another embodiment, the invention provides a storage stable adhesionpromoter composition comprising a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups, and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin.

In another embodiment, the invention provides an adhesion promotercomposition comprising a pre-reacted mixture of at least one compoundcomprising at least two isocyanate groups, and at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin, wherein the adhesion promoter composition possessesin-resin storage stability when added to a resin composition, whereinthe resin composition comprises at least one cyclic olefin.

In another embodiment, the invention provides a storage stable adhesionpromoter composition comprising a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups, and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, wherein the storage stable adhesion promotercomposition possesses in-resin storage stability when added to a resincomposition, wherein the resin composition comprises at least one cyclicolefin.

In another embodiment, the invention provides a method for preparing anadhesion promoter composition, comprising combining at least onecompound containing at least two isocyanate groups with at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin to form a mixture, and subjecting the mixtureto conditions effective such that a pre-reaction there between takesplace.

In another embodiment, the invention provides a method for preparing astorage stable adhesion promoter composition, comprising combining atleast one compound containing at least two isocyanate groups with atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin to form a mixture, and subjecting themixture to conditions effective such that a pre-reaction there betweentakes place.

In another embodiment, the invention provides a method for preparing anadhesion promoter composition comprising combining at least one compoundcontaining at least two isocyanate groups with at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin to form a mixture, and subjecting the mixture toconditions effective that a pre-reaction there between takes place,wherein the adhesion promoter composition possesses in-resin storagestability when added to a resin composition, wherein the resincomposition comprises at least one cyclic olefin.

In another embodiment, the invention provides a method for preparing astorage stable adhesion promoter composition comprising combining atleast one compound containing at least two isocyanate groups with atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin to form a mixture, and subjecting themixture to conditions effective that a pre-reaction there between takesplace, wherein the storage stable adhesion promoter compositionpossesses in-resin storage stability when added to a resin composition,wherein the resin composition comprises at least one cyclic olefin.

In another embodiment, the invention provides a method for preparing anadhesion promoter composition, comprising combining at least onecompound containing at least two isocyanate groups with at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin to form a mixture, and subjecting the mixtureto conditions effective such that a reaction there between takes place.

In another embodiment, the invention provides a method for preparing astorage stable adhesion promoter composition, comprising combining atleast one compound containing at least two isocyanate groups with atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin to form a mixture, and subjecting themixture to conditions effective such that a reaction there between takesplace.

In another embodiment, the invention provides a method for preparing anadhesion promoter composition comprising combining at least one compoundcontaining at least two isocyanate groups with at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin to form a mixture, and subjecting the mixture toconditions effective that a reaction there between takes place, whereinthe adhesion promoter composition possesses in-resin storage stabilitywhen added to a resin composition, wherein the resin compositioncomprises at least one cyclic olefin.

In another embodiment, the invention provides a method for preparing astorage stable adhesion promoter composition comprising combining atleast one compound containing at least two isocyanate groups with atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin to form a mixture, and subjecting themixture to conditions effective that a reaction there between takesplace, wherein the storage stable adhesion promoter compositionpossesses in-resin storage stability when added to a resin composition,wherein the resin composition comprises at least one cyclic olefin.

In another embodiment, the invention provides an adhesion promotercomposition comprising a pre-reacted mixture of at least one compoundcontaining at least two isocyanate groups, and at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin, where the adhesion promoter composition is suitable foruse in a cyclic olefin resin composition, and where the adhesionpromoter composition possesses in-resin storage stability when added tothe cyclic olefin resin composition.

In another embodiment, the invention provides a storage stable adhesionpromoter composition comprising a pre-reacted mixture of at least onecompound containing at least two isocyanate groups, and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, where the storage stable adhesion promotercomposition is suitable for use in a cyclic olefin resin composition,and where the storage stable adhesion promoter composition possessesin-resin storage stability when added to the cyclic olefin resincomposition.

In another embodiment, the invention provides an adhesion promotercomposition comprising a pre-reacted mixture of at least one compoundcontaining at least two isocyanate groups, and at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin, where the adhesion promoter composition is suitable foruse in a cyclic olefin resin composition.

In another embodiment, the invention provides a storage stable adhesionpromoter composition comprising a pre-reacted mixture of at least onecompound containing at least two isocyanate groups, and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, where the adhesion promoter composition issuitable for use in a cyclic olefin resin composition.

In another embodiment, the invention provides a method for improving theadhesion of a resin composition to a substrate material comprisingcombining at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one adhesion promoter composition to form theresin composition, contacting the resin composition with the substratematerial, and subjecting the resin composition to conditions effectiveto promote an olefin metathesis reaction of the cyclic olefin, whereinthe at least one adhesion promoter composition comprises a pre-reactedmixture of at least one compound containing at least two isocyanategroups and at least one compound comprising a heteroatom-containingfunctional group and a metathesis active olefin.

In another embodiment, the invention provides a method for improving theadhesion of a resin composition to a substrate material comprisingcombining at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one storage stable adhesion promoter compositionto form the resin composition, contacting the resin composition with thesubstrate material, and subjecting the resin composition to conditionseffective to promote an olefin metathesis reaction of the cyclic olefin,wherein the at least one storage stable adhesion promoter compositioncomprises a pre-reacted mixture of at least one compound containing atleast two isocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin.

In another embodiment, the invention provides a method for improving theadhesion of a resin composition to a substrate material comprisingcombining at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one adhesion promoter composition to form theresin composition, contacting the resin composition with the substratematerial, and subjecting the resin composition to conditions effectiveto promote an olefin metathesis reaction of the cyclic olefin, whereinthe at least one adhesion promoter composition comprises a pre-reactedmixture of at least one compound containing at least two isocyanategroups and at least one compound comprising a heteroatom-containingfunctional group and a metathesis active olefin, and where the adhesionpromoter composition possesses in-resin storage stability when added tothe resin composition.

In another embodiment, the invention provides a method for improving theadhesion of a resin composition to a substrate material comprisingcombining at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one storage stable adhesion promoter compositionto form the resin composition, contacting the resin composition with thesubstrate material, and subjecting the resin composition to conditionseffective to promote an olefin metathesis reaction of the cyclic olefin,wherein the at least one storage stable adhesion promoter compositioncomprises a pre-reacted mixture of at least one compound containing atleast two isocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin,and where the storage stable adhesion promoter composition possessesin-resin storage stability when added to the resin composition.

In another embodiment, the invention provides a method for improving theadhesion of a resin composition to a substrate material comprisingcombining at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one substrate material, and at least one adhesionpromoter composition to form the resin composition, and subjecting theresin composition to conditions effective to promote an olefinmetathesis reaction of the cyclic olefin, wherein the at least oneadhesion promoter composition comprises a pre-reacted mixture of atleast one compound containing at least two isocyanate groups and atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin.

In another embodiment, the invention provides a method for improving theadhesion of a resin composition to a substrate material comprisingcombining at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one substrate material, and at least one storagestable adhesion promoter composition to form the resin composition, andsubjecting the resin composition to conditions effective to promote anolefin metathesis reaction of the cyclic olefin, wherein the at leastone storage stable adhesion promoter composition comprises a pre-reactedmixture of at least one compound containing at least two isocyanategroups and at least one compound comprising a heteroatom-containingfunctional group and a metathesis active olefin.

In another embodiment, the invention provides a method for improving theadhesion of a resin composition to a substrate material comprisingcombining at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one substrate material, and at least one adhesionpromoter composition to form the resin composition, and subjecting theresin composition to conditions effective to promote an olefinmetathesis reaction of the cyclic olefin, wherein the at least oneadhesion promoter composition comprises a pre-reacted mixture of atleast one compound containing at least two isocyanate groups and atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin, and where the adhesion promotercomposition possesses in-resin storage stability when added to the resincomposition.

In another embodiment, the invention provides a method for improving theadhesion of a resin composition to a substrate material comprisingcombining at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one substrate material, and at least one storagestable adhesion promoter composition to form the resin composition, andsubjecting the resin composition to conditions effective to promote anolefin metathesis reaction of the cyclic olefin, wherein the at leastone storage stable adhesion promoter composition comprises a pre-reactedmixture of at least one compound containing at least two isocyanategroups and at least one compound comprising a heteroatom-containingfunctional group and a metathesis active olefin, and where the storagestable adhesion promoter composition possesses in-resin storagestability when added to the resin composition.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one adhesion promoter composition, where theadhesion promoter composition comprises a pre-reacted mixture of atleast one compound comprising at least two isocyanate groups and atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one storage stable adhesion promoter composition,where the storage stable adhesion promoter composition comprises apre-reacted mixture of at least one compound comprising at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one adhesion promoter composition, where theadhesion promoter composition comprises a pre-reacted mixture of atleast one compound comprising at least two isocyanate groups and atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin, wherein the adhesion promotercomposition is in-resin storage stable.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one storage stable adhesion promoter composition,where the storage stable adhesion promoter composition comprises apre-reacted mixture of at least one compound comprising at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin,wherein the storage stable adhesion promoter composition is in-resinstorage stable.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one adhesion promoter composition, where theadhesion promoter composition comprises a pre-reacted mixture of atleast one compound comprising at least two isocyanate groups and atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin, and where the adhesion promotercomposition possesses in-resin storage stability when added to the resincomposition.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, and at least one storage stable adhesion promoter composition,where the storage stable adhesion promoter composition comprises apre-reacted mixture of at least one compound comprising at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin,and where the storage stable adhesion promoter composition possessesin-resin storage stability when added to the resin composition.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, and at least one adhesionpromoter composition, where the adhesion promoter composition comprisesa pre-reacted mixture of at least one compound comprising at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, and at least one storage stableadhesion promoter composition, where the storage stable adhesionpromoter composition comprises a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, and at least one adhesionpromoter composition, where the adhesion promoter composition comprisesa pre-reacted mixture of at least one compound comprising at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin,wherein the adhesion promoter composition is in-resin storage stable.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, and at least one storage stableadhesion promoter composition, where the storage stable adhesionpromoter composition comprises a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, wherein the storage stable adhesion promotercomposition is in-resin storage stable.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, and at least one adhesionpromoter composition, where the adhesion promoter composition comprisesa pre-reacted mixture of at least one compound comprising at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin,and where the adhesion promoter composition possesses in-resin storagestability when added to the resin composition.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, and at least one storage stableadhesion promoter composition, where the storage stable adhesionpromoter composition comprises a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, and where the storage stable adhesion promotercomposition possesses in-resin storage stability when added to the resincomposition.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, at least one substrate material, and at least one adhesionpromoter composition, where the adhesion promoter composition comprisesa pre-reacted mixture of at least one compound comprising at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, at least one substrate material, and at least one storagestable adhesion promoter composition, where the storage stable adhesionpromoter composition comprises a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, at least one substrate material, and at least one adhesionpromoter composition, where the adhesion promoter composition comprisesa pre-reacted mixture of at least one compound comprising at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin,wherein the adhesion promoter composition is in-resin storage stable.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, at least one substrate material, and at least one storagestable adhesion promoter composition, where the storage stable adhesionpromoter composition comprises a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, wherein the storage stable adhesion promotercomposition is in-resin storage stable.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, at least one substrate material, and at least one adhesionpromoter composition, where the adhesion promoter composition comprisesa pre-reacted mixture of at least one compound comprising at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin,and where the adhesion promoter composition possesses in-resin storagestability when added to the resin composition.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one olefin metathesiscatalyst, at least one substrate material, and at least one storagestable adhesion promoter composition, where the storage stable adhesionpromoter composition comprises a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, and where the storage stable adhesion promotercomposition possesses in-resin storage stability when added to the resincomposition.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one substrate material,and at least one adhesion promoter composition, where the adhesionpromoter composition comprises a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one substrate material,and at least one storage stable adhesion promoter composition, where thestorage stable adhesion promoter composition comprises a pre-reactedmixture of at least one compound comprising at least two isocyanategroups and at least one compound comprising a heteroatom-containingfunctional group and a metathesis active olefin.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one substrate material,and at least one adhesion promoter composition, where the adhesionpromoter composition comprises a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, wherein the adhesion promoter is in-resinstorage stable.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one substrate material,and at least one storage stable adhesion promoter composition, where thestorage stable adhesion promoter composition comprises a pre-reactedmixture of at least one compound comprising at least two isocyanategroups and at least one compound comprising a heteroatom-containingfunctional group and a metathesis active olefin, wherein the storagestable adhesion promoter is in-resin storage stable.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one substrate material,and at least one adhesion promoter composition, where the adhesionpromoter composition comprises a pre-reacted mixture of at least onecompound comprising at least two isocyanate groups and at least onecompound comprising a heteroatom-containing functional group and ametathesis active olefin, and where the adhesion promoter compositionpossesses in-resin storage stability when added to the resincomposition.

In another embodiment, the invention provides a resin compositioncomprising at least one cyclic olefin, at least one substrate material,and at least one storage stable adhesion promoter composition, where thestorage stable adhesion promoter composition comprises a pre-reactedmixture of at least one compound comprising at least two isocyanategroups and at least one compound comprising a heteroatom-containingfunctional group and a metathesis active olefin, and where the storagestable adhesion promoter composition possesses in-resin storagestability when added to the resin composition.

In another embodiment, the invention provides a cyclic olefin resincomposition comprising at least one cyclic olefin, at least one olefinmetathesis catalyst, and at least one adhesion promoter composition,where the cyclic olefin resin composition is contacted with at least onesubstrate material to provide useful improvements in the mechanicalproperties of a polymer-matrix composite and/or polymerized resin, wherethe adhesion promoter composition comprises a pre-reacted mixture of atleast one-compound containing at least two isocyanate groups and atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin, where the adhesion promoter compositionpossesses in-resin storage stability.

In another embodiment, the invention provides a cyclic olefin resincomposition comprising at least one cyclic olefin, at least one olefinmetathesis catalyst, and at least one adhesion promoter composition,where the cyclic olefin resin composition is contacted with at least onesubstrate material to provide useful improvements in the mechanicalproperties of a polymer-matrix composite and/or polymerized resin, wherethe adhesion promoter composition comprises a pre-reacted mixture of atleast one-compound containing at least two isocyanate groups and atleast one compound comprising a heteroatom-containing functional groupand a metathesis active olefin.

In another embodiment, the invention provides a cyclic olefin resincomposition comprising at least one cyclic olefin, at least one olefinmetathesis catalyst, and at least one storage stable adhesion promotercomposition, where the cyclic olefin resin composition is contacted withat least one substrate material to provide useful improvements in themechanical properties of a polymer-matrix composite and/or polymerizedresin, where the storage stable adhesion promoter composition comprisesa pre-reacted mixture of at least one-compound containing at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin.

In another embodiment, the invention provides a cyclic olefin resincomposition comprising at least one cyclic olefin, at least one olefinmetathesis catalyst, and at least one storage stable adhesion promotercomposition, where the cyclic olefin resin composition is contacted withat least one substrate material to provide useful improvements in themechanical properties of a polymer-matrix composite and/or polymerizedresin, where the storage stable adhesion promoter composition comprisesa pre-reacted mixture of at least one-compound containing at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin,where the storage stable adhesion promoter composition possessesin-resin storage stability.

In another embodiment, the invention provides a cyclic olefin resincomposition comprising at least one cyclic olefin and at least oneadhesion promoter composition, where the cyclic olefin resin compositionis combined with at least one olefin metathesis catalyst to form acatalyzed resin composition and the catalyzed resin composition iscontacted with at least one substrate material to provide usefulimprovements in the mechanical properties of a polymer-composite and/orpolymerized resin, where the adhesion promoter composition comprises apre-reacted mixture of at least one compound containing at least twoisocyanate groups and at least one compound comprising aheteroatom-containing functional group and a metathesis active olefin,where the adhesion promoter composition possesses in-resin storagestability.

In another embodiment, the invention provides a cyclic olefin resincomposition comprising at least one cyclic olefin and at least onestorage stable adhesion promoter composition, where the cyclic olefinresin composition is combined with at least one olefin metathesiscatalyst to form a catalyzed resin composition and the catalyzed resincomposition is contacted with at least one substrate material to provideuseful improvements in the mechanical properties of a polymer-compositeand/or polymerized resin, where the storage stable adhesion promotercomposition comprises a pre-reacted mixture of at least one compoundcontaining at least two isocyanate groups and at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin, where the storage stable adhesion promoter compositionpossesses in-resin storage stability.

In another embodiment, the invention provides an article of manufacturecomprising at least one resin composition comprising at least one cyclicolefin, at least one olefin metathesis catalyst, at least one substratematerial, and at least one adhesion promoter composition, where the atleast one adhesion promoter composition comprises a pre-reacted mixtureof at least one compound containing at least two isocyanate groups andat least one compound comprising at least one heteroatom-containingfunctional group and at least one metathesis active olefin.

In another embodiment, the invention provides an article of manufacturecomprising at least one resin composition comprising at least one cyclicolefin, at least one olefin metathesis catalyst, at least one substratematerial, and at least one storage stable adhesion promoter composition,where the at least one storage stable adhesion promoter compositioncomprises a pre-reacted mixture of at least one compound containing atleast two isocyanate groups and at least one compound comprising atleast one heteroatom-containing functional group and at least onemetathesis active olefin.

In another embodiment, the invention provides an article of manufacturecomprising at least one resin composition comprising at least one cyclicolefin, at least one olefin metathesis catalyst, at least one substratematerial, and at least one storage stable adhesion promoter composition,where the at least one storage stable adhesion promoter compositioncomprises a pre-reacted mixture of at least one compound containing atleast two isocyanate groups and at least one compound comprising atleast one heteroatom-containing functional group and at least onemetathesis active olefin, and wherein the at least one storage stableadhesion promoter composition is in-resin storage stable.

In another embodiment, the invention provides an article of manufacturecomprising at least one resin composition comprising at least one cyclicolefin, at least one olefin metathesis catalyst, at least one substratematerial, and at least one storage stable adhesion promoter composition,where the at least one storage stable adhesion promoter compositioncomprises a pre-reacted mixture of at least one compound containing atleast two isocyanate groups and at least one compound comprising atleast one heteroatom-containing functional group and at least onemetathesis active olefin, and wherein the at least one storage stableadhesion promoter composition possesses in-resin storage stability.

In another embodiment, the invention provides a method of making anarticle of manufacture comprising contacting at least one resincomposition with at least one olefin metathesis catalyst to form acatalyzed resin composition, contacting the catalyzed resin compositionwith a substrate material, and subjecting the catalyzed resincomposition to conditions effective to promote an olefin metathesisreaction of the catalyzed resin composition, where the at least oneresin composition comprises at least one cyclic olefin and at least oneadhesion promoter composition, where the at least one adhesion promotercomposition comprises a pre-reacted mixture of at least one compoundcontaining at least two isocyanate groups and at least one compoundcomprising at least one heteroatom-containing functional group and atleast one metathesis active olefin. In another embodiment, the inventionprovides a method of making an article of manufacture comprisingcontacting at least one resin composition with at least one olefinmetathesis catalyst to form a catalyzed resin composition, contactingthe catalyzed resin composition with a substrate material, andsubjecting the catalyzed resin composition to conditions effective topromote an olefin metathesis reaction of the catalyzed resincomposition, where the at least one resin composition comprises at leastone cyclic olefin and at least one storage stable adhesion promotercomposition, where the at least one storage stable adhesion promotercomposition comprises a pre-reacted mixture of at least one compoundcontaining at least two isocyanate groups and at least one compoundcomprising at least one heteroatom-containing functional group and atleast one metathesis active olefin.

In another embodiment, the invention provides a method of making anarticle of manufacture comprising contacting at least one resincomposition with at least one olefin metathesis catalyst to form acatalyzed resin composition, contacting the catalyzed resin compositionwith a substrate material, and subjecting the catalyzed resincomposition to conditions effective to promote an olefin metathesisreaction of the catalyzed resin composition, where the at least oneresin composition comprises at least one cyclic olefin and at least oneadhesion promoter composition, where the at least one adhesion promotercomposition comprises a pre-reacted mixture of at least one compoundcontaining at least two isocyanate groups and at least one compoundcomprising at least one heteroatom-containing functional group and atleast one metathesis active olefin, and where the at least one adhesionpromoter composition is in-resin storage stable.

In another embodiment, the invention provides a method of making anarticle of manufacture comprising contacting at least one resincomposition with at least one olefin metathesis catalyst to form acatalyzed resin composition, contacting the catalyzed resin compositionwith a substrate material, and subjecting the catalyzed resincomposition to conditions effective to promote an olefin metathesisreaction of the catalyzed resin composition, where the at least oneresin composition comprises at least one cyclic olefin and at least onestorage stable adhesion promoter composition, where the at least onestorage stable adhesion promoter composition comprises a pre-reactedmixture of at least one compound containing at least two isocyanategroups and at least one compound comprising at least oneheteroatom-containing functional group and at least one metathesisactive olefin, and where the at least one storage stable adhesionpromoter composition is in-resin storage stable.

In another embodiment, the invention provides a method of making anarticle of manufacture comprising contacting at least one resincomposition with at least one olefin metathesis catalyst to form acatalyzed resin composition, contacting the catalyzed resin compositionwith a substrate material, and subjecting the catalyzed resincomposition to conditions effective to promote an olefin metathesisreaction of the catalyzed resin composition, where the at least oneresin composition comprises at least one cyclic olefin and at least oneadhesion promoter composition, where the at least one adhesion promotercomposition comprises a pre-reacted mixture of at least one compoundcontaining at least two isocyanate groups and at least one compoundcomprising at least one heteroatom-containing functional group and atleast one metathesis active olefin, and where the at least one adhesionpromoter composition possesses in-resin storage stability.

In another embodiment, the invention provides a method of making anarticle of manufacture comprising contacting at least one resincomposition with at least one olefin metathesis catalyst to form acatalyzed resin composition, contacting the catalyzed resin compositionwith a substrate material, and subjecting the catalyzed resincomposition to conditions effective to promote an olefin metathesisreaction of the catalyzed resin composition, where the at least oneresin composition comprises at least one cyclic olefin and at least onestorage stable adhesion promoter composition, where the at least onestorage stable adhesion promoter composition comprises a pre-reactedmixture of at least one compound containing at least two isocyanategroups and at least one compound comprising at least oneheteroatom-containing functional group and at least one metathesisactive olefin, and where the at least one storage stable adhesionpromoter composition possesses in-resin storage stability.

In another embodiment, the invention provides an adhesion promotercomposition comprising at least one compound containing at least twoisocyanate groups, and at least one compound comprising at least oneheteroatom-containing functional group and at least one metathesisactive olefin.

In another embodiment, the invention provides a storage stable adhesionpromoter composition comprising at least one compound containing atleast two isocyanate groups, and at least one compound comprising atleast one heteroatom-containing functional group and at least onemetathesis active olefin.

In another embodiment, the invention provides an adhesion promotercomposition comprising at least one compound containing at least twoisocyanate groups, and at least one compound comprising at least oneheteroatom-containing functional group and at least one metathesisactive olefin, where the adhesion promoter composition possessesin-resin storage stability when added to a resin composition, where theresin composition comprises at least one cyclic olefin.

In another embodiment, the invention provides a storage stable adhesionpromoter composition comprising at least one compound containing atleast two isocyanate groups, and at least one compound comprising atleast one heteroatom-containing functional group and at least onemetathesis active olefin, where the storage stable adhesion promotercomposition possesses in-resin storage stability when added to a resincomposition, where the resin composition comprises at least one cyclicolefin.

The invention is further directed to a resin composition, for example aROMP composition, of a cyclic olefin, which may be functionalized orunfunctionalized and may be substituted or unsubstituted, an olefinmetathesis catalyst (e.g., a cyclic olefin metathesis catalyst), asubstrate material, and an adhesion promoter composition of theinvention. The inventive resin compositions are easy to handle and use,and when combined with a substrate material and cured, form resinsubstrate composite materials with improved properties. The resincompositions may also be contacted with a substrate material, ratherthan, or in addition to the substrate material added to the resincomposition, and then subjected to conditions effective to promote anolefin metathesis reaction of the cyclic olefin in the presence of theolefin metathesis catalyst, the adhesion promoter composition accordingto the invention, and the optional added substrate material and/or incontact with the substrate material.

The invention is further directed to a resin composition, for example, aROMP composition, of a cyclic olefin, which may be functionalized orunfunctionalized and may be substituted or unsubstituted, an olefinmetathesis catalyst, an adhesion promoter composition of the invention,and a substrate material, such as, for example, a glass substratematerial or a carbon substrate material. The adhesion promotercomposition of the invention should be present in an amount effective toincrease the adhesion of the resin composition to a substrate materialwhen the resin composition is subjected to metathesis catalysisconditions in the presence of the substrate material.

The adhesion promoter composition may also comprise a pre-reactedmixture of more than one compound containing at least two isocyanategroups and more than one compound comprising a heteroatom-containingfunctional group and a metathesis active olefin. Furthermore, thecompound comprising a heteroatom-containing functional group and ametathesis active olefin, may possess more than one heteroatomcontaining functional group and more than one metathesis active olefin.

The addition of the adhesion promoter composition according to theinvention provides beneficial improvements in the adhesion of an olefinmetathesis (e.g., ROMP) composition to the substrate material, such as,for example, a glass substrate material or a carbon substrate material,as compared to a resin composition that is the same with the exceptionthat the adhesion promoter composition according to the invention is notincluded.

These and other aspects of the invention will be apparent to the skilledartisan in light of the following detailed description and examples.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a ¹³C NMR (CDCl₃, 100 MHz) spectrum of the ethylene bridgeregion of HENB from an HENB and liquid MDI (Mondur® MLQ) pre-reactedmixture at time zero, immediately after mixing.

FIG. 2 is a ¹³C NMR (CDCl₃, 100 MHz) spectrum of the ethylene bridgeregion of HENB from an HENB and liquid MDI (Mondur® MLQ) pre-reactedmixture five days after mixing.

DETAILED DESCRIPTION OF THE DISCLOSURE Terminology and Definitions

Unless otherwise indicated, the invention is not limited to specificreactants, substituents, catalysts, resin compositions, reactionconditions, or the like, as such may vary. It is also to be understoodthat the terminology used herein is for the purpose of describingparticular embodiments only and is not to be interpreted as beinglimiting.

As used in the specification and the appended claims, the singular forms“a,” “an,” and “the” include plural referents unless the context clearlydictates otherwise. Thus, for example, reference to “an α-olefin”includes a single α-olefin as well as a combination or mixture of two ormore α-olefins, reference to “a substituent” encompasses a singlesubstituent as well as two or more substituents, and the like.

As used in the specification and the appended claims, the terms “forexample,” “for instance,” “such as,” or “including” are meant tointroduce examples that further clarify more general subject matter.Unless otherwise specified, these examples are provided only as an aidfor understanding the invention, and are not meant to be limiting in anyfashion.

In this specification and in the claims that follow, reference will bemade to a number of terms, which shall be defined to have the followingmeanings:

The term “alkyl” as used herein refers to a linear, branched, or cyclicsaturated hydrocarbon group typically although not necessarilycontaining 1 to about 24 carbon atoms, preferably 1 to about 12 carbonatoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl,t-butyl, octyl, decyl, and the like, as well as cycloalkyl groups suchas cyclopentyl, cyclohexyl, and the like. Generally, although again notnecessarily, alkyl groups herein contain 1 to about 12 carbon atoms. Theterm “lower alkyl” refers to an alkyl group of 1 to 6 carbon atoms, andthe specific term “cycloalkyl” refers to a cyclic alkyl group, typicallyhaving 4 to 8, preferably 5 to 7, carbon atoms. The term “substitutedalkyl” refers to alkyl substituted with one or more substituent groups,and the terms “heteroatom-containing alkyl” and “heteroalkyl” refer toalkyl in which at least one carbon atom is replaced with a heteroatom.If not otherwise indicated, the terms “alkyl” and “lower alkyl” includelinear, branched, cyclic, unsubstituted, substituted, and/orheteroatom-containing alkyl and lower alkyl, respectively.

The term “alkylene” as used herein refers to a difunctional linear,branched, or cyclic alkyl group, where “alkyl” is as defined above.

The term “alkenyl” as used herein refers to a linear, branched, orcyclic hydrocarbon group of 2 to about 24 carbon atoms containing atleast one double bond, such as ethenyl, n-propenyl, isopropenyl,n-butenyl, isobutenyl, octenyl, decenyl, tetradecenyl, hexadecenyl,eicosenyl, tetracosenyl, and the like. Preferred alkenyl groups hereincontain 2 to about 12 carbon atoms. The term “lower alkenyl” refers toan alkenyl group of 2 to 6 carbon atoms, and the specific term“cycloalkenyl” refers to a cyclic alkenyl group, preferably having 5 to8 carbon atoms. The term “substituted alkenyl” refers to alkenylsubstituted with one or more substituent groups, and the terms“heteroatom-containing alkenyl” and “heteroalkenyl” refer to alkenyl inwhich at least one carbon atom is replaced with a heteroatom. If nototherwise indicated, the terms “alkenyl” and “lower alkenyl” includelinear, branched, cyclic, unsubstituted, substituted, and/orheteroatom-containing alkenyl and lower alkenyl, respectively.

The term “alkenylene” as used herein refers to a difunctional linear,branched, or cyclic alkenyl group, where “alkenyl” is as defined above.

The term “alkynyl” as used herein refers to a linear or branchedhydrocarbon group of 2 to about 24 carbon atoms containing at least onetriple bond, such as ethynyl, n-propynyl, and the like. Preferredalkynyl groups herein contain 2 to about 12 carbon atoms. The term“lower alkynyl” refers to an alkynyl group of 2 to 6 carbon atoms. Theterm “substituted alkynyl” refers to alkynyl substituted with one ormore substituent groups, and the terms “heteroatom-containing alkynyl”and “heteroalkynyl” refer to alkynyl in which at least one carbon atomis replaced with a heteroatom. If not otherwise indicated, the terms“alkynyl” and “lower alkynyl” include linear, branched, unsubstituted,substituted, and/or heteroatom-containing alkynyl and lower alkynyl,respectively.

The term “alkoxy” as used herein refers to an alkyl group bound througha single, terminal ether linkage; that is, an “alkoxy” group may berepresented as —O-alkyl where alkyl is as defined above. A “loweralkoxy” group refers to an alkoxy group containing 1 to 6 carbon atoms.Analogously, “alkenyloxy” and “lower alkenyloxy” respectively refer toan alkenyl and lower alkenyl group bound through a single, terminalether linkage, and “alkynyloxy” and “lower alkynyloxy” respectivelyrefer to an alkynyl and lower alkynyl group bound through a single,terminal ether linkage.

The term “aryl” as used herein, and unless otherwise specified, refersto an aromatic substituent containing a single aromatic ring or multiplearomatic rings that are fused together, directly linked, or indirectlylinked (such that the different aromatic rings are bound to a commongroup such as a methylene or ethylene moiety). Preferred aryl groupscontain 5 to 24 carbon atoms, and particularly preferred aryl groupscontain 5 to 14 carbon atoms. Exemplary aryl groups contain one aromaticring or two fused or linked aromatic rings, e.g., phenyl, naphthyl,biphenyl, diphenylether, diphenylamine, benzophenone, and the like.“Substituted aryl” refers to an aryl moiety substituted with one or moresubstituent groups, and the terms “heteroatom-containing aryl” and“heteroaryl” refer to aryl substituents in which at least one carbonatom is replaced with a heteroatom, as will be described in furtherdetail infra.

The term “aryloxy” as used herein refers to an aryl group bound througha single, terminal ether linkage, wherein “aryl” is as defined above. An“aryloxy” group may be represented as —O-aryl where aryl is as definedabove. Preferred aryloxy groups contain 5 to 24 carbon atoms, andparticularly preferred aryloxy groups contain 5 to 14 carbon atoms.Examples of aryloxy groups include, without limitation, phenoxy,o-halo-phenoxy, m-halo-phenoxy, p-halo-phenoxy, o-methoxy-phenoxy,m-methoxy-phenoxy, p-methoxy-phenoxy, 2,4-dimethoxy-phenoxy,3,4,5-trimethoxy-phenoxy, and the like.

The term “alkaryl” refers to an aryl group with an alkyl substituent,and the term “aralkyl” refers to an alkyl group with an arylsubstituent, wherein “aryl” and “alkyl” are as defined above. Preferredalkaryl and aralkyl groups contain 6 to 24 carbon atoms, andparticularly preferred alkaryl and aralkyl groups contain 6 to 16 carbonatoms. Alkaryl groups include, without limitation, p-methylphenyl,2,4-dimethylphenyl, p-cyclohexylphenyl, 2,7-dimethylnaphthyl,7-cyclooctylnaphthyl, 3-ethyl-cyclopenta-1,4-diene, and the like.Examples of aralkyl groups include, without limitation, benzyl,2-phenyl-ethyl, 3-phenyl-propyl, 4-phenyl-butyl, 5-phenyl-pentyl,4-phenylcyclohexyl, 4-benzylcyclohexyl, 4-phenylcyclohexylmethyl,4-benzylcyclohexylmethyl, and the like. The terms “alkaryloxy” and“aralkyloxy” refer to substituents of the formula —OR wherein R isalkaryl or aralkyl, respectively, as just defined.

The term “acyl” refers to substituents having the formula —(CO)-alkyl,—(CO)-aryl, —(CO)-aralkyl, —(CO)-alkaryl, —(CO)-alkenyl, or—(CO)-alkynyl, and the term “acyloxy” refers to substituents having theformula —O(CO)-alkyl, —O(CO)-aryl, —O(CO)-aralkyl, —O(CO)— alkaryl,—O(CO)-alkenyl, —O(CO)-alkynyl wherein “alkyl,” “aryl,” “aralkyl”,alkaryl, alkenyl, and alkynyl are as defined above.

The terms “cyclic” and “ring” refer to alicyclic or aromatic groups thatmay or may not be substituted and/or heteroatom containing, and that maybe monocyclic, bicyclic, or polycyclic. The term “alicyclic” is used inthe conventional sense to refer to an aliphatic cyclic moiety, asopposed to an aromatic cyclic moiety, and may be monocyclic, bicyclic,or polycyclic.

The terms “halo” and “halogen” are used in the conventional sense torefer to a chloro, bromo, fluoro, or iodo substituent.

“Hydrocarbyl” refers to univalent hydrocarbyl radicals containing 1 toabout 30 carbon atoms, preferably 1 to about 24 carbon atoms, mostpreferably 1 to about 12 carbon atoms, including linear, branched,cyclic, saturated, and unsaturated species, such as alkyl groups,alkenyl groups, alkynyl groups, aryl groups, and the like. The term“lower hydrocarbyl” intends a hydrocarbyl group of 1 to 6 carbon atoms,preferably 1 to 4 carbon atoms, and the term “hydrocarbylene” refers toa divalent hydrocarbyl moiety containing 1 to about 30 carbon atoms,preferably 1 to about 24 carbon atoms, most preferably 1 to about 12carbon atoms, including linear, branched, cyclic, saturated, andunsaturated species. The term “lower hydrocarbylene” refers to ahydrocarbylene group of 1 to 6 carbon atoms. “Substituted hydrocarbyl”refers to hydrocarbyl substituted with one or more substituent groups,and the terms “heteroatom-containing hydrocarbyl” and“heterohydrocarbyl” refer to hydrocarbyl in which at least one carbonatom is replaced with a heteroatom. Similarly, “substitutedhydrocarbylene” refers to hydrocarbylene substituted with one or moresubstituent groups, and the terms “heteroatom-containing hydrocarbylene”and “heterohydrocarbylene” refer to hydrocarbylene in which at least onecarbon atom is replaced with a heteroatom. Unless otherwise indicated,the term “hydrocarbyl” and “hydrocarbylene” are to be interpreted asincluding substituted and/or heteroatom-containing hydrocarbyl andheteroatom-containing hydrocarbylene moieties, respectively.

The term “heteroatom-containing” as in a “heteroatom-containinghydrocarbyl group” refers to a hydrocarbon molecule or a hydrocarbylmolecular fragment in which one or more carbon atoms is replaced with anatom other than carbon, e.g., nitrogen, oxygen, sulfur, phosphorus, orsilicon, typically nitrogen, oxygen, or sulfur. Similarly, the term“heteroalkyl” refers to an alkyl substituent that isheteroatom-containing, the term “heterocyclic” refers to a cyclicsubstituent that is heteroatom-containing, the terms “heteroaryl” and“heteroaromatic” respectively refer to “aryl” and “aromatic”substituents that are heteroatom-containing, and the like. It should benoted that a “heterocyclic” group or compound may or may not bearomatic, and further that “heterocycles” may be monocyclic, bicyclic,or polycyclic as described above with respect to the term “aryl.”Examples of heteroalkyl groups include without limitation alkoxyaryl,alkylsulfanyl-substituted alkyl, N-alkylated amino alkyl, and the like.Examples of heteroaryl substituents include without limitation pyrrolyl,pyrrolidinyl, pyridinyl, quinolinyl, indolyl, pyrimidinyl, imidazolyl,1,2,4-triazolyl, tetrazolyl, etc., and examples of heteroatom-containingalicyclic groups include without limitation pyrrolidino, morpholino,piperazino, piperidino, etc.

By “substituted” as in “substituted hydrocarbyl,” “substituted alkyl,”“substituted aryl,” and the like, as alluded to in some of theaforementioned definitions, is meant that in the hydrocarbyl, alkyl,aryl, or other moiety, at least one hydrogen atom bound to a carbon (orother) atom is replaced with one or more non-hydrogen substituents.Examples of such substituents include, without limitation: functionalgroups referred to herein as “Fn,” such as halo, hydroxyl, sulfhydryl,C₁-C₂₄ alkoxy, C₂-C₂₄ alkenyloxy, C₂-C₂₄ alkynyloxy, C₅-C₂₄ aryloxy,C₆-C₂₄ aralkyloxy, C₆-C₂₄ alkaryloxy, acyl (including C₂-C₂₄alkylcarbonyl (—CO-alkyl) and C₆-C₂₄ arylcarbonyl (—CO-aryl)), acyloxy(—O-acyl, including C₂-C₂₄ alkylcarbonyloxy (—O—CO-alkyl) and C₆-C₂₄arylcarbonyloxy (—O—CO-aryl)), C₂-C₂₄ alkoxycarbonyl (—(CO)—O-alkyl),C₆-C₂₄ aryloxycarbonyl (—(CO)—O-aryl), halocarbonyl (—CO)—X where X ishalo), C₂-C₂₄ alkylcarbonato (—O—(CO)—O-alkyl), C₆-C₂₄ arylcarbonato(—O—(CO)—O-aryl), carboxy (—COOH), carboxylato (—COO⁻), carbamoyl(—(CO)—NH₂), mono-(C₁-C₂₄ alkyl)-substituted carbamoyl (—(CO)—NH(C₁-C₂₄alkyl)), di-(C₁-C₂₄ alkyl)-substituted carbamoyl (—(CO)—N(C₁-C₂₄alkyl)₂), mono-(C₁-C₂₄ haloalkyl)-substituted carbamoyl (—(CO)—NH(C₁-C₂₄haloalkyl)), di-(C₁-C₂₄ haloalkyl)-substituted carbamoyl (—(CO)—N(C₁-C₂₄haloalkyl)₂), mono-(C₅-C₂₄ aryl)-substituted carbamoyl (—(CO)—NH-aryl),di-(C₅-C₂₄ aryl)-substituted carbamoyl (—(CO)—N(C₅-C₂₄ aryl)₂),di-N—(C₁-C₂₄ alkyl), N—(C₅-C₂₄ aryl)-substituted carbamoyl(—(CO)—N(C₁-C₂₄ alkyl)(C₅-C₂₄ aryl), thiocarbamoyl (—(CS)—NH₂),mono-(C₁-C₂₄ alkyl)-substituted thiocarbamoyl (—(CS)—NH(C₁-C₂₄ alkyl)),di-(C₁-C₂₄ alkyl)-substituted thiocarbamoyl (—(CS)—N(C₁-C₂₄ alkyl)₂),mono-(C₅-C₂₄ aryl)-substituted thiocarbamoyl (—(CS)—NH-aryl), di-(C₅-C₂₄aryl)-substituted thiocarbamoyl (—(CS)—N(C₅-C₂₄ aryl)₂), di-N—(C₁-C₂₄alkyl), N—(C₅-C₂₄ aryl)-substituted thiocarbamoyl (—(CS)—N(C₁-C₂₄alkyl)(C₅-C₂₄ aryl), carbamido (—NH—(CO)—NH₂), cyano (—C≡N), cyanato(—O—C≡N), thiocyanato (—S—C≡N), isocyanate (—N═C═O), thioisocyanate(—N═C═S), formyl (—(CO)—H), thioformyl (—(CS)—H), amino (—NH₂),mono-(C₁-C₂₄ alkyl)-substituted amino (—NH(C₁-C₂₄ alkyl), di-(C₁-C₂₄alkyl)-substituted amino (—N(C₁-C₂₄ alkyl)₂), mono-(C₅-C₂₄aryl)-substituted amino (—NH(C₅-C₂₄ aryl), di-(C₅-C₂₄ aryl)-substitutedamino (—N(C₅-C₂₄ aryl)₂), C₂-C₂₄ alkylamido (—NH—(CO)-alkyl), C₆-C₂₄arylamido (—NH—(CO)-aryl), imino (—CR═NH where R includes withoutlimitation hydrogen, C₁-C₂₄ alkyl, C₅-C₂₄ aryl, C₆-C₂₄ alkaryl, C₆-C₂₄aralkyl, etc.), C₂-C₂₀ alkylimino (—CR═N(alkyl), where R includeswithout limitation hydrogen, C₁-C₂₄ alkyl, C₅-C₂₄ aryl, C₆-C₂₄ alkaryl,C₆-C₂₄ aralkyl, etc.), arylimino (—CR═N(aryl), where R includes withoutlimitation hydrogen, C₁-C₂₀ alkyl, C₅-C₂₄ aryl, C₆-C₂₄ alkaryl, C₆-C₂₄aralkyl, etc.), nitro (—NO₂), nitroso (—NO), sulfo (—SO₂—OH), sulfonato(—SO₂—O⁻), C₁-C₂₄ alkylsulfanyl (—S-alkyl; also termed “alkylthio”),C₅-C₂₄ arylsulfanyl (—S-aryl; also termed “arylthio”), C₁-C₂₄alkylsulfinyl (—(SO)-alkyl), C₅-C₂₄ arylsulfinyl (—(SO)-aryl), C₁-C₂₄alkylsulfonyl (—SO₂-alkyl), C₁-C₂₄ monoalkylaminosulfonyl (—SO₂—N(H)alkyl), C₁-C₂₄ dialkylaminosulfonyl (—SO₂—N(alkyl)₂), C₅-C₂₄arylsulfonyl (—SO₂-aryl), boryl (—BH₂), borono (—B(OH)₂), boronato(—B(OR)₂ where R includes without limitation alkyl or otherhydrocarbyl), phosphono (—P(O)(OH)₂), phosphonato (—P(O)(O⁻)₂),phosphinato (—P(O)(O⁻), phospho (—PO₂), and phosphino (—PH₂); and thehydrocarbyl moieties C₁-C₂₄ alkyl (preferably C₁-C₁₂ alkyl, morepreferably C₁-C₆ alkyl), C₂-C₂₄ alkenyl (preferably C₂-C₁₂ alkenyl, morepreferably C₂-C₆ alkenyl), C₂-C₂₄ alkynyl (preferably C₂-C₁₂ alkynyl,more preferably C₂-C₆ alkynyl), C₅-C₂₄ aryl (preferably C₅-C₁₄ aryl),C₆-C₂₄ alkaryl (preferably C₆-C₁₆ alkaryl), and C₆-C₂₄ aralkyl(preferably C₆-C₁₆ aralkyl).

By “functionalized” as in “functionalized hydrocarbyl,” “functionalizedalkyl,” “functionalized olefin,” “functionalized cyclic olefin,” and thelike, is meant that in the hydrocarbyl, alkyl, olefin, cyclic olefin, orother moiety, at least one hydrogen atom bound to a carbon (or other)atom is replaced with one or more functional groups such as thosedescribed hereinabove. The term “functional group” is meant to includeany functional species that is suitable for the uses described herein.In particular, as used herein, a functional group would necessarilypossess the ability to react with or bond to corresponding functionalgroups on a substrate surface.

In addition, the aforementioned functional groups may, if a particulargroup permits, be further substituted with one or more additionalfunctional groups or with one or more hydrocarbyl moieties such as thosespecifically mentioned above. Analogously, the abovementionedhydrocarbyl moieties may be further substituted with one or morefunctional groups or additional hydrocarbyl moieties as noted above.

“Optional” or “optionally” means that the subsequently describedcircumstance may or may not occur, so that the description includesinstances where the circumstance occurs and instances where it does not.For example, the phrase “optionally substituted” means that anon-hydrogen substituent may or may not be present on a given atom, and,thus, the description includes structures wherein a non-hydrogensubstituent is present and structures wherein a non-hydrogen substituentis not present.

The term “substrate material” as used herein, is intended to generallymean any material that the resin compositions of the invention may becontacted with, applied to, or have the substrate material incorporatedin to the resin. Without limitation, such materials include reinforcingmaterials, such as filaments, fibers, rovings, mats, weaves, fabrics,knitted material, cloth or other known structures, glass fibers andfabrics, carbon fibers and fabrics, aramid fibers and fabrics, andpolyolefin or other polymer fibers or fabrics. Other suitable substratematerials include metallic density modulators, microparticulate densitymodulators, such as microspheres, and macroparticulate densitymodulators, such as glass or ceramic beads.

As used herein, the term “storage stable” means, by way of example, thatan adhesion promoter composition will exhibit little or no changes incolor, little or no changes in viscosity, little or no gel formation,and/or little or no loss of activity for at least 150 days, preferablyfor at least 90 days, and more preferably for at least 30 days, whenstored in a sealed container under a dry, inert atmosphere (e.g., underargon or nitrogen) at normal storage, shipping, and use temperatures,which by way of example may vary from as low as −10° C. to as high as60° C., preferably from 5° C. to 50° C., and more preferably from 15° C.to 40° C.

By way of example, the storage stability of adhesion promotercompositions may be measured by contacting an adhesion promotercomposition with a resin composition comprising at least one cyclicolefin, using the resin composition to prepare polymer-matrixcomposites, and measuring the ILSS of the polymer-matrix composites.Adhesion promoter compositions which are storage stable will exhibitlittle or no decrease (loss) in measured ILSS values over some specifiedtime period. Adhesion promoter compositions which are storage stable forat least 156 days have been prepared as shown herein by the measuredILSS values of polymer-matrix composites of Examples 32a-33a (Table 12).

As used herein, the term “dry” means a substantial absence of water, byway of example the water concentration may vary from 0 ppm to 70 ppm,from 5 ppm to 40 ppm, and from 10 ppm to 35 ppm.

As used herein, the term “in-resin storage stability” or “in-resinstorage stable” means that an adhesion promoter composition, whencontacted with or added to or combined with a resin compositioncomprising at least one cyclic olefin, exhibits little or no loss ofactivity for at least 150 days, preferably for at least 90 days, morepreferably for at least 30 days, when the resin composition is stored ina sealed container under a dry, inert atmosphere (e.g., under argon ornitrogen) at normal storage, shipping, and use temperatures, which byway of example may vary from as low as −10° C. to as high as 60° C.,preferably from 5° C. to 50° C., and more preferably from 15° C. to 40°C.

By way of example, the in-resin storage stability of adhesion promotercompositions may be measured by preparing polymer-matrix compositesusing a resin composition comprising at least one cyclic olefin and atleast one adhesion promoter composition, and measuring the ILSS of thepolymer-matrix composites. Adhesion promoter compositions havingin-resin storage stability will exhibit little or no decrease (loss) inmeasured ILSS values over some specified time period. Adhesion promotercompositions having in-resin storage stability for at least 326 dayshave been prepared as shown herein by the as measured ILSS values ofpolymer-matrix composites of Examples 7a-7f (Table 3). Additionally,adhesion promoter compositions having in-resin storage stability for atleast 202 days have been prepared as shown herein in by the as measuredILSS values of polymer-matrix composites of Examples 8a-8d (Table 4).

Adhesion Promoter

Adhesion promoters that may be used in the present invention disclosedherein are generally compounds containing at least two isocyanate groupssuch as, for example, methylene diphenyl diisocyanate and hexamethylenediisocyanate. The adhesion promoter may be a diisocyanate,triisocyanate, or polyisocyanate (i.e., containing four or moreisocyanate groups). The adhesion promoter may be a mixture of at leastone diisocyanate, triisocyanate, or polyisocyanate. In a more particularaspect of the invention, the adhesion promoter comprises, or is limitedto, a diisocyanate compound, or mixtures of diisocyanate compounds.

In general, adhesion promoters that may be used in the present inventionmay be any compound having at least two isocyanate groups. Suitableadhesion promoters include, without limitation, isocyanate compoundscomprising at least two isocyanate groups, and wherein the compounds areselected from hydrocarbyl, substituted hydrocarbyl,heteroatom-containing hydrocarbyl, substituted heteroatom-containinghydrocarbyl, and functionalized hydrocarbyl compounds. As describedabove, suitable hydrocarbyl adhesion promoter compounds generallyinclude alkyl, cycloalkyl, alkylene, alkenyl, alkynyl, aryl, cycloalkyl,alkyaryl, and aralkyl compounds. Substituted heteroatom-containing, andfunctionalized hydrocarbyl adhesion promoter compounds include theafore-mentioned hydrocarbyl compounds, as well as the variations thereofnoted hereinabove.

Adhesion promoters that may be used in the present invention may be analkyl diisocyanate. An alkyl diisocyanate refers to a linear, branched,or cyclic saturated or unsaturated hydrocarbon group typically althoughnot necessarily containing 1 to about 24 carbon atoms, preferably adiisocyanate containing 2 to about 12 carbon atoms, and more preferablya diisocyanate containing 6 to 12 carbon atoms such as hexamethylenediisocyanate (HDI), octamethylene diisocyanate, decamethylenediisocyanate, and the like. Cycloalkyl diisocyanates contain cyclicalkyl group, typically having 4 to 16 carbon atoms. A preferredcycloalkyl diisocyanate containing 6 to about 12 carbon atoms arecyclohexyl, cyclooctyl, cyclodecyl, and the like. A more preferredcycloalkyl diisocyanate originates as a condensation product of acetonecalled 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-cyclohexane,commonly known as Isophorone diisocyanate (IPDI) and the isomers ofisocyanato-[(isocyanatocyclohexyl)methyl]cyclohexane (H₁₂MDI). H₁₂MDI isderived from the hydrogenated form of the aryl diisocyanate methylenediphenyl diisocyanate (MDI).

Adhesion promoters that may be used in the present invention may also bean aryl diisocyanate. Aryl diisocyanates refers to aromaticdiisocyanates containing a single aromatic ring or multiple aromaticrings that are fused together, directly linked, or indirectly linked(such that the different aromatic rings are bound to a common group suchas a methylene or ethylene moiety). Preferred aryl diisocyanates contain5 to 24 carbon atoms, and particularly preferred aryl diisocyanatescontain 5 to 14 carbon atoms. Exemplary aryl diisocyanates contain onearomatic ring or two fused or linked aromatic rings, e.g., phenyl,tolyl, xylyl, napthyl, biphenyl, diphenylether, benzophenone, and thelike. Preferred aromatic diisocyanates include toluene diisocyanates,xylene diisocyanate, xylylene diisocyanate, tetramethylxylylenediisocyanate (TMXDI), and methylene diphenyl diisocyanate (MDI), whichmay comprise any mixture of its three isomers, 2.2′-MDI, 2,4′-MDI, and4,4′-MDI.

Adhesion promoters that may be used in the present invention may be apolymer-containing isocyanate, such as, for example, diisocyanates.Polymer-containing isocyanates refers to a polymer-containing two ormore terminal and/or pendant alkyl or aryl isocyanate groups. Thepolymer-containing isocyanates generally have to have a minimalsolubility in the resin to provide improved mechanical properties.Preferred polymer-containing isocyanates include, but are not limitedto, PM200 (poly MDI), Lupranate® (poly MDI from BASF), Krasol®isocyanate terminated polybutadiene prepolymers, such as, for example,Krasol® LBD2000 (TDI based), Krasol® LBD3000 (TDI based), Krasol® NN-22(MDI based), Krasol® NN-23 (MDI based), Krasol® NN-25 (MDI based), andthe like. Krasol® isocyanate terminated polybutadiene prepolymers areavailable from Cray Valley.

Adhesion promoters that may be used in the present invention may be atrimer of alkyl diisocyanates and aryl diisocyanates. In its simplestform, any combination of polyisocyanate compounds may be trimerized toform an isocyanurate ring containing isocyanate functional groups.Trimers of alkyl diisocyanate and aryl diisocyanates may also bereferred to as isocyanurates of alkyl diisocyanate or aryl diisocyanate.Preferred alkyl diisocyanate and aryl diisocyanate trimers include, butare not limited to, hexamethylene diisocyanate trimer (HDIt), isophoronediisocyanate trimer, toluene diisocyanate trimer, tetramethylxylenediisocyanate trimer, methylene diphenyl diisocyanate trimers, and thelike. More preferred adhesion promoters are toluene diisocyanates,tetramethylxylylene diisocyanate (e.g., TMXDI® diisocyanate from CytecIndustries Inc.), and methylene diphenyl diisocyanate (MDI) includingany mixture of its three isomers 2.2′-MDI, 2,4′-MDI and 4,4′-MDI; liquidMDI; solid MDI; hexamethylenediisocyanatetrimer (HDIt);hexamethylenediisocyanate (HDI); isophorone diisocyanate (IPDI);4,4′-methylene bis(cyclohexyl isocyanate) (H₁₂MDI); polymeric MDI(PM200); MDI prepolymer (Lupranate® 5080); liquid carbodiimide modified4,4′-MDI (Lupranate® MM103); liquid MDI (Lupranate® MI); liquid MDI(Mondur® ML); and liquid MDI (Mondur® MLQ). Even more preferred adhesionpromoters are methylene diphenyl diisocyanate (MDI) including anymixture of its three isomers 2,2′-MDI, 2,4′-MDI and 4,4′-MDI; liquidMDI; solid MDI; hexamethylenediisocyanatetrimer (HDIt); hexamethylenediisocyanate (HDI); isophorone diisocyanate (IPDI); 4,4′-methylenebis(cyclohexyl isocyanate) (H₁₂MDI); polymeric MDI (PM200); MDIprepolymer (Lupranate® 5080); liquid carbodiimide modified 4,4′-MDI(Lupranate® MM103); liquid MDI) (Lupranate® MI); liquid MDI (Mondur®ML); liquid MDI (Mondur® MLQ).

A compound containing at least two isocyanate groups is combined with acompound comprising a heteroatom-containing functional group and ametathesis active olefin and pre-reacted providing an adhesion promotercomposition having in-resin storage stability and providing an olefinmetathesis composite with improved mechanical properties. Anyconcentration of a compound containing at least two isocyanate groups issufficient for use in preparing adhesion promoter compositions of theinvention, where the mol % or mol equivalents of a compound containingat least two isocyanate groups used to form the pre-reacted mixture isgreater than the mol % or mol equivalents of a compound comprising aheteroatom-containing functional group and a metathesis active olefinused to form the pre-reacted mixture. Mol ratios of a compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin relative to a compound containing at least two isocyanategroups range from 0.001:1 to 0.90:1. Preferred mol ratios of a compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin relative to a compound containing at least two isocyanategroups range from 0.01:1 to 0.75:1, particularly 0.01:1 to 0.5:1, moreparticularly 0.02:1 to 0.25:1. One skilled in the art will recognizethat the optimal ratio of a compound comprising a heteroatom-containingfunctional group and a metathesis active olefin to a compound containingat least two isocyanate groups may need to be adjusted as a function ofthe amount of adhesion promoter composition added to the cyclic olefinresin composition.

Compounds Comprising a Heteroatom-Containing Functional Group and aMetathesis Active Olefin

The compound comprising a heteroatom-containing functional group and ametathesis active olefin typically contains between 2 and 20 carbonswith hydroxyl, amine, thiol, phosphorus, or silane functional groups.Compounds comprising a heteroatom-containing functional group and ametathesis active olefin that may be used in the present inventiondisclosed herein are generally compounds containing at least oneheteroatom containing functional group and at least one metathesisactive olefin and are of the following general structure:

(O^(M))-(Q*)_(n)-(X*)—H

wherein O^(M), Q*, and X* are as follows:

O^(M) is a metathesis active olefin fragment selected from cyclicolefins and acyclic olefins, where the carbon-carbon double bondtypically is not tetra-substituted (e.g., at least one substituent is ahydrogen);

Q* is an optional linker group (e.g., n=0 or 1) such as, for example, ahydrocarbylene (including, for example, substituted hydrocarbylene,heteroatom-containing hydrocarbylene, and substitutedheteroatom-containing hydrocarbylene, such as substituted and/orheteroatom-containing alkylene) or —(CO)— group; and

X* is oxygen, sulfur, or a heteroatom-containing fragment such asN(R^(X)), P(R^(X)), OP(R^(X)), OP(R^(X))O, OP(OR^(X))O, P(═O)(R^(X)),OP(═O)(R^(X)), OP(═O)(R^(X))O, OP(═O)(OR^(X))O, Si(R^(X))₂, Si(R^(X))₂O,Si(OR^(X))₂O, or Si(R^(X))(OR^(X))O,

wherein each R^(X) is, independent of one another, a hydrogen or ahydrocarbyl group optionally comprising further functional groups. EachR^(X) is, independent of one another, most commonly a hydrogen, aryl, orlower alkyl group.

Metathesis active olefins include cyclic olefins as described herein,where such cyclic olefins may be optionally substituted, optionallyheteroatom-containing, mono-unsaturated, di-unsaturated, orpoly-unsaturated C₅ to C₂₄ hydrocarbons that may be mono-, di-, orpoly-cyclic. The cyclic olefin may generally be any strained orunstrained cyclic olefin, provided the cyclic olefin is able toparticipate in a ROMP reaction either individually or as part of a ROMPcyclic olefin composition. Metathesis active olefins also includeacyclic olefins, where such acyclic olefins may be optionallysubstituted, optionally heteroatom-containing, mono-unsaturated,di-unsaturated, or poly-unsaturated C₂ to C₃₀ hydrocarbons, typically C₂to C₂₀ hydrocarbons, or more typically C₂ to C₁₂ hydrocarbons. Acyclicolefins may contain one or more terminal olefins and/or one or moreinternal olefins, and/or any combination of terminal olefins and/orinternal olefins.

In the heteroatom-containing functional group, X* is commonly oxygen,sulfur, or NR^(X) and is most commonly oxygen, i.e., ahydroxy-substituted olefin. Preferred compounds comprising aheteroatom-containing functional group and a metathesis active olefininclude, but are not limited to, 5-norbornene-2-methanol (NB-MeOH);2-hydroxyethyl bicycle[2.2.1]hept-2-ene-carboxylate (HENB);2-hydroxyethyl acrylate (HEA); allyl alcohol; oleyl alcohol;9-decen-1-ol; vinyl alcohol, allyl alcohol, cis-13-dodecenol, andtrans-9-octadecenol, and other unsaturated alcohols, norbornyl alcohol,2-cycloocten-1-ol, 2-cyclooctadiene-1-ol, and p-vinyl phenol, and otheralcohols which have an alicyclic structure; 2-hydroxyethyl methacrylate;2-hydroxy-3-acryloxypropyl methacrylate, ethoxylated hydroxyethylacrylate, ethoxylated hydroxyethyl methacrylate, polypropyleneglycolmonomethacrylate, polypropylene glycol monoacrylate, phenol acrylate,phenol methacrylate, bisphenol A type epoxy acrylate, novolac type epoxyacrylate, and brominated bisphenol A type epoxy acrylate, and othermethacrylics or acrylics which have one or more methacryl or acrylgroups and hydroxyl groups, etc.

The compound comprising a heteroatom-containing functional group and ametathesis active olefin is combined with a compound containing at leasttwo isocyanate groups and pre-reacted providing an adhesion promotercomposition having in-resin storage stability and providing an olefinmetathesis composite with improved mechanical properties. Anyconcentration of a compound comprising a heteroatom-containingfunctional group and a metathesis active olefin is sufficient for use inpreparing adhesion promoter compositions of the invention, where the mol% or mol equivalents of a compound comprising a heteroatom-containingfunctional group and a metathesis active olefin used to form thepre-reacted mixture is less than the mol % or mol equivalents of acompound containing at least two isocyanate groups used to form thepre-reacted mixture. Mol ratios of a compound comprising aheteroatom-containing functional group and a metathesis active olefinrelative to a compound containing at least two isocyanate groups rangefrom 0.001:1 to 0.90:1. Preferred mol ratios of a compound comprising aheteroatom-containing functional group and a metathesis active olefinrelative to a compound containing at least two isocyanate groups rangefrom 0.01:1 to 0.75:1, particularly 0.01:1 to 0.5:1, more particularly0.02:1 to 0.25:1. One skilled in the art will recognize that the optimalratio of a compound comprising a heteroatom-containing functional groupand a metathesis active olefin to a compound containing at least twoisocyanate groups may need to be adjusted as a function of the amount ofadhesion promoter composition added to the cyclic olefin resincomposition.

Adhesion Promoter Compositions

Adhesion promoter compositions that may be used in the present inventiondisclosed herein are generally compositions comprising at least oneadhesion promoter, discussed supra (i.e., at least one compoundcontaining at least two isocyanate groups (e.g., methylene diphenyldiisocyanate, hexamethylene diisocyanate)) and at least one compoundcomprising a heteroatom-containing functional group and a metathesisactive olefin, discussed supra (e.g., 2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate (HENB), 2-hydroxyethyl acrylate(HEA), oleyl alcohol, 9-decen-1-ol), where the compounds may be combinedin various ratios to form a pre-reacted mixture, wherein the pre-reactedmixture is then subsequently added to a cyclic olefin resin composition,and where the adhesion promoter composition possesses in-resin storagestability. Furthermore, adhesion promoter compositions of the inventionmay also be storage stable.

Compounds containing at least two isocyanate groups and compoundscomprising a heteroatom-containing functional group and a metathesisactive olefin useful for preparing adhesion promoter compositions of theinvention are disclosed herein.

Preferred adhesion promoter compositions include pre-reacted mixtures ofliquid MDI (Mondur® MLQ) and 2-hydroxyethylbicycle[2.2.1]hept-2-ene-carboxylate (HENB); pre-reacted mixtures ofliquid MDI (Mondur® MLQ) and 2-hydroxyethyl acrylate (HEA); pre-reactedmixtures of liquid MDI (Mondur® MLQ) and oleyl alcohol; and pre-reactedmixtures of liquid MDI (Mondur® MLQ) and 9-decen-1-ol.

More preferred adhesion promoter compositions include prereactedmixtures of liquid MDI (Mondur® MLQ) and 2-hydroxyethylbicycle[2.2.1]hept-2-ene-carboxylate (HENB).

Any concentration of adhesion promoter composition which improves themechanical properties of the olefin composite is sufficient for theinvention. In general, suitable amounts of adhesion promoter compositionrange from 0.001-50 phr, particularly 0.05-10 phr, more particularly0.1-10 phr, or even more particularly, 0.5-4.0 phr.

Substrate Surfaces

The present invention is generally suitable for use with any substratematerial in which the addition of an adhesion promoter composition ofthe invention provides beneficial improvements in the adhesion of aresin (e.g., ROMP) composition to the substrate material as compared toa resin composition that is the same with the exception that theadhesion promoter composition of the invention is not included.Furthermore, the present invention is generally suitable for use withany substrate material in which the addition of an adhesion promotercomposition of the invention provides beneficial improvements in theadhesion of a polymer-matrix (e.g., ROMP polymer-matrix) to a substratematerial compared to a polymer-matrix that is the same with theexception that the adhesion promoter composition of the invention is notincluded. The present invention is particularly beneficial for use withglass and carbon material surfaces suitable for use with epoxy andmethacrylate resins, including those containing finishes or sizings, inwhich case the finishes or sizings do not need to be removed (e.g., bywashing or heat cleaning) for the inventive adhesion promotercompositions to be effective. The present invention is also suitable foruse with wood and aluminum materials. Suitable substrate materials mayalso be selected from fibrous, woven, microparticulate, ceramic, metal,polymer, and semiconductor materials. A polymer-matrix composite (e.g.,ROMP polymer matrix composite) may be comprised of one substratematerial or a mixture of different substrate materials.

Cyclic Olefin

Resin compositions that may be used with the present invention disclosedherein comprise one or more cyclic olefins. In general, any cyclicolefin suitable for the metathesis reactions disclosed herein may beused. Such cyclic olefins may be optionally substituted, optionallyheteroatom-containing, mono-unsaturated, di-unsaturated, orpoly-unsaturated C₅ to C₂₄ hydrocarbons that may be mono-, di-, orpoly-cyclic. The cyclic olefin may generally be any strained orunstrained cyclic olefin, provided the cyclic olefin is able toparticipate in a ROMP reaction either individually or as part of a ROMPcyclic olefin composition. While certain unstrained cyclic olefins suchas cyclohexene are generally understood to not undergo ROMP reactions bythemselves, under appropriate circumstances, such unstrained cyclicolefins may nonetheless be ROMP active. For example, when present as aco-monomer in a ROMP composition, unstrained cyclic olefins may be ROMPactive. Accordingly, as used herein and as would be appreciated by theskilled artisan, the term “unstrained cyclic olefin” is intended torefer to those unstrained cyclic olefins that may undergo a ROMPreaction under any conditions, or in any ROMP composition, provided theunstrained cyclic olefin is ROMP active.

In general, the cyclic olefin may be represented by the structure offormula (A)

wherein J, R^(A1), and R^(A2) are as follows:

R^(A1) and R^(A2) is selected independently from the group consisting ofhydrogen, hydrocarbyl (e.g., C₁-C₂₀ alkyl, C₅-C₂₀ aryl, C₅-C₃₀ aralkyl,or C₅-C₃₀ alkaryl), substituted hydrocarbyl (e.g., substituted C₁-C₂₀alkyl, C₅-C₂₀ aryl, C₅-C₃₀ aralkyl, or C₅-C₃₀ alkaryl),heteroatom-containing hydrocarbyl (e.g., C₁-C₂₀ heteroalkyl, C₅-C₂₀heteroaryl, heteroatom-containing C₅-C₃₀ aralkyl, orheteroatom-containing C₅-C₃₀ alkaryl), and substitutedheteroatom-containing hydrocarbyl (e.g., substituted C₁-C₂₀ heteroalkyl,C₅-C₂₀ heteroaryl, heteroatom-containing C₅-C₃₀ aralkyl, orheteroatom-containing C₅-C₃₀ alkaryl) and, if substituted hydrocarbyl orsubstituted heteroatom-containing hydrocarbyl, wherein the substituentsmay be functional groups (“Fn”) such as phosphonato, phosphoryl,phosphanyl, phosphino, sulfonato, C₁-C₂₀ alkylsulfanyl, C₅-C₂₀arylsulfanyl, C₁-C₂₀ alkylsulfonyl, C₅-C₂₀ arylsulfonyl, C₁-C₂₀alkylsulfinyl, C₅-C₂₀ arylsulfinyl, sulfonamido, amino, amido, imino,nitro, nitroso, hydroxyl, C₁-C₂₀ alkoxy, C₅-C₂₀ aryloxy, C₂-C₂₀alkoxycarbonyl, C₅-C₂₀ aryloxycarbonyl, carboxyl, carboxylato, mercapto,formyl, C₁-C₂₀ thioester, cyano, cyanato, thiocyanato, isocyanate,thioisocyanate, carbamoyl, epoxy, styrenyl, silyl, silyloxy, silanyl,siloxazanyl, boronato, boryl, or halogen, or a metal-containing ormetalloid-containing group (wherein the metal may be, for example, Sn orGe). R^(A1) and R^(A2) may itself be one of the aforementioned groups,such that the Fn moiety is directly bound to the olefinic carbon atomindicated in the structure. In the latter case, however, the functionalgroup will generally not be directly bound to the olefinic carbonthrough a heteroatom containing one or more lone pairs of electrons,e.g., an oxygen, sulfur, nitrogen, or phosphorus atom, or through anelectron-rich metal or metalloid such as Ge, Sn, As, Sb, Se, Te, etc.With such functional groups, there will normally be an interveninglinkage Z*, such that R^(A1) and/or R^(A2) then has the structure—(Z*)_(n)-Fn wherein n is 1, Fn is the functional group, and Z* is ahydrocarbylene linking group such as an alkylene, substituted alkylene,heteroalkylene, substituted heteroalkene, arylene, substituted arylene,heteroarylene, or substituted heteroarylene linkage.

J is a saturated or unsaturated hydrocarbylene, substitutedhydrocarbylene, heteroatom-containing hydrocarbylene, or substitutedheteroatom-containing hydrocarbylene linkage, wherein when J issubstituted hydrocarbylene or substituted heteroatom-containinghydrocarbylene, the substituents may include one or more —(Z*)_(n)-Fngroups, wherein n is zero or 1, and Fn and Z* are as defined previously.Additionally, two or more substituents attached to ring carbon (orother) atoms within J may be linked to form a bicyclic or polycyclicolefin. J will generally contain in the range of approximately 5 to 14ring atoms, typically 5 to 8 ring atoms, for a monocyclic olefin, and,for bicyclic and polycyclic olefins, each ring will generally contain 4to 8, typically 5 to 7, ring atoms.

Mono-unsaturated cyclic olefins encompassed by structure (A) may berepresented by the structure (B)

wherein b is an integer generally although not necessarily in the rangeof 1 to 10, typically 1 to 5, R^(A1) and R^(A2) are as defined above forstructure (A), and R^(B1), R^(B2), R^(B3), R^(B4), R^(B5), and R^(B6)are independently selected from the group consisting of hydrogen,hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl,substituted heteroatom-containing hydrocarbyl and —(Z*)_(n)-Fn where n,Z* and Fn are as defined previously, and wherein if any of the R^(B1)through R^(B6) moieties is substituted hydrocarbyl or substitutedheteroatom-containing hydrocarbyl, the substituents may include one ormore —(Z*)_(n)-Fn groups. Accordingly, R^(B1), R^(B2), R^(B3), R^(B4),R^(B5), and R^(B6) may be, for example, hydrogen, hydroxyl, C₁-C₂₀alkyl, C₅-C₂₀ aryl, C₁-C₂₀ alkoxy, C₅-C₂₀ aryloxy, C₂-C₂₀alkoxycarbonyl, C₅-C₂₀ aryloxycarbonyl, amino, amido, nitro, etc.Furthermore, any of the R^(B1), R^(B2), R^(B3), R^(B4), R^(B5), andR^(B6) moieties can be linked to any of the other R^(B1), R^(B2),R^(B3), R^(B4), R^(B5), and R^(B6) moieties to provide a substituted orunsubstituted alicyclic group containing 4 to 30 ring carbon atoms or asubstituted or unsubstituted aryl group containing 6 to 18 ring carbonatoms or combinations thereof and the linkage may include heteroatoms orfunctional groups, e.g., the linkage may include without limitation anether, ester, thioether, amino, alkylamino, imino, or anhydride moiety.The alicyclic group can be monocyclic, bicyclic, or polycyclic. Whenunsaturated the cyclic group can contain monounsaturation ormultiunsaturation, with monounsaturated cyclic groups being preferred.When substituted, the rings contain monosubstitution ormultisubstitution wherein the substituents are independently selectedfrom hydrogen, hydrocarbyl, substituted hydrocarbyl,heteroatom-containing hydrocarbyl, substituted heteroatom-containinghydrocarbyl, —(Z*)_(n)-Fn where n is zero or 1, Z* and Fn are as definedpreviously, and functional groups (Fn) provided above.

Examples of monounsaturated, monocyclic olefins encompassed by structure(B) include, without limitation, cyclopentene, cyclohexene,cycloheptene, cyclooctene, cyclononene, cyclodecene, cycloundecene,cyclododecene, tricyclodecene, tetracyclodecene, octacyclodecene, andcycloeicosene, and substituted versions thereof such as1-methylcyclopentene, 1-ethylcyclopentene, 1-isopropylcyclohexene,1-chloropentene, 1-fluorocyclopentene, 4-methylcyclopentene,4-methoxy-cyclopentene, 4-ethoxy-cyclopentene, cyclopent-3-ene-thiol,cyclopent-3-ene, 4-methyl sulfanyl-cyclopentene, 3-methylcyclohexene,1-methylcyclooctene, 1,5-dimethylcyclooctene, etc.

Monocyclic diene reactants encompassed by structure (A) may be generallyrepresented by the structure (C)

wherein c and d are independently integers in the range of 1 to about 8,typically 2 to 4, preferably 2 (such that the reactant is acyclooctadiene), R^(A1) and R^(A2) are as defined above for structure(A), and R^(C1), R^(C2), R^(C3), R^(C4), R^(C5), and R^(C6) are definedas for R^(B1) through R^(B6). In this case, it is preferred that R^(C3)and R^(C4) be non-hydrogen substituents, in which case the secondolefinic moiety is tetrasubstituted. Examples of monocyclic dienereactants include, without limitation, 1,3-cyclopentadiene,1,3-cyclohexadiene, 1,4-cyclohexadiene, 5-ethyl-1,3-cyclohexadiene,1,3-cycloheptadiene, cyclohexadiene, 1,5-cyclooctadiene,1,3-cyclooctadiene, and substituted analogs thereof. Triene reactantsare analogous to the diene structure (C), and will generally contain atleast one methylene linkage between any two olefinic segments.

Bicyclic and polycyclic olefins encompassed by structure (A) may begenerally represented by the structure (D)

wherein R^(A1) and R^(A2) are as defined above for structure (A),R^(D1), R^(D2), R^(D3), and R^(D4) are as defined for R^(B1) throughR^(B6), e is an integer in the range of 1 to 8 (typically 2 to 4) f isgenerally 1 or 2; T is lower alkylene or alkenylene (generallysubstituted or unsubstituted methyl or ethyl), CHR^(G1), C(R^(G1))₂, O,S, N—R^(G1), P—R^(G1), O═P—R^(G1), Si(R^(G1))₂, B—R^(G1), or As—R^(G1)where R^(G1) is alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, alkaryl,aralkyl, or alkoxy. Furthermore, any of the R^(D1), R^(D2), R^(D3), andR^(D4) moieties can be linked to any of the other R^(D1), R^(D2),R^(D3), and R^(D4) moieties to provide a substituted or unsubstitutedalicyclic group containing 4 to 30 ring carbon atoms or a substituted orunsubstituted aryl group containing 6 to 18 ring carbon atoms orcombinations thereof and the linkage may include heteroatoms orfunctional groups, e.g., the linkage may include without limitation anether, ester, thioether, amino, alkylamino, imino, or anhydride moiety.The cyclic group can be monocyclic, bicyclic, or polycyclic. Whenunsaturated the cyclic group can contain monounsaturation ormultiunsaturation, with monounsaturated cyclic groups being preferred.When substituted, the rings contain monosubstitution ormultisubstitution wherein the substituents are independently selectedfrom hydrogen, hydrocarbyl, substituted hydrocarbyl,heteroatom-containing hydrocarbyl, substituted heteroatom-containinghydrocarbyl, —(Z*)_(n)-Fn where n is zero or 1, Z* and Fn are as definedpreviously, and functional groups (Fn) provided above.

Cyclic olefins encompassed by structure (D) are in the norbornenefamily. As used herein, norbornene means any compound that includes atleast one norbornene or substituted norbornene moiety, including withoutlimitation norbornene, substituted norbornene(s), norbornadiene,substituted norbornadiene(s), polycyclic norbornenes, and substitutedpolycyclic norbornene(s). Norbornenes within this group may be generallyrepresented by the structure (E)

wherein R^(A1) and R^(A2) are as defined above for structure (A), T isas defined above for structure (D), R^(E1), R^(E2), R^(E3), R^(E4),R^(E5), R^(E6), R^(E7), and R^(E8) are as defined for R^(B1) throughR^(B6), and “a” represents a single bond or a double bond, f isgenerally 1 or 2, “g” is an integer from 0 to 5, and when “a” is adouble bond one of R^(E5), R^(E6) and one of R^(E7), R^(E8) is notpresent.

Furthermore, any of the R^(E5), R^(E6), R^(E7), and R^(E8) moieties canbe linked to any of the other R^(E5), R^(E6), R^(E7), and R^(E8)moieties to provide a substituted or unsubstituted alicyclic groupcontaining 4 to 30 ring carbon atoms or a substituted or unsubstitutedaryl group containing 6 to 18 ring carbon atoms or combinations thereofand the linkage may include heteroatoms or functional groups, e.g., thelinkage may include without limitation an ether, ester, thioether,amino, alkylamino, imino, or anhydride moiety. The cyclic group can bemonocyclic, bicyclic, or polycyclic. When unsaturated the cyclic groupcan contain monounsaturation or multiunsaturation, with monounsaturatedcyclic groups being preferred. When substituted, the rings containmonosubstitution or multisubstitution wherein the substituents areindependently selected from hydrogen, hydrocarbyl, substitutedhydrocarbyl, heteroatom-containing hydrocarbyl, substitutedheteroatom-containing hydrocarbyl, —(Z*)_(n)-Fn where n is zero or 1, Z*and Fn are as defined previously, and functional groups (Fn) providedabove.

More preferred cyclic olefins possessing at least one norbornene moietyhave the structure (F):

wherein R^(F1), R^(F2), R^(F3), and R^(F4) are as defined for R^(B1)through R^(B6), and “a” represents a single bond or a double bond, “g”is an integer from 0 to 5, and when “a” is a double bond one of R^(F1),R^(F2) and one of R^(F3), R^(F4) is not present.

Furthermore, any of the R^(F1), R^(F2), R^(F3), and R^(F4) moieties canbe linked to any of the other R^(F1), R^(F2), R^(F3), and R^(F4)moieties to provide a substituted or unsubstituted alicyclic groupcontaining 4 to 30 ring carbon atoms or a substituted or unsubstitutedaryl group containing 6 to 18 ring carbon atoms or combinations thereofand the linkage may include heteroatoms or functional groups, e.g., thelinkage may include without limitation an ether, ester, thioether,amino, alkylamino, imino, or anhydride moiety. The alicyclic group canbe monocyclic, bicyclic, or polycyclic. When unsaturated the cyclicgroup can contain monounsaturation or multiunsaturation, withmonounsaturated cyclic groups being preferred. When substituted, therings contain monosubstitution or multisubstitution wherein thesubstituents are independently selected from hydrogen, hydrocarbyl,substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substitutedheteroatom-containing hydrocarbyl, —(Z*)_(n)-Fn where n is zero or 1, Z*and Fn are as defined previously, and functional groups (Fn) providedabove.

One route for the preparation of hydrocarbyl substituted andfunctionally substituted norbornenes employs the Diels-Aldercycloaddition reaction in which cyclopentadiene or substitutedcyclopentadiene is reacted with a suitable dienophile at elevatedtemperatures to form the substituted norbornene adduct generally shownby the following reaction Scheme 1:

wherein R^(F1) to R^(F4) are as previously defined for structure (F).

Other norbornene adducts can be prepared by the thermal pyrolysis ofdicyclopentadiene in the presence of a suitable dienophile. The reactionproceeds by the initial pyrolysis of dicyclopentadiene tocyclopentadiene followed by the Diels-Alder cycloaddition ofcyclopentadiene and the dienophile to give the adduct shown below inScheme 2:

wherein “g” is an integer from 0 to 5, and R^(F1) to R^(F4) are aspreviously defined for structure (F).

Norbornadiene and higher Diels-Alder adducts thereof similarly can beprepared by the thermal reaction of cyclopentadiene anddicyclopentadiene in the presence of an acetylenic reactant as shownbelow in Scheme 3:

wherein “g” is an integer from 0 to 5, R^(F1) and R^(F4) are aspreviously defined for structure (F)

Examples of bicyclic and polycyclic olefins thus include, withoutlimitation, dicyclopentadiene (DCPD); trimer and other higher orderoligomers of cyclopentadiene including without limitationtricyclopentadiene (cyclopentadiene trimer), cyclopentadiene tetramer,and cyclopentadiene pentamer; ethylidenenorbornene; dicyclohexadiene;norbornene; 5-methyl-2-norbornene; 5-ethyl-2-norbornene;5-isobutyl-2-norbornene; 5,6-dimethyl-2-norbornene; 5-phenylnorbornene;5-benzylnorbornene; 5-acetylnorbornene; 5-methoxycarbonylnorbornene;5-ethyoxycarbonyl-1-norbornene; 5-methyl-5-methoxy-carbonylnorbornene;5-cyanonorbornene; 5,5,6-trimethyl-2-norbornene;cyclo-hexenylnorbornene; endo, exo-5,6-dimethoxynorbornene; endo,endo-5,6-dimethoxynorbornene; endo, exo-5,6-dimethoxycarbonylnorbornene;endo,endo-5,6-dimethoxycarbonylnorbornene; 2,3-dimethoxynorbornene;norbornadiene; tricycloundecene; tetracyclododecene;8-methyltetracyclododecene; 8-ethyltetracyclododecene;8-methoxycarbonyltetracyclododecene; 8-methyl-8-tetracyclododecene;8-cyanotetracyclododecene; pentacyclopentadecene; pentacyclohexadecene;and the like, and their structural isomers, stereoisomers, and mixturesthereof. Additional examples of bicyclic and polycyclic olefins include,without limitation, C₂-C₁₂ hydrocarbyl substituted norbornenes such as5-butyl-2-norbornene, 5-hexyl-2-norbornene, 5-octyl-2-norbornene,5-decyl-2-norbornene, 5-dodecyl-2-norbornene, 5-vinyl-2-norbornene,5-ethylidene-2-norbornene, 5-isopropenyl-2-norbornene,5-propenyl-2-norbornene, and 5-butenyl-2-norbornene, and the like.

Preferred cyclic olefins include C₅ to C₂₄ unsaturated hydrocarbons.Also preferred are C₅ to C₂₄ cyclic hydrocarbons that contain one ormore (typically 2 to 12) heteroatoms such as O, N, S, or P. For example,crown ether cyclic olefins may include numerous O heteroatoms throughoutthe cycle, and these are within the scope of the invention. In addition,preferred cyclic olefins are C₅ to C₂₄ hydrocarbons that contain one ormore (typically 2 or 3) olefins. For example, the cyclic olefin may bemono-, di-, or tri-unsaturated. Examples of cyclic olefins includewithout limitation cyclooctene, cyclododecene, and(c,t,t)-1,5,9-cyclododecatriene.

The cyclic olefins may also comprise multiple (typically 2 or 3) rings.For example, the cyclic olefin may be mono-, di-, or tri-cyclic. Whenthe cyclic olefin comprises more than one ring, the rings may or may notbe fused. Preferred examples of cyclic olefins that comprise multiplerings include norbornene, dicyclopentadiene, tricyclopentadiene, and5-ethylidene-2-norbornene.

The cyclic olefin may also be substituted, for example, a C₅ to C₂₄cyclic hydrocarbon wherein one or more (typically 2, 3, 4, or 5) of thehydrogens are replaced with non-hydrogen substituents. Suitablenon-hydrogen substituents may be chosen from the substituents describedhereinabove. For example, functionalized cyclic olefins, i.e., C₅ to C₂₄cyclic hydrocarbons wherein one or more (typically 2, 3, 4, or 5) of thehydrogens are replaced with functional groups, are within the scope ofthe invention. Suitable functional groups may be chosen from thefunctional groups described hereinabove. For example, a cyclic olefinfunctionalized with an alcohol group may be used to prepare a telechelicpolymer comprising pendent alcohol groups. Functional groups on thecyclic olefin may be protected in cases where the functional groupinterferes with the metathesis catalyst, and any of the protectinggroups commonly used in the art may be employed. Acceptable protectinggroups may be found, for example, in Greene et al., Protective Groups inOrganic Synthesis, 3rd Ed. (New York: Wiley, 1999). Examples offunctionalized cyclic olefins include without limitation2-hydroxymethyl-5-norbornene,2-[(2-hydroxyethyl)carboxylate]-5-norbornene, cydecanol,5-n-hexyl-2-norbornene, 5-n-butyl-2-norbornene.

Cyclic olefins incorporating any combination of the abovementionedfeatures (i.e., heteroatoms, substituents, multiple olefins, multiplerings) are suitable for the methods disclosed herein. Additionally,cyclic olefins incorporating any combination of the abovementionedfeatures (i.e., heteroatoms, substituents, multiple olefins, multiplerings) are suitable for the invention disclosed herein.

The cyclic olefins useful in the methods disclosed herein may bestrained or unstrained. It will be appreciated that the amount of ringstrain varies for each cyclic olefin compound, and depends upon a numberof factors including the size of the ring, the presence and identity ofsubstituents, and the presence of multiple rings. Ring strain is onefactor in determining the reactivity of a molecule towards ring-openingolefin metathesis reactions. Highly strained cyclic olefins, such ascertain bicyclic compounds, readily undergo ring opening reactions witholefin metathesis catalysts. Less strained cyclic olefins, such ascertain unsubstituted hydrocarbon monocyclic olefins, are generally lessreactive. In some cases, ring opening reactions of relatively unstrained(and therefore relatively unreactive) cyclic olefins may become possiblewhen performed in the presence of the olefinic compounds disclosedherein. Additionally, cyclic olefins useful in the invention disclosedherein may be strained or unstrained.

The resin compositions of the present invention may comprise a pluralityof cyclic olefins. A plurality of cyclic olefins may be used to preparemetathesis polymers from the olefinic compound. For example, two cyclicolefins selected from the cyclic olefins described hereinabove may beemployed in order to form metathesis products that incorporate bothcyclic olefins. Where two or more cyclic olefins are used, one exampleof a second cyclic olefin is a cyclic alkenol, i.e., a C₅-C₂₄ cyclichydrocarbon wherein at least one of the hydrogen substituents isreplaced with an alcohol or protected alcohol moiety to yield afunctionalized cyclic olefin.

The use of a plurality of cyclic olefins, and in particular when atleast one of the cyclic olefins is functionalized, allows for furthercontrol over the positioning of functional groups within the products.For example, the density of cross-linking points can be controlled inpolymers and macromonomers prepared using the methods disclosed herein.Control over the quantity and density of substituents and functionalgroups also allows for control over the physical properties (e.g.,melting point, tensile strength, glass transition temperature, etc.) ofthe products. Control over these and other properties is possible forreactions using only a single cyclic olefin, but it will be appreciatedthat the use of a plurality of cyclic olefins further enhances the rangeof possible metathesis products and polymers formed.

More preferred cyclic olefins include dicyclopentadiene;tricyclopentadiene; dicyclohexadiene; norbornene; 5-methyl-2-norbornene;5-ethyl-2-norbornene; 5-isobutyl-2-norbornene;5,6-dimethyl-2-norbornene; 5-phenylnorbornene; 5-benzylnorbornene;5-acetylnorbornene; 5-methoxycarbonylnorbornene;5-ethoxycarbonyl-1-norbornene; 5-methyl-5-methoxy-carbonylnorbornene;5-cyanonorbornene; 5,5,6-trimethyl-2-norbornene;cyclo-hexenylnorbornene; endo, exo-5,6-dimethoxynorbornene; endo,endo-5,6-dimethoxynorbornene; endo, exo-5-6-dimethoxycarbonylnorbornene;endo, endo-5,6-dimethoxycarbonylnorbornene; 2,3-dimethoxynorbornene;norbornadiene; tricycloundecene; tetracyclododecene;8-methyltetracyclododecene; 8-ethyl-tetracyclododecene;8-methoxycarbonyltetracyclododecene; 8-methyl-8-tetracyclo-dodecene;8-cyanotetracyclododecene; pentacyclopentadecene; pentacyclohexadecene;higher order oligomers of cyclopentadiene such as cyclopentadienetetramer, cyclopentadiene pentamer, and the like; and C₂-C₁₂ hydrocarbylsubstituted norbornenes such as 5-butyl-2-norbornene;5-hexyl-2-norbornene; 5-octyl-2-norbornene; 5-decyl-2-norbornene;5-dodecyl-2-norbornene; 5-vinyl-2-norbornene; 5-ethylidene-2-norbornene;5-isopropenyl-2-norbornene; 5-propenyl-2-norbornene; and5-butenyl-2-norbornene, and the like. Even more preferred cyclic olefinsinclude dicyclopentadiene, tricyclopentadiene, and higher orderoligomers of cyclopentadiene, such as cyclopentadiene tetramer,cyclopentadiene pentamer, and the like, tetracyclododecene, norbornene,and C₂-C₁₂ hydrocarbyl substituted norbornenes, such as5-butyl-2-norbornene, 5-hexyl-2-norbornene, 5-octyl-2-norbornene,5-decyl-2-norbornene, 5-dodecyl-2-norbornene, 5-vinyl-2-norbornene,5-ethylidene-2-norbornene, 5-isopropenyl-2-norbornene,5-propenyl-2-norbornene, 5-butenyl-2-norbornene, and the like.

Olefin Metathesis Catalysts

An olefin metathesis catalyst that may be used in the inventiondisclosed herein, is preferably a Group 8 transition metal complexhaving the structure of formula (I)

in which:

M is a Group 8 transition metal;

L¹, L², and L³ are neutral electron donor ligands;

n is 0 or 1, such that L³ may or may not be present;

m is 0, 1, or 2;

k is 0 or 1;

X¹ and X² are anionic ligands; and

R¹ and R² are independently selected from hydrogen, hydrocarbyl,substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substitutedheteroatom-containing hydrocarbyl, and functional groups,

wherein any two or more of X¹, X², L¹, L², L³, R¹, and R² can be takentogether to form one or more cyclic groups, and further wherein any oneor more of X¹, X², L¹, L², L³, R¹, and R² may be attached to a support.

Additionally, in formula (I), one or both of R¹ and R² may have thestructure —(W)_(n)—U⁺V⁻, in which W is selected from hydrocarbylene,substituted hydrocarbylene, heteroatom-containing hydrocarbylene, orsubstituted heteroatom-containing hydrocarbylene; U is a positivelycharged Group 15 or Group 16 element substituted with hydrogen,hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl,or substituted heteroatom-containing hydrocarbyl; V is a negativelycharged counterion; and n is zero or 1. Furthermore, R¹ and R² may betaken together to form an indenylidene moiety. Additionally, R¹ and R²may be taken together to form a phenylindenylidene.

Preferred catalysts contain Ru or Os as the Group 8 transition metal,with Ru particularly preferred.

Numerous embodiments of the catalysts useful in the reactions disclosedherein are described in more detail infra. For the sake of convenience,the catalysts are described in groups, but it should be emphasized thatthese groups are not meant to be limiting in any way. That is, any ofthe catalysts useful in the invention may fit the description of morethan one of the groups described herein.

A first group of catalysts, then, are commonly referred to as FirstGeneration Grubbs-type catalysts, and have the structure of formula (I).For the first group of catalysts, M is a Group 8 transition metal, m is0, 1, or 2, and n, X¹, X², L¹, L², L³, R¹ and R² are described asfollows.

For the first group of catalysts, n is 0, and L¹ and L² areindependently selected from phosphine, sulfonated phosphine, phosphite,phosphinite, phosphonite, arsine, stibine, ether, (including cyclicethers), amine, amide, imine, sulfoxide, carboxyl, nitrosyl, pyridine,substituted pyridine, imidazole, substituted imidazole, pyrazine,substituted pyrazine and thioether. Exemplary ligands are trisubstitutedphosphines. Preferred trisubstituted phosphines are of the formulaPR^(H1)R^(H2)R^(H3), where R^(H1), R^(H2), and R^(H3) are eachindependently substituted or unsubstituted aryl or C₁-C₁₀ alkyl,particularly primary alkyl, secondary alkyl, or cycloalkyl. In the mostpreferred, L¹ and L² are independently selected from the groupconsisting of trimethylphosphine (PMe₃), triethylphosphine (PEt₃),tri-n-butylphosphine (PBu₃), tri(ortho-tolyl)phosphine (P-o-tolyl₃),tri-tert-butylphosphine (P-tert-Bu₃), tricyclopentylphosphine(PCyclopentyl₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine(P-i-Pr₃), trioctylphosphine (POct₃), triisobutylphosphine, (P-i-Bu₃),triphenylphosphine (PPh₃), tri(pentafluorophenyl)phosphine (P(C₆F₅)₃),methyldiphenylphosphine (PMePh₂), dimethylphenylphosphine (PMe₂Ph), anddiethylphenylphosphine (PEt₂Ph). Alternatively, L¹ and L² may beindependently selected from phosphabicycloalkane (e.g., monosubstituted9-phosphabicyclo-[3.3.1]nonane, or monosubstituted9-phosphabicyclo[4.2.1]nonane] such as cyclohexylphoban,isopropylphoban, ethylphoban, methylphoban, butylphoban, pentylphobanand the like).

X¹ and X² are anionic ligands, and may be the same or different, or arelinked together to form a cyclic group, typically although notnecessarily a five- to eight-membered ring. In preferred embodiments, X¹and X² are each independently hydrogen, halide, or one of the followinggroups: C₁-C₂₀ alkyl, C₅-C₂₄ aryl, C₁-C₂₀ alkoxy, C₅-C₂₄ aryloxy, C₂-Caoalkoxycarbonyl, C₆-C₂₄ aryloxycarbonyl, C₂-C₂₄ acyl, C₂-C₂₄ acyloxy,C₁-C₂₀ alkylsulfonato, C₅-C₂₄ arylsulfonato, C₁-C₂₀ alkylsulfanyl,C₅-C₂₄ arylsulfanyl, C₁-C₂₀ alkylsulfinyl, NO₃, —N═C═O, —N═C═S, orC₅-C₂₄ arylsulfinyl. Optionally, X¹ and X² may be substituted with oneor more moieties selected from C₁-C₁₂ alkyl, C₁-C₁₂ alkoxy, C₅-C₂₄ aryl,and halide, which may, in turn, with the exception of halide, be furthersubstituted with one or more groups selected from halide, C₁-C₆ alkyl,C₁-C₆ alkoxy, and phenyl. In more preferred embodiments, X¹ and X² arehalide, benzoate, C₂-C₆ acyl, C₂-C₆ alkoxycarbonyl, C₁-C₆ alkyl,phenoxy, C₁-C₆ alkoxy, C₁-C₆ alkylsulfanyl, aryl, or C₁-C₆alkylsulfonyl. In even more preferred embodiments, X¹ and X² are eachhalide, CF₃CO₂, CH₃CO₂, CFH₂CO₂, (CH₃)₃CO, (CF₃)₂(CH₃)CO, (CF₃)(CH₃)₂CO,PhO, MeO, EtO, tosylate, mesylate, or trifluoromethane-sulfonate. In themost preferred embodiments, X¹ and X² are each chloride.

R¹ and R² are independently selected from hydrogen, hydrocarbyl (e.g.,C₁-C₂₀ alkyl, C₂-C₂₀ alkenyl, C₂-C₂₀ alkynyl, C₅-C₂₄ aryl, C₆-C₂₄alkaryl, C₆-C₂₄ aralkyl, etc.), substituted hydrocarbyl (e.g.,substituted C₁-C₂₀ alkyl, C₂-C₂₀ alkenyl, C₂-C₂₀ alkynyl, C₅-C₂₄ aryl,C₆-C₂₄ alkaryl, C₆-C₂₄ aralkyl, etc.), heteroatom-containing hydrocarbyl(e.g., heteroatom-containing C₁-C₂₀ alkyl, C₂-C₂₀ alkenyl, C₂-C₂₀alkynyl, C₅-C₂₄ aryl, C₆-C₂₄ alkaryl, C₆-C₂₄ aralkyl, etc.), andsubstituted heteroatom-containing hydrocarbyl (e.g., substitutedheteroatom-containing C₁-C₂₀ alkyl, C₂-C₂₀ alkenyl, C₂-C₂₀ alkynyl,C₅-C₂₄ aryl, C₆-C₂₄ alkaryl, C₆-C₂₄ aralkyl, etc.), and functionalgroups. R¹ and R² may also be linked to form a cyclic group, which maybe aliphatic or aromatic, and may contain substituents and/orheteroatoms. Generally, such a cyclic group will contain 4 to 12,preferably 5, 6, 7, or 8 ring atoms.

In preferred catalysts, R¹ is hydrogen and R² is selected from C₁-C₂₀alkyl, C₂-C₂₀ alkenyl, and C₅-C₂₄ aryl, more preferably C₁-C₆ alkyl,C₂-C₆ alkenyl, and C₅-C₁₄ aryl. Still more preferably, R² is phenyl,vinyl, methyl, isopropyl, or t-butyl, optionally substituted with one ormore moieties selected from C₁-C₆ alkyl, C₁-C₆ alkoxy, phenyl, and afunctional group Fn as defined earlier herein. Most preferably, R² isphenyl or vinyl substituted with one or more moieties selected frommethyl, ethyl, chloro, bromo, iodo, fluoro, nitro, dimethylamino,methyl, methoxy, and phenyl. Optimally, R² is phenyl or —CH═C(CH₃)₂.

Any two or more (typically two, three, or four) of X¹, X², L¹, L², L³,R¹, and R² can be taken together to form a cyclic group, includingbidentate or multidentate ligands, as disclosed, for example, in U.S.Pat. No. 5,312,940, the disclosure of which is incorporated herein byreference. When any of X¹, X², L¹, L², L³, R¹, and R² are linked to formcyclic groups, those cyclic groups may contain 4 to 12, preferably 4, 5,6, 7, or 8 atoms, or may comprise two or three of such rings, which maybe either fused or linked. The cyclic groups may be aliphatic oraromatic, and may be heteroatom-containing and/or substituted. Thecyclic group may, in some cases, form a bidentate ligand or a tridentateligand. Examples of bidentate ligands include, but are not limited to,bisphosphines, dialkoxides, alkyldiketonates, and aryldiketonates.

A second group of catalysts, commonly referred to as Second GenerationGrubbs-type catalysts, have the structure of formula (I), wherein L¹ isa carbene ligand having the structure of formula (II)

such that the complex may have the structure of formula (III)

wherein M, m, n, X¹, X², L², L³, R¹, and R² are as defined for the firstgroup of catalysts, and the remaining substituents are as follows;

X and Y are heteroatoms typically selected from N, O, S, and P. Since Oand S are divalent, p is necessarily zero when X is O or S, q isnecessarily zero when Y is O or S, and k is zero or 1. However, when Xis N or P, then p is 1, and when Y is N or P, then q is 1. In apreferred embodiment, both X and Y are N;

Q¹, Q², Q³, and Q⁴ are linkers, e.g., hydrocarbylene (includingsubstituted hydrocarbylene, heteroatom-containing hydrocarbylene, andsubstituted heteroatom-containing hydrocarbylene, such as substitutedand/or heteroatom-containing alkylene) or —(CO)—, and w, x, y, and z areindependently zero or 1, meaning that each linker is optional.Preferably, w, x, y, and z are all zero. Further, two or moresubstituents on adjacent atoms within Q¹, Q², Q³, and Q⁴ may be linkedto form an additional cyclic group; and

R³, R^(3A), R⁴, and R^(4A) are independently selected from hydrogen,hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl,and substituted heteroatom-containing hydrocarbyl. In addition, X and Ymay be independently selected from carbon and one of the heteroatomsmentioned above, preferably no more than one of X or Y is carbon. Also,L² and L³ may be taken together to form a single bindentateelectron-donating heterocyclic ligand. Furthermore, R¹ and R² may betaken together to form an indenylidene moiety. Moreover, X¹, X², L², L³,X and Y may be further coordinated to boron or to a carboxylate.Additionally, R¹ and R² may be taken together to form aphenylindenylidene.

In addition, any two or more of X¹, X², L¹, L², L³, R¹, R², R³, R^(3A),R⁴, R^(4A), Q¹, Q², Q³, and Q⁴ can be taken together to form a cyclicgroup, and any one or more of X¹, X², L², L³, Q¹, Q², Q³, Q⁴, R¹, R²,R³, R^(3A), R⁴, and R^(4A) may be attached to a support. Any two or moreof X¹, X², L¹, L², L³, R¹, R², R³, R^(3A), R⁴, and R^(4A) can also betaken to be -A-Fn, wherein “A” is a divalent hydrocarbon moiety selectedfrom alkylene and arylalkylene, wherein the alkyl portion of thealkylene and arylalkylene groups can be linear or branched, saturated orunsaturated, cyclic or acyclic, and substituted or unsubstituted,wherein the aryl portion of the of arylalkylene can be substituted orunsubstituted, and wherein hetero atoms and/or functional groups may bepresent in either the aryl or the alkyl portions of the alkylene andarylalkylene groups, and Fn is a functional group, or together to form acyclic group, and any one or more of X¹, X², L², L³, Q¹, Q², Q³, Q⁴, R¹,R², R³, R^(3A), R⁴, and R^(4A) may be attached to a support.

A particular class of carbene ligands having the structure of formula(II), where R^(3A) and R^(4A) are linked to form a cyclic group and atleast one of X or Y is a nitrogen, or at least one of Q³ or Q⁴ is aheteroatom-containing hydrocarbylene or substitutedheteroatom-containing hydrocarbylene, where at least one heteroatom is anitrogen, are commonly referred to as N-heterocyclic carbene (NHC)ligands.

Preferably, R^(3A) and R^(4A) are linked to form a cyclic group so thatthe carbene ligand has the structure of formula (IV)

wherein R³ and R⁴ are as defined for the second group of catalystsabove, with preferably at least one of R³ and R⁴, and more preferablyboth R³ and R⁴, being alicyclic or aromatic of one to about five rings,and optionally containing one or more heteroatoms and/or substituents. Qis a linker, typically a hydrocarbylene linker, including substitutedhydrocarbylene, heteroatom-containing hydrocarbylene, and substitutedheteroatom-containing hydrocarbylene linkers, wherein two or moresubstituents on adjacent atoms within Q may also be linked to form anadditional cyclic structure, which may be similarly substituted toprovide a fused polycyclic structure of two to about five cyclic groups.Q is often, although not necessarily, a two-atom linkage or a three-atomlinkage.

Examples of N-heterocyclic carbene (NHC) ligands and acyclicdiaminocarbene ligands suitable as L¹ thus include, but are not limitedto, the following where DIPP or DiPP is diisopropylphenyl and Mes is2,4,6-trimethylphenyl:

Additional examples of N-heterocyclic carbene (NHC) ligands and acyclicdiaminocarbene ligands suitable as L′ thus include, but are not limitedto the following:

wherein R^(W1), R^(W2), R^(W3), R^(W4) are independently hydrogen,unsubstituted hydrocarbyl, substituted hydrocarbyl, or heteroatomcontaining hydrocarbyl, and where one or both of R^(W3) and R^(W4) maybe in independently selected from halogen, nitro, amido, carboxyl,alkoxy, aryloxy, sulfonyl, carbonyl, thio, or nitroso groups.

Additional examples of N-heterocyclic carbene (NHC) ligands suitable asL¹ are further described in U.S. Pat. Nos. 7,378,528; 7,652,145;7,294,717; 6,787,620; 6,635,768; and 6,552,139 the contents of each areincorporated herein by reference.

Additionally, thermally activated N-Heterocyclic Carbene Precursors asdisclosed in U.S. Pat. No. 6,838,489, the contents of which areincorporated herein by reference, may also be used with the presentinvention.

When M is ruthenium, then, the preferred complexes have the structure offormula (V)

In a more preferred embodiment, Q is a two-atom linkage having thestructure —CR¹¹R¹²CR¹³R¹⁴— or —CR¹¹═CR¹³—, preferably —CR¹¹R¹²—CR¹³R¹⁴—,wherein R¹¹, R¹², R¹³ and R¹⁴ are independently selected from hydrogen,hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl,substituted heteroatom-containing hydrocarbyl, and functional groups.Examples of functional groups here include without limitation carboxyl,C₁-C₂₀ alkoxy, C₅-C₂₄ aryloxy, C₂-C₂₀ alkoxycarbonyl, C₅-C₂₄alkoxycarbonyl, C₂-C₂₄ acyloxy, C₁-C₂₀ alkylthio, C₅-C₂₄ arylthio,C₁-C₂₀ alkylsulfonyl, and C₁-C₂₀ alkylsulfinyl, optionally substitutedwith one or more moieties selected from C₁-C₁₂ alkyl, C₁-C₁₂ alkoxy,C₅-C₁₄ aryl, hydroxyl, sulfhydryl, formyl, and halide. R¹¹, R¹², R¹³,and R¹⁴ are preferably independently selected from hydrogen, C₁-C₁₂alkyl, substituted C₁-C₁₂ alkyl, C₁-C₁₂ heteroalkyl, substituted C₁-C₁₂heteroalkyl, phenyl, and substituted phenyl. Alternatively, any two ofR¹¹, R¹², R¹³, and R¹⁴ may be linked together to form a substituted orunsubstituted, saturated or unsaturated ring structure, e.g., a C₄-C₁₂alicyclic group or a C₅ or C₆ aryl group, which may itself besubstituted, e.g., with linked or fused alicyclic or aromatic groups, orwith other substituents. In one further aspect, any one or more of R¹¹,R¹², R¹³, and R¹⁴ comprises one or more of the linkers. Additionally, R³and R⁴ may be unsubstituted phenyl or phenyl substituted with one ormore substituents selected from C₁-C₂₀ alkyl, substituted C₁-C₂₀ alkyl,C₁-C₂₀ heteroalkyl, substituted C₁-C₂₀ heteroalkyl, C₅-C₂₄ aryl,substituted C₅-C₂₄ aryl, C₅-C₂₄ heteroaryl, C₆-C₂₄ aralkyl, C₆-C₂₄alkaryl, or halide. Furthermore, X¹ and X² may be halogen.

When R³ and R⁴ are aromatic, they are typically although not necessarilycomposed of one or two aromatic rings, which may or may not besubstituted, e.g., R³ and R⁴ may be phenyl, substituted phenyl,biphenyl, substituted biphenyl, or the like. In one preferredembodiment, R³ and R⁴ are the same and are each unsubstituted phenyl orphenyl substituted with up to three substituents selected from C₁-C₂₀alkyl, substituted C₁-C₂₀ alkyl, C₁-C₂₀ heteroalkyl, substituted C₁-C₂₀heteroalkyl, C₅-C₂₄ aryl, substituted C₅-C₂₄ aryl, C₅-C₂₄ heteroaryl,C₆-C₂₄ aralkyl, C₆-C₂₄ alkaryl, or halide. Preferably, any substituentspresent are hydrogen, C₁-C₁₂ alkyl, C₁-C₁₂ alkoxy, C₅-C₁₄ aryl,substituted C₅-C₁₄ aryl, or halide. As an example, R³ and R⁴ are mesityl(i.e., Mes as defined herein).

In a third group of catalysts having the structure of formula (I), M, m,n, X¹, X², R¹, and R² are as defined for the first group of catalysts,L¹ is a strongly coordinating neutral electron donor ligand such as anyof those described for the first and second group of catalysts, and L²and L³ are weakly coordinating neutral electron donor ligands in theform of optionally substituted heterocyclic groups. Again, n is zero or1, such that L³ may or may not be present. Generally, in the third groupof catalysts, L² and L³ are optionally substituted five- or six-memberedmonocyclic groups containing 1 to 4, preferably 1 to 3, most preferably1 to 2 heteroatoms, or are optionally substituted bicyclic or polycyclicstructures composed of 2 to 5 such five- or six-membered monocyclicgroups. If the heterocyclic group is substituted, it should not besubstituted on a coordinating heteroatom, and any one cyclic moietywithin a heterocyclic group will generally not be substituted with morethan 3 substituents.

For the third group of catalysts, examples of L² and L³ include, withoutlimitation, heterocycles containing nitrogen, sulfur, oxygen, or amixture thereof.

Examples of nitrogen-containing heterocycles appropriate for L² and L³include pyridine, bipyridine, pyridazine, pyrimidine, bipyridamine,pyrazine, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, pyrrole,2H-pyrrole, 3H-pyrrole, pyrazole, 2H-imidazole, 1,2,3-triazole,1,2,4-triazole, indole, 3H-indole, 1H-isoindole, cyclopenta(b)pyridine,indazole, quinoline, bisquinoline, isoquinoline, bisisoquinoline,cinnoline, quinazoline, naphthyridine, piperidine, piperazine,pyrrolidine, pyrazolidine, quinuclidine, imidazolidine, picolylimine,purine, benzimidazole, bisimidazole, phenazine, acridine, and carbazole.Additionally, the nitrogen-containing heterocycles may be optionallysubstituted on a non-coordinating heteroatom with a non-hydrogensubstituent.

Examples of sulfur-containing heterocycles appropriate for L² and L³include thiophene, 1,2-dithiole, 1,3-dithiole, thiepin,benzo(b)thiophene, benzo(c)thiophene, thionaphthene, dibenzothiophene,2H-thiopyran, 4H-thiopyran, and thioanthrene.

Examples of oxygen-containing heterocycles appropriate for L² and L³include 2H-pyran, 4H-pyran, 2-pyrone, 4-pyrone, 1,2-dioxin, 1,3-dioxin,oxepin, furan, 2H-1-benzopyran, coumarin, coumarone, chromene,chroman-4-one, isochromen-1-one, isochromen-3-one, xanthene,tetrahydrofuran, 1,4-dioxan, and dibenzofuran.

Examples of mixed heterocycles appropriate for L² and L³ includeisoxazole, oxazole, thiazole, isothiazole, 1,2,3-oxadiazole,1,2,4-oxadiazole, 1,3,4-oxadiazole, 1,2,3,4-oxatriazole,1,2,3,5-oxatriazole, 3H-1,2,3-dioxazole, 3H-1,2-oxathiole,1,3-oxathiole, 4H-1,2-oxazine, 2H-1,3-oxazine, 1,4-oxazine,1,2,5-oxathiazine, o-isooxazine, phenoxazine, phenothiazine,pyrano[3,4-b]pyrrole, indoxazine, benzoxazole, anthranil, andmorpholine.

Preferred L² and L³ ligands are aromatic nitrogen-containing andoxygen-containing heterocycles, and particularly preferred L² and L³ligands are monocyclic N-heteroaryl ligands that are optionallysubstituted with 1 to 3, preferably 1 or 2, substituents. Specificexamples of particularly preferred L² and L³ ligands are pyridine andsubstituted pyridines, such as 3-bromopyridine, 4-bromopyridine,3,5-dibromopyridine, 2,4,6-tribromopyridine, 2,6-dibromopyridine,3-chloropyridine, 4-chloropyridine, 3,5-dichloropyridine,2,4,6-trichloropyridine, 2,6-dichloropyridine, 4-iodopyridine,3,5-diiodopyridine, 3,5-dibromo-4-methylpyridine,3,5-dichloro-4-methylpyridine, 3,5-dimethyl-4-bromopyridine,3,5-dimethylpyridine, 4-methylpyridine, 3,5-diisopropylpyridine,2,4,6-trimethylpyridine, 2,4,6-triisopropylpyridine,4-(tert-butyl)pyridine, 4-phenylpyridine, 3,5-diphenylpyridine,3,5-dichloro-4-phenylpyridine, and the like.

In general, any substituents present on L² and/or L³ are selected fromhalo, C₁-C₂₀ alkyl, substituted C₁-C₂₀ alkyl, C₁-C₂₀ heteroalkyl,substituted C₁-C₂₀ heteroalkyl, C₅-C₂₄ aryl, substituted C₅-C₂₄ aryl,C₅-C₂₄ heteroaryl, substituted C₅-C₂₄ heteroaryl, C₆-C₂₄ substitutedC₆-C₂₄ alkaryl, C₆-C₂₄ heteroalkaryl, substituted C₆-C₂₄ heteroalkaryl,C₆-C₂₄ aralkyl, substituted C₆-C₂₄ aralkyl, C₆-C₂₄ heteroaralkyl,substituted C₆-C₂₄ heteroaralkyl, and functional groups, with suitablefunctional groups including, without limitation, C₁-C₂₀ alkoxy, C₅-C₂₄aryloxy, C₂-C₂₀ alkylcarbonyl, C₆-C₂₄ arylcarbonyl, C₂-C₂₀alkylcarbonyloxy, C₆-C₂₄ arylcarbonyloxy, C₂-C₂₀ alkoxycarbonyl, C₆-C₂₄aryloxycarbonyl, halocarbonyl, C₂-C₂₀ alkylcarbonato, C₆-C₂₄arylcarbonato, carboxy, carboxylato, carbamoyl, mono-(C₁-C₂₀alkyl)-substituted carbamoyl, di-(C₁-C₂₀ alkyl)-substituted carbamoyl,di-N—(C₁-C₂₀ alkyl), N—(C₅-C₂₄ aryl)-substituted carbamoyl, mono-(C₅-C₂₄aryl)-substituted carbamoyl, di-(C₆-C₂₄ aryl)-substituted carbamoyl,thiocarbamoyl, mono-(C₁-C₂₀ alkyl)-substituted thiocarbamoyl, di-(C₁-C₂₀alkyl)-substituted thiocarbamoyl, di-N—(C₁-C₂₀ alkyl)-N—(C₆-C₂₄aryl)-substituted thiocarbamoyl, mono-(C₆-C₂₄ aryl)-substitutedthiocarbamoyl, di-(C₆-C₂₄ aryl)-substituted thiocarbamoyl, carbamido,formyl, thioformyl, amino, mono-(C₁-C₂₀ alkyl)-substituted amino,di-(C₁-C₂₀ alkyl)-substituted amino, mono-(C₅-C₂₄ aryl)-substitutedamino, di-(C₅-C₂₄ aryl)-substituted amino, di-N—(C₁-C₂₀ alkyl),N—(C₅-C₂₄ aryl)-substituted amino, C₂-C₂₀ alkylamido, C₆-C₂₄ arylamido,imino, C₁-C₂₀ alkylimino, C₅-C₂₄ arylimino, nitro, and nitroso. Inaddition, two adjacent substituents may be taken together to form aring, generally a five- or six-membered alicyclic or aryl ring,optionally containing 1 to 3 heteroatoms and 1 to 3 substituents asabove.

Preferred substituents on L² and L³ include, without limitation, halo,C₁-C₁₂ alkyl, substituted C₁-C₁₂ alkyl, C₁-C₁₂ heteroalkyl, substitutedC₁-C₁₂ heteroalkyl, C₅-C₁₄ aryl, substituted C₅-C₁₄ aryl, C₅-C₁₄heteroaryl, substituted C₅-C₁₄ heteroaryl, C₆-C₁₆ alkaryl, substitutedC₆-C₁₆ alkaryl, C₆-C₁₆ heteroalkaryl, substituted C₆-C₁₆ heteroalkaryl,C₆-C₁₆ aralkyl, substituted C₆-C₁₆ aralkyl, C₆-C₁₆ heteroaralkyl,substituted C₆-C₁₆ heteroaralkyl, C₁-C₁₂ alkoxy, C₅-C₁₄ aryloxy, C₂-C₁₂alkylcarbonyl, C₆-C₁₄ arylcarbonyl, C₂-C₁₂ alkylcarbonyloxy, C₆-C₁₄arylcarbonyloxy, C₂-C₁₂ alkoxycarbonyl, C₆-C₁₄ aryloxycarbonyl,halocarbonyl, formyl, amino, mono-(C₁-C₁₂ alkyl)-substituted amino,di-(C₁-C₁₂ alkyl)-substituted amino, mono-(C₅-C₁₄ aryl)-substitutedamino, di-(C₅-C₁₄ aryl)-substituted amino, and nitro.

Of the foregoing, the most preferred substituents are halo, C₁-C₆ alkyl,C₁-C₆ haloalkyl, C₁-C₆ alkoxy, phenyl, substituted phenyl, formyl,N,N-di(C₁-C₆ alkyl)amino, nitro, and nitrogen heterocycles as describedabove (including, for example, pyrrolidine, piperidine, piperazine,pyrazine, pyrimidine, pyridine, pyridazine, etc.).

In certain embodiments, L² and L³ may also be taken together to form abidentate or multidentate ligand containing two or more, generally two,coordinating heteroatoms such as N, O, S, or P, with preferred suchligands being diimine ligands of the Brookhart type. One representativebidentate ligand has the structure of formula (VI)

wherein R¹⁵, R¹⁶, R¹⁷, and R¹⁸ hydrocarbyl (e.g., C₁-C₂₀ alkyl, C₂-C₂₀alkenyl, C₂-C₂₀ alkynyl, C₅-C₂₄ aryl, C₆-C₂₄ alkaryl, or C₆-C₂₄aralkyl), substituted hydrocarbyl (e.g., substituted C₁-C₂₀ alkyl,C₂-C₂₀ alkenyl, C₂-C₂₀ alkynyl, C₅-C₂₄ aryl, C₆-C₂₄ alkaryl, or C₆-C₂₄aralkyl), heteroatom-containing hydrocarbyl (e.g., C₁-C₂₀ heteroalkyl,C₅-C₂₄ heteroaryl, heteroatom-containing C₆-C₂₄ aralkyl, orheteroatom-containing C₆-C₂₄ alkaryl), or substitutedheteroatom-containing hydrocarbyl (e.g., substituted C₁-C₂₀ heteroalkyl,C₅-C₂₄ heteroaryl, heteroatom-containing C₆-C₂₄ aralkyl, orheteroatom-containing C₆-C₂₄ alkaryl), or (1) R¹⁵ and R¹⁶, (2) R¹⁷ andR¹⁸, (3) R¹⁶ and R¹⁷, or (4) both R¹⁵ and R¹⁶, and R¹⁷ and R¹⁸, may betaken together to form a ring, i.e., an N-heterocycle. Preferred cyclicgroups in such a case are five- and six-membered rings, typicallyaromatic rings.

In a fourth group of catalysts that have the structure of formula (I),two of the substituents are taken together to form a bidentate ligand ora tridentate ligand. Examples of bidentate ligands include, but are notlimited to, bisphosphines, dialkoxides, alkyldiketonates, andaryldiketonates. Specific examples include —P(Ph)₂CH₂CH₂P(Ph)₂-,—As(Ph)₂CH₂CH₂As(Ph₂)-, —P(Ph)₂CH₂CH₂C(CF₃)₂O—, binaphtholate dianions,pinacolate dianions, —P(CH₃)₂(CH₂)₂P(CH₃)₂—, and —OC(CH₃)₂(CH₃)₂CO—.Preferred bidentate ligands are —P(Ph)₂CH₂CH₂P(Ph)₂- and—P(CH₃)₂(CH₂)₂P(CH₃)₂—. Tridentate ligands include, but are not limitedto, (CH₃)₂NCH₂CH₂P(Ph)CH₂CH₂N(CH₃)₂. Other preferred tridentate ligandsare those in which any three of X¹, X², L¹, L², L³, R¹, and R² (e.g.,X¹, L¹, and L²) are taken together to be cyclopentadienyl, indenyl, orfluorenyl, each optionally substituted with C₂-C₂₀ alkenyl, C₂-C₂₀alkynyl, C₁-C₂₀ alkyl, C₅-C₂₀ aryl, C₁-C₂₀ alkoxy, C₂-C₂₀ alkenyloxy,C₂-C₂₀ alkynyloxy, C₅-C₂₀ aryloxy, C₂-C₂₀ alkoxycarbonyl, C₁-C₂₀alkylthio, C₁-C₂₀ alkylsulfonyl, or C₁-C₂₀ alkylsulfinyl, each of whichmay be further substituted with C₁-C₆ alkyl, halide, C₁-C₆ alkoxy orwith a phenyl group optionally substituted with halide, C₁-C₆ alkyl, orC₁-C₆ alkoxy. More preferably, in compounds of this type, X, L¹, and L²are taken together to be cyclopentadienyl or indenyl, each optionallysubstituted with vinyl, C₁-C₁₀ alkyl, C₅-C₂₀ aryl, C₁-C₁₀ carboxylate,C₂-C₁₀ alkoxycarbonyl, C₁-C₁₀ alkoxy, or C₅-C₂₀ aryloxy, each optionallysubstituted with C₁-C₆ alkyl, halide, C₁-C₆ alkoxy or with a phenylgroup optionally substituted with halide, C₁-C₆ alkyl or C₁-C₆ alkoxy.Most preferably, X, L¹ and L² may be taken together to becyclopentadienyl, optionally substituted with vinyl, hydrogen, methyl,or phenyl. Tetradentate ligands include, but are not limited toO₂C(CH₂)₂P(Ph)(CH₂)₂P(Ph)(CH₂)₂CO₂, phthalocyanines, and porphyrins.

Complexes wherein Y is coordinated to the metal are examples of a fifthgroup of catalysts, and are commonly called “Grubbs-Hoveyda” catalysts.Grubbs-Hoveyda metathesis-active metal carbene complexes may bedescribed by the formula (VII)

wherein:

M is a Group 8 transition metal, particularly Ru or Os, or, moreparticularly, Ru;

X¹, X², and L¹ are as previously defined herein for the first and secondgroups of catalysts;

Y is a heteroatom selected from N, O, S, and P; preferably Y is O or N;

R⁵, R⁶, R⁷, and R⁸ are each, independently, selected from the groupconsisting of hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl,heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl,alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino,alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl,alkyl sulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl,perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano,isocyanate, hydroxyl, ester, ether, amine, imine, amide,halogen-substituted amide, trifluoroamide, sulfide, disulfide,sulfonate, carbamate, silane, siloxane, phosphine, phosphate, borate, or-A-Fn, wherein “A” and Fn have been defined above; and any combinationof Y, Z, R⁵, R⁶, R⁷, and R⁸ can be linked to form one or more cyclicgroups;

n is 0, 1, or 2, such that n is 1 for the divalent heteroatoms O or S,and n is 2 for the trivalent heteroatoms N or P; and

Z is a group selected from hydrogen, alkyl, aryl, functionalized alkyl,functionalized aryl where the functional group(s) may independently beone or more or the following: alkoxy, aryloxy, halogen, carboxylic acid,ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether,amine, imine, amide, trifluoroamide, sulfide, disulfide, carbamate,silane, siloxane, phosphine, phosphate, or borate; methyl, isopropyl,sec-butyl, t-butyl, neopentyl, benzyl, phenyl and trimethylsilyl; andwherein any combination or combinations of X¹, X², L¹, Y, Z, R⁵, R⁶, R⁷,and R⁸ may be linked to a support. Additionally, R⁵, R⁶, R⁷, R⁸, and Zmay independently be thioisocyanate, cyanato, or thiocyanato.

Examples of complexes comprising Grubbs-Hoveyda ligands suitable in theinvention include:

wherein L¹, X¹, X², and M are as described for any of the other groupsof catalysts. Suitable chelating carbenes and carbene precursors arefurther described by Pederson et al. (U.S. Pat. Nos. 7,026,495 and6,620,955, the disclosures of both of which are incorporated herein byreference) and Hoveyda et al. (U.S. Pat. No. 6,921,735 and WO0214376,the disclosures of both of which are incorporated herein by reference).

Other useful complexes include structures wherein L² and R² according toformulae (I), (III), or (V) are linked, such as styrenic compounds thatalso include a functional group for attachment to a support. Examples inwhich the functional group is a trialkoxysilyl functionalized moietyinclude, but are not limited to, the following:

Further examples of complexes having linked ligands include those havinglinkages between a neutral NHC ligand and an anionic ligand, a neutralNHC ligand and an alkylidine ligand, a neutral NHC ligand and an L²ligand, a neutral NHC ligand and an L³ ligand, an anionic ligand and analkylidine ligand, and any combination thereof. While the possiblestructures are too numerous to list herein, some suitable structuresbased on formula (III) include:

In addition to the catalysts that have the structure of formula (I), asdescribed above, other transition metal carbene complexes include, butare not limited to:

neutral ruthenium or osmium metal carbene complexes containing metalcenters that are formally in the +2 oxidation state, have an electroncount of 16, are penta-coordinated, and are of the general formula (IX);

neutral ruthenium or osmium metal carbene complexes containing metalcenters that are formally in the +2 oxidation state, have an electroncount of 18, are hexa-coordinated, and are of the general formula (X);

cationic ruthenium or osmium metal carbene complexes containing metalcenters that are formally in the +2 oxidation state, have an electroncount of 14, are tetra-coordinated, and are of the general formula (XI);and

cationic ruthenium or osmium metal carbene complexes containing metalcenters that are formally in the +2 oxidation state, have an electroncount of 14 or 16, are tetra-coordinated or penta-coordinated,respectively, and are of the general formula (XII)

wherein:

M, X¹, X², L¹, L², L³, R¹, and R² are as defined for any of thepreviously defined four groups of catalysts;

r and s are independently zero or 1;

t is an integer in the range of zero to 5;

k is an integer in the range of zero to 1;

Y is any non-coordinating anion (e.g., a halide ion, BF₄ ⁻, etc.);

Z¹ and Z² are independently selected from —O—, —S—, —NR²—, —PR²—,—P(═O)R²—, —P(OR²)—, —P(═O)(OR²)—, —C(═O)—, —C(═O)O—, —OC(═O)—,—OC(═O)O—, —S(═O)—, —S(═O)₂—, and an optionally substituted and/oroptionally heteroatom-containing C₁-C₂₀ hydrocarbylene linkage;

Z³ is any cationic moiety such as —P(R²)₃ ⁺ or —N(R²)₃ ⁺; and

any two or more of X¹, X², L¹, L², L³, Z¹, Z², Z³, R¹, and R² may betaken together to form a cyclic group, e.g., a multidentate ligand, andwherein any one or more of X¹, X², L¹, L², L³, Z¹, Z², Z³, R¹, and R²may be attached to a support.

Additionally, another group of olefin metathesis catalysts that may beused in the invention disclosed herein, is a Group 8 transition metalcomplex having the structure of formula (XIII):

wherein M is a Group 8 transition metal, particularly ruthenium orosmium, or more particularly, ruthenium;

X¹, X², L¹ and L² are as defined for the first and second groups ofcatalysts defined above; and

R^(G1), R^(G2), R^(G3), R^(G4), R^(G5), and R^(G6) are eachindependently selected from the group consisting of hydrogen, halogen,alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroatom containingalkenyl, heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy,alkoxycarbonyl, carbonyl, alkylamino, alkylthio, aminosulfonyl,monoalkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, nitrile,nitro, alkylsulfinyl, trihaloalkyl, perfluoroalkyl, carboxylic acid,ketone, aldehyde, nitrate, cyano, isocyanate, thioisocyanate, cyanato,thiocyanato, hydroxyl, ester, ether, thioether, amine, alkylamine,imine, amide, halogen-substituted amide, trifluoroamide, sulfide,disulfide, sulfonate, carbamate, silane, siloxane, phosphine, phosphate,borate, or -A-Fn, wherein “A” is a divalent hydrocarbon moiety selectedfrom alkylene and arylalkylene, wherein the alkyl portion of thealkylene and arylalkylene groups can be linear or branched, saturated orunsaturated, cyclic or acyclic, and substituted or unsubstituted,wherein the aryl portion of the arylalkylene can be substituted orunsubstituted, and wherein hetero atoms and/or functional groups may bepresent in either the aryl or the alkyl portions of the alkylene andarylalkylene groups, and Fn is a functional group, or any one or more ofthe R^(G1), R^(G2), R^(G3), R^(G4), R^(G5), and R^(G6) may be linkedtogether to form a cyclic group, or any one or more of the R^(G1),R^(G2), R^(G3), R^(G4), R^(G5), and R^(G6) may be attached to a support.

Additionally, one preferred embodiment of the Group 8 transition metalcomplex of formula (XIII) is a Group 8 transition metal complex offormula (XIV):

wherein M, X¹, X², L¹, and L² are as defined above for Group 8transition metal complex of formula (XIII); and

R^(G7), R^(G8), R^(G9), R^(G10), R^(G11), R^(G12), R^(G13), R^(G14),R^(G15), and R^(G16) are as defined above for R^(G1), R^(G2), R^(G3),R^(G4), R^(G5), and R^(G6) for Group 8 transition metal complex offormula (XIII) or any one or more of the R^(G7), R^(G8), R^(G9),R^(G10), R^(G11), R^(G12), R^(G13), R^(G14), R^(G15), and R^(G16) may belinked together to form a cyclic group, or any one or more of theR^(G7), R^(G8), R^(G9), R^(G10), R^(G11), R^(G12), R^(G13), R^(G14),R^(G15), and R^(G16) may be attached to a support.

Additionally, another preferred embodiment of the Group 8 transitionmetal complex of formula (XIII) is a Group 8 transition metal complex offormula (XV):

wherein M, X¹, X², L¹, and L² are as defined above for Group 8transition metal complex of formula (XIII).

Additionally, another group of olefin metathesis catalysts that may beused in the invention disclosed herein, is a Group 8 transition metalcomplex comprising a Schiff base ligand having the structure of formula(XVI):

wherein M is a Group 8 transition metal, particularly ruthenium orosmium, or more particularly, ruthenium;

X¹ and L¹ are as defined for the first and second groups of catalystsdefined above;

Z is selected from the group consisting of oxygen, sulfur, selenium,NR^(J11), PR^(J11), AsR^(J11), and SbR^(J11); and

R^(J1), R^(J2), R^(J3), R^(J4), R^(J5), R^(J6), R^(J7), R^(J8), R^(J9),R^(J10), and R^(J11) are each independently selected from the groupconsisting of hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl,heteroalkyl, heteroatom containing alkenyl, heteroalkenyl, heteroaryl,alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino,alkylthio, aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl,alkyl sulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl,perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano,isocyanate, thioisocyanate, cyanato, thiocyanato, hydroxyl, ester,ether, thioether, amine, alkylamine, imine, amide, halogen-substitutedamide, trifluoroamide, sulfide, disulfide, sulfonate, carbamate, silane,siloxane, phosphine, phosphate, borate, or -A-Fn, wherein “A” is adivalent hydrocarbon moiety selected from alkylene and arylalkylene,wherein the alkyl portion of the alkylene and arylalkylene groups can belinear or branched, saturated or unsaturated, cyclic or acyclic, andsubstituted or unsubstituted, wherein the aryl portion of thearylalkylene can be substituted or unsubstituted, and wherein heteroatoms and/or functional groups may be present in either the aryl or thealkyl portions of the alkylene and arylalkylene groups, and Fn is afunctional group, or any one or more of the R^(J1), R^(J2), R^(J3),R^(J4), R^(J5), R^(J6), R^(J7), R^(J8), R^(J9), R^(J10), and R^(J11) maybe linked together to form a cyclic group, or any one or more of theR^(J1), R^(J2), R^(J3), R^(J4), R^(J5), R^(J6), R^(J7), R^(J8), R^(J9),R^(J10), and R^(J11) may be attached to a support.

Additionally, one preferred embodiment of the Group 8 transition metalcomplex of formula (XVI) is a Group 8 transition metal complexcomprising a Schiff base ligand having the structure of formula (XVII):

wherein M, X¹, L¹, Z, R^(J7), R^(J8), R^(J9), R^(J10), and R^(J11) areas defined above for Group 8 transition metal complex of formula (XVI);and

R^(J12), R^(J13), R^(J14), R^(J15), R^(J16), R^(J17), R^(J18), R^(J19),R^(J20), and R^(J21) are as defined above for R^(J1), R^(J2), R^(J3),R^(J4), R^(J5), and R^(J6) for Group 8 transition metal complex offormula (XVI), or any one or more of the R^(J7), R^(J8), R^(J9),R^(J10), R^(J11), R^(J12), R^(J13), R^(J14), R^(J15), R^(J16), R^(J17),R^(J18), R^(J19), R^(J20), and R^(J21) may be linked together to form acyclic group, or any one or more of the R^(J7), R^(J8), R^(J9), R^(J10),R^(J11), R^(J12), R^(J13), R^(J14), R^(J15), R^(J16), R^(J17), R^(J18),R^(J19), R^(J20) and R^(J21) may be attached to a support.

Additionally, another preferred embodiment of the Group 8 transitionmetal complex of formula (XVI) is a Group 8 transition metal complexcomprising a Schiff base ligand having the structure of formula (XVIII):

wherein M, X¹, L¹, Z, R^(J7), R^(J8), R^(J9), R^(J10), and R^(J11) areas defined above for Group 8 transition metal complex of formula (XVI).

Additionally, another group of olefin metathesis catalysts that may beused in the invention disclosed herein, is a Group 8 transition metalcomplex comprising a Schiff base ligand having the structure of formula(XIX):

wherein M is a Group 8 transition metal, particularly ruthenium orosmium, or more particularly, ruthenium;

X¹, L¹, R¹, and R² are as defined for the first and second groups ofcatalysts defined above;

Z is selected from the group consisting of oxygen, sulfur, selenium,NR^(K5), PR^(K5), AsR^(K5), and SbR^(K5);

m is 0, 1, or 2; and

R^(K1), R^(K2), R^(K3), R^(K4), and R^(K5) are each independentlyselected from the group consisting of hydrogen, halogen, alkyl, alkenyl,alkynyl, aryl, heteroalkyl, heteroatom containing alkenyl,heteroalkenyl, heteroaryl, alkoxy, alkenyloxy, aryloxy, alkoxycarbonyl,carbonyl, alkylamino, alkylthio, aminosulfonyl, monoalkylaminosulfonyl,dialkylaminosulfonyl, alkyl sulfonyl, nitrile, nitro, alkylsulfinyl,trihaloalkyl, perfluoroalkyl, carboxylic acid, ketone, aldehyde,nitrate, cyano, isocyanate, thioisocyanate, cyanato, thiocyanato,hydroxyl, ester, ether, thioether, amine, alkylamine, imine, amide,halogen-substituted amide, trifluoroamide, sulfide, disulfide,sulfonate, carbamate, silane, siloxane, phosphine, phosphate, borate, or-A-Fn, wherein “A” is a divalent hydrocarbon moiety selected fromalkylene and arylalkylene, wherein the alkyl portion of the alkylene andarylalkylene groups can be linear or branched, saturated or unsaturated,cyclic or acyclic, and substituted or unsubstituted, wherein the arylportion of the arylalkylene can be substituted or unsubstituted, andwherein hetero atoms and/or functional groups may be present in eitherthe aryl or the alkyl portions of the alkylene and arylalkylene groups,and Fn is a functional group, or any one or more of the R^(K1), R^(K2),R^(K3), R^(K4), and R^(K5) may be linked together to form a cyclicgroup, or any one or more of the R^(K1), R^(K2), R^(K3), R^(K4), andR^(K5) may be attached to a support.

In addition, catalysts of formulas (XVI) to (XIX) may be optionallycontacted with an activating compound, where at least partial cleavageof a bond between the Group 8 transition metal and at least one Schiffbase ligand occurs, wherein the activating compound is either a metal orsilicon compound selected from the group consisting of copper (I)halides; zinc compounds of the formula Zn(R^(Y1))₂, wherein R^(Y1) ishalogen, C₁-C₇ alkyl or aryl; tin compounds represented by the formulaSnR^(Y2)R^(Y3)R^(Y4)R^(Y5) wherein each of R^(Y2), R^(Y3), R^(Y4), andR^(Y5) is independently selected from the group consisting of halogen,C₁-C₂₀ alkyl, C₃-C₁₀ cycloalkyl, aryl, benzyl, and C₂-C₇ alkenyl; andsilicon compounds represented by the formula SiR^(Y6)R^(Y7)R^(Y8)R^(Y9)wherein each of R^(Y6), R^(Y7), R^(Y8), and R^(Y9) is independentlyselected from the group consisting of hydrogen, halogen, C₁-C₂₀ alkyl,halo, C₁-C₇ alkyl, aryl, heteroaryl, and vinyl. In addition, catalystsof formulas (XVI) to (XIX) may be optionally contacted with anactivating compound where at least partial cleavage of a bond betweenthe Group 8 transition metal and at least one Schiff base ligand occurs,wherein the activating compound is an inorganic acid such as hydrogeniodide, hydrogen bromide, hydrogen chloride, hydrogen fluoride, sulfuricacid, nitric acid, iodic acid, periodic acid, perchloric acid, HOClO,HOClO₂, and HOIO₃. In addition, catalysts of formulas (XVI) to (XIX) maybe optionally contacted with an activating compound where at leastpartial cleavage of a bond between the Group 8 transition metal and atleast one Schiff base ligand occurs, wherein the activating compound isan organic acid such as sulfonic acids including but not limited tomethanesulfonic acid, aminobenzenesulfonic acid, benzenesulfonic acid,napthalenesulfonic acid, sulfanilic acid and trifluoromethanesulfonicacid; monocarboxylic acids including but not limited to acetoaceticacid, barbituric acid, bromoacetic acid, bromobenzoic acid, chloroaceticacid, chlorobenzoic acid, chlorophenoxyacetic acid, chloropropionicacid, cis-cinnamic acid, cyanoacetic acid, cyanobutyric acid,cyanophenoxyacetic acid, cyanopropionic acid, dichloroacetic acid,dichloroacetylacetic acid, dihydroxybenzoic acid, dihydroxymalic acid,dihydroxytartaric acid, dinicotinic acid, diphenylacetic acid,fluorobenzoic acid, formic acid, furancarboxylic acid, furoic acid,glycolic acid, hippuric acid, iodoacetic acid, iodobenzoic acid, lacticacid, lutidinic acid, mandelic acid, α-naphtoic acid, nitrobenzoic acid,nitrophenylacetic acid, o-phenylbenzoic acid, thioacetic acid,thiophene-carboxylic acid, trichloroacetic acid, and trihydroxybenzoicacid; and other acidic substances such as but not limited to picric acidand uric acid.

In addition, other examples of catalysts that may be used with thepresent invention are located in the following disclosures, each ofwhich is incorporated herein by reference, U.S. Pat. Nos. 7,687,635;7,671,224; 6,284,852; 6,486,279; and 5,977,393; InternationalPublication Number WO2010/037550; and U.S. patent application Ser. Nos.12/303,615; 10/590,380; 11/465,651 (Publication No.: US 2007/0043188);and Ser. No. 11/465,651 (Publication No.: US 2008/0293905 CorrectedPublication); and European Pat. Nos. EP1757613B1 and EP1577282B1.

Non-limiting examples of catalysts that may be used to prepare supportedcomplexes and in the reactions disclosed herein include the following,some of which for convenience are identified throughout this disclosureby reference to their molecular weight:

In the foregoing molecular structures and formulae, Ph representsphenyl, Cy represents cyclohexyl, Cp represents cyclopentyl, Merepresents methyl, Bu represents n-butyl, t-Bu represents tert-butyl,i-Pr represents isopropyl, py represents pyridine (coordinated throughthe N atom), Mes represents mesityl (i.e., 2,4,6-trimethylphenyl), DiPPand DIPP represents 2,6-diisopropylphenyl, and MiPP represents2-isopropylphenyl.

Further examples of catalysts useful to prepare supported complexes andin the reactions disclosed herein include the following: ruthenium (II)dichloro (3-methyl-2-butenylidene) bis(tricyclopentylphosphine) (C716);ruthenium (II) dichloro (3-methyl-2-butenylidene)bis(tricyclohexylphosphine) (C801); ruthenium (II)dichloro(phenylmethylene) bis(tricyclohexylphosphine) (C823); ruthenium(II) (1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene) dichloro(phenylmethylene) (triphenylphosphine) (C830); ruthenium (II) dichloro(phenylvinylidene) bis(tricyclohexylphosphine) (C835); ruthenium (II)dichloro (tricyclohexylphosphine) (o-isopropoxyphenylmethylene) (C601);ruthenium (II) (1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro (phenylmethylene) bis(3-bromopyridine) (C884);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(o-isopropoxyphenylmethylene)ruthenium(II)(C627); [1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene] dichloro(benzylidene) (triphenylphosphine) ruthenium(II) (C831);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene] dichloro(benzylidene)(methyldiphenylphosphine)ruthenium(II) (C769);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(benzylidene)(tricyclohexylphosphine)ruthenium(II)(C848); [1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(benzylidene) (diethylphenylphosphine) ruthenium(II) (C735);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(benzylidene)(tri-n-butylphosphine)ruthenium(II)(C₇₇₁);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(3-methyl-2-butenylidene)(triphenylphosphine)ruthenium(II)(C809);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(3-methyl-2-butenylidene)(methyldiphenylphosphine)ruthenium(II)(C747);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(3-methyl-2-butenylidene)(tricyclohexylphosphine) ruthenium(II) (C827);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(3-methyl-2-butenylidene)(diethylphenylphosphine)ruthenium(II)(C713); [1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene] dichloro(3-methyl-2-butenylidene) (tri-n-butylphosphine)ruthenium(II) (C749);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylindenylidene)(triphenylphosphine)ruthenium(II) (C931);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene] dichloro(phenylindenylidene) (methylphenylphosphine) ruthenium(II) (C869);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene] dichloro(phenylindenylidene) (tricyclohexylphosphine) ruthenium(II) (C949);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylindenylidene)(diethylphenylphosphine)ruthenium(II)(C835); and[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylindenylidene)(tri-n-butylphosphine)ruthenium(II)(C871).

Additional examples of catalysts useful to prepare supported complexesand in the reactions disclosed herein include the following:[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(tert-butylvinylidene)(tricyclohexylphosphine)ruthenium(II) (C841);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylvinylidene)(tricyclohexylphosphine)ruthenium(II), ruthenium (II) and dichloro(tert-butylvinylidene) bis(tricyclohexylphosphine) (C815).

Still further catalysts useful in ROMP reactions, and/or in othermetathesis reactions, such as ring-closing metathesis, cross metathesis,ring-opening cross metathesis, self-metathesis, ethenolysis,alkenolysis, acyclic diene metathesis polymerization, and combinationsthereof, include the following structures:

In general, the transition metal complexes used as catalysts herein canbe prepared by several different methods, such as those described bySchwab et al. (1996) J. Am. Chem. Soc. 118:100-110, Scholl et al. (1999)Org. Lett. 6:953-956, Sanford et al. (2001) J. Am. Chem. Soc.123:749-750, U.S. Pat. Nos. 5,312,940, and 5,342,909, the disclosures ofeach of which are incorporated herein by reference. Also see U.S. Pat.Pub. No. 2003/0055262 to Grubbs et al., WO 02/079208, and U.S. Pat. No.6,613,910 to Grubbs et al., the disclosures of each of which areincorporated herein by reference. Preferred synthetic methods aredescribed in WO 03/11455A1 to Grubbs et al., the disclosure of which isincorporated herein by reference.

Preferred olefin metathesis catalysts are Group 8 transition metalcomplexes having the structure of formula (I) commonly called “FirstGeneration Grubbs” catalysts, formula (III) commonly called “SecondGeneration Grubbs” catalysts, or formula (VII) commonly called“Grubbs-Hoveyda” catalysts.

More preferred olefin metathesis catalysts have the structure of formula(I)

wherein:

M is a Group 8 transition metal;

L¹, L², and L³ are neutral electron donor ligands;

n is 0 or 1;

m is 0, 1, or 2;

k is 0 or 1;

X¹ and X² are anionic ligands; and

R¹ and R² are independently selected from hydrogen, hydrocarbyl,substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substitutedheteroatom-containing hydrocarbyl, and functional groups,

wherein any two or more of X¹, X², L¹, L², L³, R¹, and R² can be takentogether to form one or more cyclic groups, and further wherein any oneor more of X¹, X², L¹, L², L³, R¹, and R² may be attached to a support;

and formula (VII)

wherein:

M is a Group 8 transition metal;

L¹ is a neutral electron donor ligand;

X¹ and X² are anionic ligands;

Y is a heteroatom selected from 0 or N;

R⁵, R⁶, R⁷, and R⁸ are independently selected from hydrogen,hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl,substituted heteroatom-containing hydrocarbyl, and functional groups;

n is 0, 1, or 2; and

Z is selected from hydrogen, hydrocarbyl, substituted hydrocarbyl,heteroatom-containing hydrocarbyl, substituted heteroatom-containinghydrocarbyl, and functional groups,

wherein any combination of Y, Z, R⁵, R⁶, R⁷, and R⁸ can be linked toform one or more cyclic groups, and further wherein any combination ofX¹, X², L¹, Y, Z, R⁵, R⁶, R⁷, and R⁸ may be attached to a support.

Most preferred olefin metathesis catalysts have the structure of formula(I)

wherein:

M is ruthenium;

n is 0;

m is 0;

k is 1;

L¹ and L² are trisubstituted phosphines independently selected from thegroup consisting of tri-n-butylphosphine (Pn-Bu₃),tricyclopentylphosphine (PCp₃), tricyclohexylphosphine (PCy₃),triisopropylphosphine (P-i-Pr₃), triphenylphosphine (PPh₃),methyldiphenylphosphine (PMePh₂), dimethylphenylphosphine (PMe₂Ph), anddiethylphenylphosphine (PEt₂Ph); or L¹ is an N-heterocyclic carbeneselected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene,1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene,1,3-bis(2,6-di-isopropylphenyl)-2-imidazolidinylidene, and1,3-bis(2,6-di-isopropylphenyl)imidazol-2-ylidene and L² is atrisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ is hydrogen and R² is phenyl or —CH═C(CH₃)₂ or thienyl; or R¹ and R²are taken together to form 3-phenyl-1H-indene;

and formula (VII)

wherein:

M is ruthenium;

L¹ is a trisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);or L¹ is an N-heterocyclic carbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene,1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene,1,3-bis(2,6-di-isopropylphenyl)-2-imidazolidinylidene, and1,3-bis(2,6-di-isopropylphenyl)imidazol-2-ylidene;

X¹ and X² are chloride;

Y is oxygen;

R⁵, R⁶, R⁷, and R⁸ are each hydrogen;

n is 1; and

Z is isopropyl.

Most preferred olefin metathesis catalysts have the structure of formula(I)

wherein:

M is ruthenium;

n is 0;

m is 0;

k is 1;

L¹ and L² are trisubstituted phosphines independently selected from thegroup consisting of tri-n-butylphosphine (Pn-Bu₃),tricyclopentylphosphine (PCp₃), tricyclohexylphosphine (PCy₃),triisopropylphosphine (P-i-Pr₃), triphenylphosphine (PPh₃),methyldiphenylphosphine (PMePh₂), dimethylphenylphosphine (PMe₂Ph), anddiethylphenylphosphine (PEt₂Ph); or L¹ is an N-heterocyclic carbeneselected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene,1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene,1,3-bis(2,6-di-isopropylphenyl)-2-imidazolidinylidene, and1,3-bis(2,6-di-isopropylphenyl)imidazol-2-ylidene and L² is atrisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ is hydrogen and R² is phenyl or —CH═C(CH₃)₂ or thienyl; or R¹ and R²are taken together to form phenylindenylidene;

and formula (VII)

wherein:

M is ruthenium;

L¹ is a trisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);or L¹ is an N-heterocyclic carbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene,1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene,1,3-bis(2,6-di-isopropylphenyl)-2-imidazolidinylidene, and1,3-bis(2,6-di-isopropylphenyl)imidazol-2-ylidene;

X¹ and X² are chloride;

Y is oxygen;

R⁵, R⁶, R⁷, and R⁸ are each hydrogen;

n is 1; and

Z is isopropyl.

Examples of preferred olefin metathesis catalysts have the structure offormula (VII)

wherein:

M is ruthenium;

L¹ is a trisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);or L¹ is an N-heterocyclic carbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene,1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene,1,3-bis(2,6-di-isopropylphenyl)-2-imidazolidinylidene, and1,3-bis(2,6-di-isopropylphenyl)imidazol-2-ylidene;

X¹ and X² are chloride;

Y is oxygen;

R⁵, R⁶, R⁷, and R⁸ are each hydrogen;

n is 1; and

Z is isopropyl.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene and1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ is hydrogen and R² is phenyl or —CH═C(CH₃)₂ or thienyl; or R¹ and R²are taken together to form phenylindenylidene.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ is hydrogen and R² is phenyl or —CH═C(CH₃)₂ or thienyl; or R¹ and R²are taken together to form phenylindenylidene.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ is hydrogen and R² is phenyl or —CH═C(CH₃)₂ or thienyl; or R¹ and R²are taken together to form phenylindenylidene.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene and1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ is hydrogen and R² is phenyl or —CH═C(CH₃)₂; or R¹ and R² are takentogether to form phenylindenylidene.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ is hydrogen and R² is phenyl or —CH═C(CH₃)₂; or R¹ and R² are takentogether to form phenylindenylidene.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ is hydrogen and R² is phenyl or —CH═C(CH₃)₂; or R¹ and R² are takentogether to form phenylindenylidene.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene and1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride;

R¹ is hydrogen; and

R² is phenyl or —CH═C(CH₃)₂.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride;

R¹ is hydrogen; and

R² is phenyl or —CH═C(CH₃)₂.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride;

R¹ is hydrogen; and

R² is phenyl or —CH═C(CH₃)₂.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene and1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ and R² are taken together to form phenylindenylidene.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is Ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ and R² are taken together to form phenylindenylidene.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is ruthenium;

n is 0;

m is 0;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride; and

R¹ and R² are taken together to form phenylindenylidene.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is ruthenium;

n is 0;

m is 1;

k is 1;

L¹ and L² are trisubstituted phosphines independently selected from thegroup consisting of tri-n-butylphosphine (Pn-Bu₃),tricyclopentylphosphine (PCp₃), tricyclohexylphosphine (PCy₃),triisopropylphosphine (P-i-Pr₃), triphenylphosphine (PPh₃),methyldiphenylphosphine (PMePh₂), dimethylphenylphosphine (PMe₂Ph), anddiethylphenylphosphine (PEt₂Ph); or L¹ is an N-heterocyclic carbeneselected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene, and1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, and L² is atrisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride;

R¹ is hydrogen; and

R² is phenyl or tert-butyl.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is ruthenium;

n is 0;

m is 1;

k is 1;

L¹ is an N-heterocyclic carbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene and1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride;

R¹ is hydrogen; and

R² is phenyl or tert-butyl.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

wherein:

M is ruthenium;

n is 0;

m is 1;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene;

L² is a trisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride;

R¹ is hydrogen; and

R² is phenyl or tert-butyl.

Examples of preferred olefin metathesis catalysts have the structure offormula (I)

in which:

M is ruthenium;

n is 0;

m is 1;

k is 1;

L¹ is an N-heterocyclic carbene1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene;

L² is a trisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);

X¹ and X² are chloride;

R¹ is hydrogen; and

R² is phenyl or tert-butyl.

Suitable supports for any of the catalysts described herein may be ofsynthetic, semi-synthetic, or naturally occurring materials, which maybe organic or inorganic, e.g., polymeric, ceramic, or metallic.Attachment to the support will generally, although not necessarily, becovalent, and the covalent linkage may be direct or indirect. Indirectcovalent linkages are typically, though not necessarily, through afunctional group on a support surface. Ionic attachments are alsosuitable, including combinations of one or more anionic groups on themetal complexes coupled with supports containing cationic groups, orcombinations of one or more cationic groups on the metal complexescoupled with supports containing anionic groups.

When utilized, suitable supports may be selected from silicas,silicates, aluminas, aluminum oxides, silica-aluminas, aluminosilicates,zeolites, titanias, titanium dioxide, magnetite, magnesium oxides, boronoxides, clays, zirconias, zirconium dioxide, carbon, polymers,cellulose, cellulosic polymers amylose, amylosic polymers, or acombination thereof. The support preferably comprises silica, asilicate, or a combination thereof.

In certain embodiments, it is also possible to use a support that hasbeen treated to include functional groups, inert moieties, and/or excessligands. Any of the functional groups described herein are suitable forincorporation on the support, and may be generally accomplished throughtechniques known in the art. Inert moieties may also be incorporated onthe support to generally reduce the available attachment sites on thesupport, e.g., in order to control the placement, or amount, of acomplex linked to the support.

The metathesis catalysts that are described infra may be utilized inolefin metathesis reactions according to techniques known in the art.The catalyst is typically added to the resin composition as a solid, asolution, or as a suspension. When the catalyst is added to the resincomposition as a suspension, the catalyst is suspended in a dispersingcarrier such as mineral oil, paraffin oil, soybean oil,tri-isopropylbenzene, or any hydrophobic liquid which has a sufficientlyhigh viscosity so as to permit effective dispersion of the catalyst, andwhich is sufficiently inert and which has a sufficiently high boilingpoint so that is does not act as a low-boiling impurity in the olefinmetathesis reaction. It will be appreciated that the amount of catalystthat is used (i.e., the “catalyst loading”) in the reaction is dependentupon a variety of factors such as the identity of the reactants and thereaction conditions that are employed. It is therefore understood thatcatalyst loading may be optimally and independently chosen for eachreaction. In general, however, the catalyst will be present in an amountthat ranges from a low of about 0.1 ppm, 1 ppm, or 5 ppm, to a high ofabout 10 ppm, 15 ppm, 25 ppm, 50 ppm, 100 ppm, 200 ppm, 500 ppm, or 1000ppm relative to the amount of an olefinic substrate.

The catalyst will generally be present in an amount that ranges from alow of about 0.00001 mol %, 0.0001 mol %, or 0.0005 mol %, to a high ofabout 0.001 mol %, 0.0015 mol %, 0.0025 mol %, 0.005 mol %, 0.01 mol %,0.02 mol %, 0.05 mol %, or 0.1 mol % relative to the olefinic substrate.

When expressed as the molar ratio of monomer to catalyst, the catalyst(the “monomer to catalyst ratio”), loading will generally be present inan amount that ranges from a low of about 10,000,000:1, 1,000,000:1, or200,000:1, to a high of about 100,000:1 66,667:1, 40,000:1, 20,000:1,10,000:1, 5,000:1, or 1,000:1.

Cyclic Olefin (Resin) Compositions and Articles

Cyclic olefin resin, particularly ROMP, compositions according to theinvention, generally comprise at least one cyclic olefin, at least oneolefin metathesis catalyst, at least one adhesion promoter compositionof the invention, and at least one substrate material, such as, forexample, a glass or carbon substrate material. In another embodiment,cyclic olefin resin, particularly ROMP, compositions according to theinvention, generally comprise at least one cyclic olefin, at least oneolefin metathesis catalyst, at least one adhesion promoter compositionof the invention, and at least one heteroatom-functionalized substrate.The cyclic olefins described hereinabove are suitable for use and may befunctionalized or unfunctionalized, and may be substituted orunsubstituted. In general, particularly advantageous results may beobtained for ROMP resin compositions wherein an adhesion promotercomposition of the invention is present in an amount effective toimprove the adhesion of the ROMP composition to the substrate materialwhen the ROMP composition is subjected to metathesis catalysisconditions in the presence of the substrate material. Additionally,cyclic olefin resin compositions according to the invention may alsocomprise at least one cyclic olefin, at least one adhesion promotercomposition of the invention, where the resin composition is combinedwith at least one olefin metathesis catalyst, and the resulting resincomposition is applied to at least one substrate, such as, for example,a glass substrate or carbon substrate. Additionally, cyclic olefin resincompositions according to the invention may also comprise at least onecyclic olefin, at least one adhesion promoter composition of theinvention, where the resin composition is combined with at least oneolefin metathesis catalyst, and the resulting resin composition isapplied to at least one substrate, wherein the substrate may befunctionalized substrate, such as, for example, aheteroatom-functionalized substrate, such as, for example, anamino-functionalized substrate.

The amounts of the adhesion promoter composition in the resincomposition may vary over a wide range and may vary depending on themanufacturing operation or the particular end-use application.Generally, any level of adhesion promoter composition which produces adesired increase in mechanical properties is of particular interest.When formulated or combined with a resin composition, the concentrationof the adhesion promoter composition typically ranges from 0.001-50 phr,particularly 0.05-10 phr, more particularly 0.1-10 phr, or even moreparticularly 0.5-4.0 phr.

In a preferred aspect of the invention, increased mechanical propertiesmay also be obtained for resin compositions comprising at least onecyclic olefin, at least one olefin metathesis catalyst, at least oneadhesion promoter composition of the invention, and at least onesubstrate material, or resin compositions comprising at least one cyclicolefin, at least one olefin metathesis catalyst, at least one adhesionpromoter composition of the invention where the resin composition isapplied to at least one substrate material, compared to such resincompositions without the adhesion promoter composition of the invention.For example, the inclusion of an adhesion promoter composition of theinvention may provide an improvement in mechanical properties, such asinterlaminar shear strength (ILSS) compared to the same resincomposition that does not contain an adhesion promoter composition ofthe invention. In particular aspects of the present invention, substratematerials may advantageously comprise an aminosilane-treated substrate.

In another embodiment, resin compositions according to the invention mayadditionally comprise an exogenous inhibitor. Exogenous inhibitors or“gel modification additives”, for use in the present invention aredisclosed in U.S. Pat. No. 5,939,504, the contents of which areincorporated herein by reference. In another embodiment, resincompositions according to the invention may additionally comprise ahydroperoxide gel modifier. Hydroperoxide gel modifiers for use in thepresent invention are disclosed in International Pat. App. No.PCT/US2012/042850, the contents of which are incorporated herein byreference.

Resin compositions of the invention may be optionally formulated withadditives. Suitable additives include, but are not limited to, gelmodifiers, hardness modulators, antioxidants, antiozonants, stabilizers,impact modifiers, fillers, binders, coupling agents, thixotropes,wetting agents, biocides, plasticizers, pigments, flame retardants,dyes, fibers and reinforcement materials, including sized reinforcementsand substrates, such as those treated with finishes, coatings, couplingagents, film formers and/or lubricants. Furthermore, the amount ofadditives present in the resin compositions may vary depending on theparticular type of additive used. The concentration of the additives inthe resin compositions typically ranges from, for example, 0.001-85percent by weight, particularly, from 0.1-75 percent by weight, or evenmore particularly, from 2-60 percent by weight.

Suitable impact modifiers or elastomers include without limitationnatural rubber, butyl rubber, polyisoprene, polybutadiene,polyisobutylene, ethylene-propylene copolymer, styrene-butadiene-styrenetriblock rubber, random styrene-butadiene rubber,styrene-isoprene-styrene triblock rubber,styrene-ethylene/butylene-styrene copolymer,styrene-ethylene/propylene-styrene copolymer, ethylene-propylene-dieneterpolymers, ethylene-vinyl acetate and nitrile rubbers. Preferredimpact modifiers or elastomers are polybutadiene Diene 55AC10(Firestone), polybutadiene Diene 55AM5 (Firestone), EPDM Royalene 301T,EPDM Buna T9650 (Lanxess), styrene-ethylene/butylene-styrene copolymerKraton G1651H, Butyl 301 isobutylene-isoprene copolymer (Lanxess), BunaCB 710 polybutadiene (formerly Taktene® 710; Lanxess),styrene-ethylene/butylene-styrene Kraton G1726M, Ethylene-Octene Engage8150 (DuPont-Dow), styrene-butadiene Kraton D1184, EPDM Nordel 1070(DuPont-Dow), and polyisobutylene Vistanex MML-140 (Exxon). Suchmaterials are normally employed in the resin composition at levels ofabout 0.10 phr to 10 phr, but more preferably at levels of about 0.1 phrto 5 phr. Various polar impact modifiers or elastomers can also be used.

Resin compositions of the invention may be optionally formulated with orwithout a crosslinker, for example, a crosslinker selected from dialkylperoxides, diacyl peroxides, and peroxyacids.

Antioxidants and antiozonants include any antioxidant or antiozonantused in the rubber or plastics industry. An “Index of CommercialAntioxidants and Antiozonants, Fourth Edition” is available fromGoodyear Chemicals, The Goodyear Tire and Rubber Company, Akron, Ohio44316. Suitable stabilizers (i.e., antioxidants or antiozonants) includewithout limitation: 2,6-di-tert-butyl-4-methylphenol (BHT); styrenatedphenol, such as Wingstay® S (Goodyear); 2- and3-tert-butyl-4-methoxyphenol; alkylated hindered phenols, such asWingstay C (Goodyear); 4-hydroxymethyl-2,6-di-tert-butylphenol;2,6-di-tert-butyl-4-sec-butylphenol;2,2′-methylenebis(4-methyl-6-tert-butylphenol);2,2′-methylenebis(4-ethyl-6-tert-butylphenol);4,4′-methylenebis(2,6-di-tert-butylphenol); miscellaneous bisphenols,such as Cyanox® 53 and Permanax WSO;2,2′-ethylidenebis(4,6-di-tert-butylphenol);2,2′-methylenebis(4-methyl-6-(1-methylcyclohexyl)phenol);4,4′-butylidenebis(6-tert-butyl-3-methylphenol); polybutylated BisphenolA; 4,4′-thiobis(6-tert-butyl-3-methylphenol);4,4′-methylenebis(2,6-dimethylphenol); 1,1′-thiobis(2-naphthol);methylene bridged polyaklylphenol, such as Ethyl antioxidant 738;2,2′-thiobis(4-methyl-6-tert-butylphenol);2,2′-isobutylidenebis(4,6-dimethylphenol);2,2′-methylenebis(4-methyl-6-cyclohexylphenol); butylated reactionproduct of p-cresol and dicyclopentadiene, such as Wingstay L;tetrakis(methylene-3,5-di-tert-butyl-4-hydroxyhydrocinnamate)methane,i.e., Irganox 1010;1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene,e.g., Ethanox 330; 4,4′-methylenebis (2,6-di-tertiary-butylphenol),e.g., Ethanox 4702 or Ethanox 4710;1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, i.e.,Good-rite 3114, 2,5-di-tert-amylhydroquinone, tert-butylhydroquinone,tris(nonylphenylphosphite),bis(2,4-di-tert-butyl)pentaerythritol)diphosphite, distearylpentaerythritol diphosphite, phosphited phenols and bisphenols, such asNaugard 492, phosphite/phenolic antioxidant blends, such as IrganoxB215; di-n-octadecyl(3,5-di-tert-butyl-4-hydroxybenzyl)phosphonate, suchas Irganox 1093; 1,6-hexamethylenebis(3-(3,5-di-tert-butyl-4-hydroxyphenylpropionate), such as Irganox259, and octadecyl-3,5-di-tert-butyl-4-hydroxyhydrocinnamate, i.e.,Irganox 1076,tetrakis(2,4-di-tert-butylphenyl)4,4′-biphenylylenediphosphonite,diphenylamine, and 4,4′-diemthoxydiphenylamine. Such materials arenormally employed in the resin composition at levels of about 0.10 phrto 10 phr, but more preferably at levels of about 0.1 phr to 5 phr.

Suitable reinforcing materials include those that add to the strength orstiffness of a polymer composite when incorporated with the polymer.Reinforcing materials can be in the form of filaments, fibers, rovings,mats, weaves, fabrics, knitted material, cloth, or other knownstructures. Suitable reinforcement materials include glass fibers andfabrics, carbon fibers and fabrics, aramid fibers and fabrics,polyolefin fibers or fabrics (including ultrahigh molecular weightpolyethylene fabrics such as those produced by Honeywell under theSpectra trade name), and polyoxazole fibers or fabrics (such as thoseproduced by the Toyobo Corporation under the Zylon trade name).Reinforcing materials containing surface finishes, sizings, or coatingsare particularly suitable for the described invention including Ahlstromglass roving (R338-2400), Johns Manville glass roving (Star ROV®-086),Owens Corning rovings (OCV 366-AG-207, R25H-X14-2400, SE1200-207,SE1500-2400, SE2350-250), PPG glass rovings (Hybon® 2002, Hybon® 2026),Toho Tenax® carbon fiber tow (HTR-40), and Zoltek carbon fiber tow(Panex® 35). Furthermore, any fabrics prepared using reinforcingmaterials containing surface finishes, sizings or coatings are suitablefor the invention. Advantageously, the invention does not require theexpensive process of removing of surface finishes, sizings, or coatingsfrom the reinforcing materials. Additionally, glass fibers or fabricsmay include without limitation A-glass, E-glass or S-glass, S-2 glass,C-glass, R-glass, ECR-glass, M-glass, D-glass, and quartz, andsilica/quartz. Preferred glass fiber reinforcements are those withfinishes formulated for use with epoxy, vinyl ester, and/or polyurethaneresins. When formulated for use with a combination of these resin types,the reinforcements are sometimes described as “multi-compatible.” Suchreinforcements are generally treated during their manufacture withorganosilane coupling agents comprising vinyl, amino, glycidoxy, ormethacryloxy functional groups (or various combinations thereof) and arecoated with a finish to protect the fiber surface and facilitatehandling and processing (e.g., spooling and weaving). Finishes typicallycomprise a mixture of chemical and polymeric compounds such as filmformers, surfactants, and lubricants. Especially preferred glassreinforcements are those containing some amount of amino-functionalizedsilane coupling agent. Especially preferred finishes are thosecomprising and epoxy-based and/or polyurethane-based film formers.Examples of preferred glass-fiber reinforcements are those based onHybon® 2026, 2002, and 2001 (PPG) multi-compatible rovings; AhlstromR338 epoxysilane-sized rovings; StarRov® 086 (Johns Manville) softsilane sized multi-compatible rovings; OCV™ 366, SE 1200, and R25H(Owens Corning) multi-compatible rovings; OCV™ SE 1500 and 2350 (OwensCorning) epoxy-compatible rovings; and Jushi Group multi-compatibleglass rovings (752 type, 396 type, 312 type, 386 type). Additionalsuitable polymer fibers and fabrics may include without limitation oneor more of polyester, polyamide (for example, NYLON polamide availablefrom E.I. DuPont, aromatic polyamide (such as KEVLAR aromatic polyamideavailable from E.I. DuPont, or P84 aromatic polyamide available fromLenzing Aktiengesellschaft), polyimide (for example KAPTON polyimideavailable from E.I. DuPont, polyethylene (for example, DYNEEMApolyethylene from Toyobo Co., Ltd.). Additional suitable carbon fibersmay include without limitation AS2C, AS4, AS4C, AS4D, AS7, IM6, IM7,IM9, and PV42/850 from Hexcel Corporation; TORAYCA T300, T300J, T400H,T600S, T700S, T700G, T800H, T800S, T1000G, M35J, M40J, M46J, M50J, M55J,M60J, M305, M30G and M40 from Toray Industries, Inc.; HTS12K/24K,G30-500 3k/6K/12K, G30-500 12K, G30-700 12K, G30-7000 24K F402, G40-80024K, STS 24K, HTR 40 F22 24K 1550tex from Toho Tenax, Inc.; 34-700,34-700WD, 34-600, 34-600WD, and 34-600 unsized from Grafil Inc.; T-300,T-650/35, T-300C, and T-650/35C from Cytec Industries. Additionallysuitable carbon fibers may include without limitation AKSACA (A42/D011),AKSACA (A42/D012), Blue Star Starafil (10253512-90), Blue Star Starafil(10254061-130), SGL Carbon (C30 T050 1.80), SGL Carbon (C50 T024 1.82),Grafil (347R1200U), Grafil (THR 6014A), Grafil (THR 6014K), HexcelCarbon (AS4C/EXP 12K), Mitsubishi (Pyrofil TR 50S 12L AF), Mitsubishi(Pyrofil TR 50S 12L AF), Toho Tenax (T700SC 12000-50C), Toray (T700SC12000-90C), Zoltek (Panex 35 50K, sizing 11), Zoltek (Panex 35 50K,sizing 13). Additional suitable carbon fabrics may include withoutlimitation Carbon fabrics by Vectorply (C-L 1800) and Zoltek (Panex 35UD Fabic-PX35UD0500-1220). Additionally suitable glass fabrics mayinclude without limitation glass fabrics as supplied by Vectorply (E-LT3500-10) based on PPG Hybon® 2026; Saertex (U14EU970-01190-T2525-125000)based on PPG Hybon® 2002; Chongqing Polycomp Internation Corp. (CPICFiberglass) (EKU 1150(0)/50-600); and Owens Corning (L1020/07A06 Xweft200tex), and SGL Kumpers (HPT970) based on PPG Hybon® 2002.

Other suitable fillers include, for example, metallic densitymodulators, microparticulate density modulators, such as, for example,microspheres, and macroparticulate density modulators, such as, forexample, glass or ceramic beads. Metallic density modulators include,but are not limited to, powdered, sintered, shaved, flaked, filed,particulated, or granulated metals, metal oxides, metal nitrides, and/ormetal carbides, and the like. Preferred metallic density modulatorsinclude, among others, tungsten, tungsten carbide, aluminum, titanium,iron, lead, silicon oxide, aluminum oxide, boron carbide, and siliconcarbide. Microparticulate density modulators include, but are notlimited to, glass, metal, thermoplastic (either expandable orpre-expanded) or thermoset, and/or ceramic/silicate microspheres.Macroparticulate density modulators include, but are not limited to,glass, plastic, or ceramic beads; metal rods, chunks, pieces, or shot;hollow glass, ceramic, plastic, or metallic spheres, balls, or tubes;and the like.

The invention is also directed to articles manufactured from a resincomposition comprising a at least one cyclic olefin, at least one olefinmetathesis catalyst, at least one storage stable adhesion promotercomposition, and at least one substrate material, where the at least onestorage stable adhesion promoter composition is a pre-reacted mixture ofat least one compound containing at least two isocyanate groups and atleast one compound comprising at least one heteroatom-containingfunctional group and at least one metathesis active olefin.Additionally, the invention is directed to articles manufactured from aresin composition comprising at least one cyclic olefin and at least onestorage stable adhesion promoter composition, where the where the atleast one storage stable adhesion promoter composition is a pre-reactedmixture of at least one compound containing at least two isocyanategroups and at least one compound comprising at least oneheteroatom-containing functional group and at least one metathesisactive olefin, where the resin composition is combined with an olefinmetathesis catalyst, and the resulting resin composition is applied to asubstrate, which may be, for example, a functionalized substrate, suchas, for example, a heteroatom-functionalized substrate, such as, forexample, an amino-functionalized substrate.

Articles may include, but are not limited to, those formed by standardmanufacturing techniques including casting, centrifugal casting,pultrusion, molding, rotational molding, open molding, reactioninjection molding (RIM), resin transfer molding (RTM), pouring, vacuumimpregnation, surface coating, filament winding and other methods knownto be useful for production of polymer articles. Molded parts includebut are not limited to reaction injection molding, resin transfermolding, and vacuum assisted resin transfer molding. Furthermore, thecompositions and articles of manufacture of the invention are notlimited to a single polymer-surface interface but include alsomultilayers and laminates containing multiple polymer-surfaceinterfaces. The invention is also suitable for manufacture of articlesby the infusion of the resin into a porous material. Such porousmaterials include but are not limited to wood, cement, concrete,open-cell and reticulated foams and sponges, papers, cardboards, felts,ropes or braids of natural or synthetic fibers, and various sinteredmaterials. Additionally, other manufacturing techniques include withoutlimitation cell casting, dip casting, continuous casting, embedding,potting, encapsulation, film casting or solvent casting, gated casting,mold casting, slush casting, extrusion, mechanical foaming, chemicalfoaming, physical foaming, compression molding or matched die molding,spray up, Vacuum Assisted Resin Transfer Molding (VARTM), Seeman'sComposite Resin Infusion Molding Process (SCRIMP), blow molding, in moldcoating, in-mold painting or injection, vacuum forming, ReinforcedReaction Injection Molding (RRIM), Structural Reaction Injection Molding(SRIM), thermal expansion transfer molding (TERM), resin injectionrecirculation molding (RICM), controlled atmospheric pressure resininfusion (CAPRI), hand-layup. For manufacturing techniques requiring theuse of a RIM or impingement style mixhead, including without limitationRIM, SRIM, and RRIM, articles of manufacture may be molded using asingle mixhead or a plurality of mixheads as well as a plurality ofmaterial injection streams (e.g., two resin streams and one catalyststream).

Furthermore, the present invention also allows for the making ofarticles of manufacture of any configuration, weight, size, thickness,or geometric shape. Examples of articles of manufacture include withoutlimitation any molded or shaped article for use as an aerospacecomponent, a marine component, an automotive component, a sporting goodscomponent, an electrical component, and industrial component, medicalcomponent, dental component, or military component. In one embodiment anarticle may be a turbine component used on aircraft or general powergeneration. In one embodiment, turbine components may include withoutlimitation one or more of an inlet, pylon, pylon fairing, an acousticpanel, a thrust reverser panel, a fan blade, a fan containment case, abypass duct, an aerodynamic cowl, or an airfoil component. In oneembodiment, an article may be a turbine blade component or may be aturbine blade. In one embodiment, an article may be a wind rotor blade,tower, spar cap, or nacelle for wind turbines. In one embodiment, anarticle may be an airframe component. Examples of aerospace componentsmay include without limitation one or more of fuselage skin, wing,fairing, doors, access panel, aerodynamic control surface, or stiffner.In one embodiment an article may be an automotive component. Examples ofautomotive components may include without limitation one or more of bodypanel, fender, spoiler, truck bad, protective plate, hood, longitudinalrail, pillar, or door. Examples of industrial components may includewithout limitation one or more of risers platforms, impact protectionstructures for oil and gas; bridges, pipes, pressure vessels, powerpoles, coils, containers, tanks, liners, containment vessels, articlesfor application in corrosive environments (e.g., chlor-alkali, caustic,acidic, brine, etc.), reinforcement structures for concretearchitectures and roads, or radiators. Examples of electrical componentsmay include without limitation one or more wound articles, such as coilsor electric motors, or insulating devices. In one embodiment, an articlemay be an eddy-current shielding component of a magnetic resonanceimaging system or shielding component for any electromagnetic radiation.In one embodiment, an article may be a military component includingwithout limitation ballistics resistant armor for personnel or vehicles,or ballistics resistant structures for protecting personnel orequipment. In one embodiment, an article may be a sporting goodscomponent including without limitation an arrow shaft, a tennis racketframe, a hockey stick, compound bow limbs, or a golf club shaft.

Resin compositions according to the invention may further comprise asizing composition, or be used to provide improved adhesion to substratematerials that are sized with certain commercial silanes commonly usedin the industry. As is known in the art, glass fibers are typicallytreated with a chemical solution (e.g., a sizing composition) soon aftertheir formation to reinforce the glass fibers and protect the strands'mechanical integrity during processing and composite manufacture. Sizingtreatments compatible with olefin metathesis catalysts andpolydicyclopentadiene composites have been described in U.S. Pat. Nos.6,890,650 and 6,436,476, the disclosures of both of which areincorporated herein by reference. However, these disclosures are basedon the use of specialty silane treatments that are not commonly used inindustrial glass manufacture. By comparison, the current invention mayprovide improved mechanical properties for polymer-glass composites thatare sized with silanes commonly used in the industry.

Glass sizing formulations typically comprise at least one film former(typically a film forming polymer), at least one silane, and at leastone lubricant. Any components of a sizing formulation that do notinterfere with or substantially decrease the effectiveness of themetathesis catalyst or olefin polymerization reaction are considered tobe compatible with the current invention and may generally be usedherein.

Film formers that are compatible with ROMP catalysts include epoxies,polyesters, polyurethanes, polyolefins, and/or polyvinyl acetates. Othercommon film formers that do not adversely affect the performance of theolefin metathesis catalyst may also be used. Film formers are typicallyused as nonionic, aqueous emulsions. More than one film former may beused in a given sizing formulation, to achieve a desired balance ofglass processability and composite mechanical properties.

More particularly, the film former may comprise a low molecular weightepoxy emulsion, defined as an epoxy monomer or oligomer with an averagemolecular weight per epoxide group (EEW) of less than 500, and/or a highmolecular weight epoxy emulsion, defined as an epoxy monomer or oligomerwith an average molecular weight per epoxide group (EEW) of greater than500. Examples of suitable low molecular weight products include aqueousepoxy emulsions produced by Franklin International, including FranklinK8-0203 (EEW 190) and Franklin E-102 (EEW 225-275). Other examples oflow molecular weight epoxy emulsions are available from Hexion,including EPI-REZ™ 3510-W-60 (EEW 185-215), and EPI-REZ™ 3515-W-60 (EEW225-275). Further examples of low molecular weight epoxy emulsions areavailable from COIM, including Filco 309 (EEW 270) and Filco 306 (EEW330). Further examples of low molecular weight epoxy emulsions areavailable from DSM, including Neoxil® 965 (EEW 220-280) and Neoxil® 4555(EEW 220-260). Examples of suitable high molecular weight epoxy emulsionproducts include epoxy emulsions produced by Hexion, including EPI-REZ™3522-W-60 (EEW 615-715).

Aqueous emulsions of modified epoxies, polyesters, and polyurethanes mayalso be used in the film former. Examples of suitable modified epoxyproducts include emulsions produced by DSM, including Neoxil® 2626 (aplasticized epoxy with an EEW of 500-620), Neoxil® 962/D (an epoxy-esterwith an EEW of 470-550), Neoxil® 3613 (an epoxy-ester with an EEW of500-800), Neoxil® 5716 (an epoxy-novolac with an EEW of 210-290),Neoxil® 0035 (a plasticized epoxy-ester with an EEW of 2500), andNeoxil® 729 (a lubricated epoxy with an EEW of 200-800). Furtherexamples of modified epoxy emulsions are available from COIM, includingFilco 339 (an unsaturated polyester-epoxy with an EEW of 2000) and Filco362 (an epoxy-ester with an EEW of 530). Examples of suitable polyesterproducts include emulsions produced by DSM, including Neoxil® 954/D,Neoxil® 2635, and Neoxil® 4759 (unsaturated bisphenolic polyesters).Additional suitable products from DSM include Neoxil® 9166 and Neoxil®968/60 (adipate polyesters). Further examples of suitable productsinclude emulsions produced by COIM, including Filco 354/N (unsaturatedbisphenolic polyester), Filco 350 (unsaturated polyester), and Filco 368(saturated polyester). Examples of suitable polyurethane productsinclude emulsions produced by Bayer Material Science, including Baybond®330 and Baybond® 401.

The film former may also comprise polyolefins or polyolefin-acryliccopolymers, polyvinylacetates, modified polyvinylacetates, orpolyolefin-acetate copolymers. Suitable polyolefins include, but are notlimited to, polyethylenes, polypropylenes, polybutylenes, and copolymersthereof, and the polyolefins may be oxidized, maleated, or otherwisetreated for effective film former use. Examples of suitable productsinclude emulsions produced by Michelman, including Michem® Emulsion91735, Michem® Emulsion 35160, Michem® Emulsion 42540, Michem® Emulsion69230, Michem® Emulsion 34040M1, Michem® Prime 4983R, and Michem® Prime4982SC. Examples of suitable products include emulsions produced by HBFuller, including PD 708H, PD 707, and PD 0166. Additional suitableproducts include emulsions produced by Franklin International, includingDuracet® 637. Additional suitable products include emulsions produced byCelanese, including Vinamul® 8823 (plasticized polyvinylacetate),Dur-O-Set® E-200 (ethylene-vinyl acetate copolymer), Dur-O-Set®TX840(ethylene-vinyl acetate copolymer), and Resynx 1971 (epoxy-modifiedpolyvinylacetate).

While not limited thereto, preferred film formers include low- andhigh-molecular weight epoxies, saturated and unsaturated polyesters, andpolyolefins, such as Franklin K80-203, Franklin E-102, Hexion 3510-W-60,Hexion 3515-W-60, and Michelman 35160.

Nonionic lubricants may also be added to the sizing composition.Suitable nonionic lubricants that are compatible with ROMP compositionsinclude esters of polyethylene glycols and block copolymers of ethyleneoxide and propylene oxide. More than one nonionic lubricant may be usedin a given sizing formulation if desired, e.g., to achieve a desiredbalance of glass processability and composite mechanical properties.

Suitable lubricants may contain polyethylene glycol (PEG) units with anaverage molecular weight between 200 and 2000, preferably between200-600. These PEG units can be esterified with one or more fatty acids,including oleate, tallate, laurate, stearate, and others. Particularlypreferred lubricants include PEG 400 dilaurate, PEG 600 dilaurate, PEG400 distearate, PEG 600 distearate, PEG 400 dioleate, and PEG 600dioleate. Examples of suitable products include compounds produced byBASF, including MAPEG® 400 DO, MAPEG® 400 DOT, MAPEG® 600 DO, MAPEG® 600DOT, and MAPEG® 600 DS. Additional suitable products include compoundsproduced by Zschimmer & Schwarz, including Mulsifan 200 DO, Mulsifan 400DO, Mulsifan 600 DO, Mulsifan 200 DL, Mulsifan 400 DL, Mulsifan 600 DL,Mulsifan 200 DS, Mulsifan 400 DS, and Mulsifan 600 DS. Additionalsuitable products include compounds produced by Cognis, includingAgnique® PEG 300 DO, Agnique® PEG 400 DO, and Agnique® PEG 600 DO.

Suitable nonionic lubricants also include block copolymers of ethyleneoxide and propylene oxide. Examples of suitable products includecompounds produced by BASF, including Pluronic® L62, Pluronic® L101,Pluronic® P103, and Pluronic® P105.

Cationic lubricants may also be added to the sizing composition.Cationic lubricants that are compatible with ROMP include modifiedpolyethyleneimines, such as Emery 6760L produced by Pulcra Chemicals.

Silane coupling agent may optionally be added to the sizing composition,non-limiting examples including, methacrylate, acrylate, amino, or epoxyfunctionalized silanes along with alkyl, alkenyl, and norbornenylsilanes.

Optionally, the sizing composition may contain one or more additives formodifying the pH of the sizing resin. One preferred pH modifier isacetic acid.

The sizing composition may optionally contain other additives useful inglass sizing compositions. Such additives may include emulsifiers,defoamers, cosolvents, biocides, antioxidants, and additives designed toimprove the effectiveness of the sizing composition. The sizingcomposition can be prepared by any method and applied to substratematerials for use herein, such as glass fibers or fabric, by anytechnique or method.

In a preferred embodiment, the metathesis reactions disclosed herein arecarried out under a dry, inert atmosphere. Such an atmosphere may becreated using any inert gas, including such gases as nitrogen and argon.The use of an inert atmosphere is optimal in terms of promoting catalystactivity, and reactions performed under an inert atmosphere typicallyare performed with relatively low catalyst loading. The reactionsdisclosed herein may also be carried out in an oxygen-containing and/ora water-containing atmosphere, and in one embodiment, the reactions arecarried out under ambient conditions. The presence of oxygen or water inthe reaction may, however, necessitate the use of higher catalystloadings as compared with reactions performed under an inert atmosphere.Where the vapor pressure of the reactants allows, the reactionsdisclosed herein may also be carried out under reduced pressure.

The reactions disclosed herein may be carried out in a solvent, and anysolvent that is inert towards cross-metathesis may be employed.Generally, solvents that may be used in the metathesis reactions includeorganic, protic, or aqueous solvents, such as aromatic hydrocarbons,chlorinated hydrocarbons, ethers, aliphatic hydrocarbons, alcohols,water, or mixtures thereof. Example solvents include benzene, toluene,p-xylene, methylene chloride, 1,2-dichloroethane, dichlorobenzene,chlorobenzene, tetrahydrofuran, diethylether, pentane, methanol,ethanol, water, or mixtures thereof. In a preferred embodiment, thereactions disclosed herein are carried out neat, i.e., without the useof a solvent.

It will be appreciated that the temperature at which a metathesisreaction according to methods disclosed herein is conducted can beadjusted as needed, and may be at least about −78° C., −40° C., −10° C.,0° C., 10° C., 20° C., 25° C., 35° C., 50° C., 70° C., 100° C., or 150°C., or the temperature may be in a range that has any of these values asthe upper or lower bounds. In a preferred embodiment, the reactions arecarried out at a temperature of at least about 35° C., and in anotherpreferred embodiment, the reactions are carried out at a temperature ofat least about 50° C.

It is to be understood that while the invention has been described inconjunction with specific embodiments thereof, the description above aswell as the examples that follow are intended to illustrate and notlimit the scope of the invention. Other aspects, advantages, andmodifications within the scope of the invention will be apparent tothose skilled in the art to which the invention pertains.

EXPERIMENTAL

In the following examples, efforts have been made to ensure accuracywith respect to numbers used (e.g., amounts, temperature, etc.) but someexperimental error and deviation should be accounted for. Unlessindicated otherwise, temperature is in degrees Celsius (° C.), pressureis at or near atmospheric, viscosity is in centipoise (cP).

The following examples are to be considered as not being limiting of theinvention as described herein, and are instead provided asrepresentative examples of the adhesion promoter compositions of theinvention and the methods for their use.

EXAMPLES Materials and Methods

All glassware was oven dried and reactions were performed under ambientconditions unless otherwise noted. All solvents and reagents werepurchased from commercial suppliers and used as received unlessotherwise noted.

Dicyclopentadiene (Ultrene® 99) (DCPD) was obtained from CymetechCorporation. A modified DCPD base resin containing 20-25%tricyclopentadiene (and small amounts of higher cyclopentadienehomologs) was prepared by heat treatment of Ultrene® 99 generally asdescribed in U.S. Pat. No. 4,899,005. A modified DCPD base resincontaining 6-8% tricyclopentadiene (and small amounts of highercyclopentadiene homologs) was prepared by heat treatment of Ultrene® 99generally as described in U.S. Pat. No. 4,899,005.

Liquid MDI (50/50 mixture of 4,4′-MDI and 2,4′-MDI) was used as receivedfrom Bayer Material Science (Mondur® MLQ) and was used where indicated.Solid MDI (4,4′-methylene diphenyl diisocyanate) was used as receivedfrom Sigma Aldrich (98% purity). Ethanox® 4702 antioxidant(4,4′-methylenebis(2,6-di-tertiary-butylphenol), Albemarle Corporation)was used where indicated. Crystal Plus 70FG mineral oil, containing 2phr CAB-O-SIL® TS610 fumed silica (Cabot), was used to prepare thecatalyst suspensions. Triphenylphosphine (TPP) was used as received fromArkema. A hydroperoxide gel modifier, cumene hydroperoxide (CHP) wasused as received from Sigma Aldrich (88% purity, unless otherwisespecified) or Syrgis Performance Initiators (Norox® CHP, 85%). CHP wasadded to resin formulations as a 1,000 ppm concentration stock solutionin DCPD. Additionally, CHP from Akzo Nobel Polymer Chemicals (Trigonox®K-90, 88%) was used as received and added to the resin formulation(Table 10, Example 31(d) and Table 11, Example 32(d). Oleyl alcohol wasused as received from Sigma Aldrich (technical grade, 85%). 9-decen-1-olwas used as received from Sigma Aldrich (97% purity).

Olefin metathesis catalysts were prepared by standard methods andinclude[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(3-methyl-2-butenylidene)(tricyclohexylphosphine) ruthenium(II) (C827); ruthenium (II) dichloro(3-methyl-2-butenylidene) bis(tricyclohexylphosphine) (C801);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(o-isopropoxyphenylmethylene)ruthenium(II)(C627);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(benzylidene)(tri-n-butylphosphine)ruthenium(II)(C771);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(3-methyl-2-butenylidene)(methyldiphenylphosphine)ruthenium(II)(C747);[1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylindenylidene)(diethylphenylphosphine)ruthenium(II)(C835).

Glass fabrics were used as supplied by Vectorply (E-LT 3500-10) based onPPG Hybon® 2026 (“Vectorply Glass Fabric”); Saertex(U14EU970-01190-T2525-125000) based on PPG Hybon® 2002 (“Saertex GlassFabric”); Chongqing Polycomp Internation Corp. (CPIC Fiberglass) (EKU1150(0)/50-600) (“CPIC Glass Fabric”); Owens Corning (L1020/07A06 Xweft200tex) (“Owens Corning Glass Fabric”); SGL Kumpers (HPT970) based onPPG Hybon® 2002 (“SGL Glass Fabric”).

Carbon fabrics were used as supplied by Vectorply (C-L 1800) (“VectorplyCarbon Fabric”); Zoltek (Panex 35 UD Fabic-PX35UD0500-1220) (“ZoltekCarbon Fabric”).

Additives to the resin are reported as ppm, which is defined as theweight in grams of additive per million grams of resin, or as phr, whichis defined as the weight in grams of the additive per hundred grams ofresin.

Composite laminates were fabricated for testing by a VARTM process. Asealed and release-treated aluminum plate, possessing inlet and outletports affixed to the bottom surface, was utilized as the bottom moldsurface. Plies of glass or carbon fabric cut to dimensions of 3″×6″ werearranged on top of the aluminum mold to achieve a ⅛″ laminate thickness.A peel ply (Bron Aerotech; PTFE-coated) was placed over the fabricplies, and nylon resin distribution media (Airtech Greenflow 75) waspositioned on top of the peel ply at opposite ends of the compositelaminate corresponding to the position of the inlet port and outletport, respectively. A sheet of vacuum bagging film (Umeco ProcessMaterials Stretch-Vac 2000) was placed over the completed layup andaffixed to the mold surface using sealant tape (Airtech AT200-Y tape).Vacuum was applied to the outlet port to evacuate air from the layup toa vacuum level of between 28 inches-Hg to 29 inches-Hg. Resin preparedas per the examples presented below herein was degassed under vacuumwith stirring for at least 20 minutes. Catalyst suspension was injectedinto the resin under vacuum and the catalyzed resin was stirred undervacuum for at least one minute. The resin and catalyst suspension wereat ambient temperature (20-25° C.) immediately prior to mixing. After atleast one minute, stirring of the catalyzed resin was stopped, thevacuum source was clamped off, and the catalyzed resin was backfilledwith argon. The catalyzed resin was then infused through the fabricplies, driven by the pressure gradient between the ambient pressure andthe evacuated fabric layup.

The glass composite laminates of the examples in Tables 1, 5, 6, 7, and8 presented below herein were prepared using the VARTM process with fourplies of glass fabric reinforcement. After the infusion was complete,the glass composite laminate was heated from ambient temperature (20-25°C.) to 35° C. for two hours. After two hours at 35° C. the glasscomposite laminate was heated to 100° C. at a heating rate of 1° C./minand held at 100° C. for 1 hour and then allowed to cool to ambienttemperature (20-25° C.) and subsequently demolded.

The carbon composite laminates of the examples in Tables 1, 5, 6, 7, and8 presented below herein were prepared using the VARTM process with sixplies of carbon fabric reinforcement. After the infusion was complete,the carbon composite laminate was heated from ambient temperature(20-25° C.) to 35° C. for two hours. After two hours at 35° C. thecarbon composite laminate was heated to 100° C. at a heating rate of 1°C./min and held at 100° C. for 1 hour and then allowed to cool toambient temperature (20-25° C.) and subsequently demolded.

The glass composite laminates of the examples in Tables 2, 3, 4, and 9presented below herein were prepared using the VARTM process with fourplies of glass fabric reinforcement, except that each ply was cutdimensions of 6″×10″ and a release film (Airtech Wrightlon® 5200B) wasused instead of the Bron Aerotech peel ply. After the infusion wascomplete, the glass composite laminate was heated from ambienttemperature (20-25° C.) to 75° C. at 2° C./min, and then heated from 75°C. to 120° C. at 2° C./min and held at 120° C. for 2 hours, and thenallowed to cool to ambient temperature (20-25° C.) and subsequentlydemolded.

The glass composite laminates of the examples in Tables 10 and 12presented below herein were prepared using the VARTM process with fourplies of glass fabric reinforcement. After the infusion was complete,the glass composite laminate was heated from ambient temperature (20-25°C.) to 35° C. for 2 hours. After 2 hours at 35° C. the glass compositelaminate was heated to 120° C. at a heating rate of 2° C./min and heldat 120° C. for 2 hours and then allowed to cool to ambient temperature(20-25° C.) and subsequently demolded.

The carbon composite laminates of the examples in Table 11 and 12presented below herein were prepared using the VARTM process with sixplies of carbon fabric reinforcement. After the infusion was complete,the carbon composite laminate was heated from ambient temperature(20-25° C.) to 35° C. for 2 hours. After 2 hours at 35° C. the carboncomposite laminate was heated to 120° C. at a heating rate of 2° C./minand held at 120° C. for 2 hours and then allowed to cool to ambienttemperature (20-25° C.) and subsequently demolded.

The mechanical properties were measured using standard techniques.Interlaminar shear strength (ILSS) at 10% strain was measured by theshort-beam shear method according to ASTM D2344 on 1″×¼″×⅛″ samples. TheILSS values were reported in units of pounds per square inch (psi).Interlaminar shear strength (ILSS) is a measure of the adhesion and/orcompatibility between polymer matrix and fiber reinforcement in acomposite. Reported ILSS values are the average of 3 samples. All ILSSsamples were stored and tested at ambient room conditions. The followingcriteria, based on interlaminar shear strength values, was used tocharacterize the adhesion and/or compatibility between the polymermatrix and the glass or carbon fiber reinforcement materials. Compositeshaving poor adhesion and/or compatibility between the polymer matrix andfiber reinforcement were characterized as having ILSS values less thanabout 3,000 psi suggesting a lack of covalent adhesion between thepolymer matrix and fiber reinforcement. Composites having moderateadhesion and/or compatibility between the polymer matrix and fiberreinforcement were characterized as having ILSS values from about 3,000psi to about 6,000 psi suggesting minimal to no covalent adhesionbetween the polymer matrix and fiber reinforcement. Composites havingsuperior adhesion and/or compatibility between the polymer matrix andfiber reinforcement were characterized as having ILSS values greaterthan about 6,000 psi suggesting a higher degree of covalent adhesionbetween the polymer matrix and fiber reinforcement.

Synthesis of HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) HEA (2-hydroxyethyl acrylate)(640 g, 1.0 mol eq.) was added to a 3 L round bottom flask containingtoluene (1 kg). DCPD (dicyclopentadiene) (1.5 kg) was added to aseparate 3 L round bottom flask, and the 3 L flask containing DCPD wasaffixed with a Vigreaux column and distillation head connected to thecondenser. The 3 L flask containing HEA and toluene was connected to thecondenser. The DCPD was heated to >160° C. under an inter atmosphere to“crack” the DCPD and form CPD (cyclopentadiene). The CPD (740 g, 2.0 moleq.) was added dropwise to the HEA/toluene mixture at 10-40° C. under aninert atmosphere. Conversion of HEA to HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) was monitored by GC (gaschromatography). Toluene and reformed DCPD (364 g) were removed from thereaction mixture by vacuum distillation to give the desired HENB productas a colorless liquid (1,004 g, quantitative yield, approx. 98% purity).

Adhesion Promoter Composition (A). Liquid MDI (Modur® MLQ) (465 g) wasadded to a 2 L round bottom flask containing toluene (800 g, dried overmolecular sieves). Synthesized HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) (35 g) was added to the 2 Lround bottom flask containing the toluene and liquid MDI. The 2 L roundbottom flask was stirred overnight at 40° C. under an inert atmosphere.The toluene was removed in vacuo and the remaining reaction mixture wasanalyzed by ¹³C NMR as described below herein. The remaining reactionmixture was used as prepared.

Adhesion Promoter Composition (B). Synthesized HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) (0.001 mol eq., 0.0728 g) wasadded to liquid MDI (Mondur® MLQ) (1.0 mol eq., 99.93 g) at ambienttemperature (22-25° C.) in a 125 mL round bottom flask and stirred underan inert atmosphere for a minimum of 24 hours. The progress of thereaction was monitored by ¹³C NMR as described below herein. Thereaction mixture was used as prepared.

Adhesion Promoter Composition (C). Synthesized HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) (0.01 mol eq., 0.7229 g) wasadded to liquid MDI (Mondur® MLQ) (1.0 mol eq., 99.28 g) at ambienttemperature (22-25° C.) in a 125 mL round bottom flask and stirred underan inert atmosphere for a minimum of 24 hours. The progress of thereaction was monitored by ¹³C NMR as described below herein. Thereaction mixture was used as prepared.

Adhesion Promoter Composition (D). Synthesized HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) (0.10 mol eq., 338 g) was addedto liquid MDI (Mondur® MLQ) (1.0 mol eq., 4646 g) at ambient temperature(22-25° C.) and stirred under an inert atmosphere for a minimum of 24hours. The progress of the reaction was monitored by ¹³C NMR asdescribed below herein. The reaction mixture was used as prepared.

Adhesion Promoter Composition (E). Synthesized HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) (0.25 mol eq., 15.4 g) was addedto liquid MDI (Mondur® MLQ) (1.0 mol eq., 84.6 g) at ambient temperature(22-25° C.) in a 100 mL round bottom flask and stirred under an inertatmosphere for a minimum of 24 hours. The progress of the reaction wasmonitored by ¹³C NMR as described below herein. The reaction mixture wasused as prepared.

Adhesion Promoter Composition (F). Synthesized HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) (0.40 mol eq., 22.6 g) was addedto liquid MDI (Mondur® MLQ) (1.0 mol eq., 77.4 g) at ambient temperature(22-25° C.) in a 100 mL round bottom flask and stirred under an inertatmosphere for a minimum of 24 hours. The progress of the reaction wasmonitored by ¹³C NMR as described below herein. The reaction mixture wasused as prepared.

Adhesion Promoter Composition (G). Synthesized HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) (0.50 mol eq., 26.7 g) was addedto liquid MDI (Mondur® MLQ) (1.0 mol eq., 73.3 g) at ambient temperature(22-25° C.) in a 100 mL round bottom flask and stirred under an inertatmosphere for a minimum of 24 hours. The progress of the reaction wasmonitored by ¹³C NMR as described below herein. The reaction mixture wasused as prepared.

Adhesion Promoter Composition (H). Synthesized HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) (0.75 mol eq., 35.3 g) was addedto liquid MDI (Mondur® MLQ) (1.0 mol eq., 69.7) at ambient temperature(22-25° C.) in a 100 mL round bottom flask and stirred under an inertatmosphere for a minimum of 24 hours. The progress of the reaction wasmonitored by ¹³C NMR as described below herein. The reaction mixture wasused as prepared.

Adhesion Promoter Composition (I). Synthesized HENB (2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate) (1.0 mol eq., 42.1 g) was addedto liquid MDI (Mondur® MLQ) (1.0 mol eq., 57.9 g) at ambient temperature(22-25° C.) in a 100 mL round bottom flask and stirred under an inertatmosphere for a minimum of 24 hours. The progress of the reaction wasmonitored by ¹³C NMR as described below herein. The reaction mixture wasused as prepared.

Adhesion Promoter Composition (J). 2-Hydroxyethyl acrylate (HEA) (0.1mol eq., 4.3 g) was added to liquid MDI (Mondur® MLQ) (1.0 mol eq., 93.0g) at ambient temperature (22-25° C.) in a 100 mL round bottom flask andstirred under an inert atmosphere for a minimum of 24 hours. Theprogress of the reaction was monitored by ¹³C NMR in a similar manner asdescribed below herein. The reaction mixture was used as prepared.

Adhesion Promoter Composition (K). 9-Decen-1-ol (0.1 mol eq., 6 g) wasadded to liquid MDI (Mondur® MLQ) (1.0 mol eq., 93 g) at ambienttemperature (22-25° C.) in a 100 mL round bottom flask and stirred underan inert atmosphere for a minimum of 24 hours. The progress of thereaction was monitored by ¹³C NMR in a similar manner as described belowherein. The reaction mixture was used as prepared.

Adhesion Promoter Composition (L). Oleyl alcohol (0.1 mol eq., 10 g) wasadded to liquid MDI (Mondur® MLQ) (1.0 mol eq., 93 g) at ambienttemperature (22-25° C.) in a 125 mL round bottom flask and stirred underan inert atmosphere for a minimum of 24 hours. The progress of thereaction was monitored by ¹³C NMR in a similar manner as described belowherein. The reaction mixture was used as prepared.

Synthesis of MDI-HENB Mono Adduct, C₂₅H₂₄N₂O₅.

-   -   Chemical Formula: C₂₅H₂₄N₂O₅    -   Exact Mass: 432.17    -   Molecular Weight: 432.47

In a glovebox under argon atmosphere, 20.0 g (79.9 mmol, 1.0 equiv)4,4′-methylene diphenyl diisocyanate (solid MDI) was charged to a 1-L3-neck round bottom flask equipped with a large stirbar. 500 mLanhydrous toluene (Sigma Aldrich) was added. The flask was capped withrubber septa and a gas-adapter and removed from the glovebox. The gasadapter was connected to a Schlenk line. Under a strong flow of argon, areflux condenser and digital thermometer were connected to the tworemaining 24/40 ports. 29.87 g (163.8 mmol, 2.05 equiv) synthesized HENBwas added dropwise via syringe in ˜1 mL portions over 45 minutes. Theresulting suspension was heating to an internal temperature of 70° C.for 24 h then cooled to room temperature. After several minutes at 70°C. the mixture becomes completely homogeneous followed by slowprecipitation of a transparent solid. Upon cooling to room temperature,more solid precipitates leaving a cloudy suspension. The mixture wasfiltered through a course glass frit and the resulting solids washedwith 100 mL toluene. Volatiles were subsequently removed by rotaryevaporation at 50° C., leaving a thick, viscous oil with the strong odorof HENB. This oil was dissolved in dichloromethane and purified bycolumn chromatography (10% EtOAc in DCM). Volatiles were removed fromthe fraction of interest, first by rotovap then by drying on a Schlenkline overnight, yielding 29.0 g (83.9%) of a hard, hygroscopic solid,which was stored under argon. ¹H and ¹³C NMR reveals a clean mixture(78:22) of the desired products (endo- and exo-configuration ofnorbornene ring, respectively).

¹H NMR (CDCl₃, 400 MHz): δ=7.30 (m, overlapping, phenyls), 7.10 (broad,distorted d, phenyls), 6.99 (broad s, phenyls), 6.16 (m, endo-C═CH),6.11 (m, exo-C═CH), 6.09 (m, exo-CH═C), 5.92 (m, endo-CH═C) 4.2-4.4(overlapping m, O—CH₂CH₂—O), 3.87 (s, Ph-CH₂-Ph), 3.20 (s, norbornene),3.04 (s, norbornene), 2.97 (m, norbornene), 2.89 (broad s, norbornene),2.25 (broad m, norbornene); 2.01 (m, norbornene), 1.89 (distorted m,norbornene), 1.24-1.55 (overlapping peaks, norbornene).

¹³C NMR (CDCl₃, 100 MHz): δ=176.23 (exo-NB—CO—O), 174.75(endo-NB—C(O)—O), 155.37 (NHC(O)—O), 138.21, 137.97, 135.94, 135.75,132.37, 129.49, 119.09 (NCO), 63.07 (O—CH₂CH₂—O), 62.56(exo-O—CH₂CH₂—O), 62.30 (endo-O—CH₂CH₂—O), 49.71, 46.88, 46.40, 45.83,43.31, 43.15, 42.61, 41.75, 40.62, 30.45, 29.37.

¹³C NMR (CDCl₃, 100 MHz) Analysis of Adhesion Promoter Compositions(HENB and MDI Pre-Reacted Mixtures). The primary diagnostic region ofHENB and liquid MDI (Mondur® MLQ) pre-reacted mixtures is the—C(═O)O—CH₂—CH₂—OH region (ethylene bridge region) of HENB. FIG. 1 is a¹³C NMR spectrum of the ethylene bridge region of an HENB and liquid MDI(Mondur® MLQ) pre-reacted mixture at time zero, immediately aftermixing. In CDCl₃ HENB gives carbon peaks in two groups, Group A andGroup B (FIG. 1) corresponding to the carbons of the ethylene bridgeregion. The two carbon peaks in Group A have chemical shifts around66.1011 ppm and 65.9157 ppm corresponding to the —CH₂— carbon connectedto the to the oxygen of the ester group (—CH₂—O—C(═O)—) of HENB, exo andendo isomers, respectively (FIG. 1). The two carbon peaks in Group Bhave chemical shifts around 61.1841 ppm and 61.2156 ppm corresponding tothe —CH₂— carbon connected to the to the oxygen of the hydroxyl group(—CH₂—OH) of HENB, exo and endo isomers, respectively (FIG. 1). As thereaction between HENB and liquid MDI (Mondur® MLQ) proceeds, these peaksdisappear and are replaced by carbon peaks in two groups, Group C andGroup D (FIG. 2), thereby demonstrating that HENB is no longer presentin the mixture in its native form. FIG. 2 is a ¹³C NMR spectrum of theethylene bridge region of an HENB and liquid MDI (Mondur® MLQ)pre-reacted mixture after mixing for 5 days under inert atmosphere atambient temperature (20-25° C.). In FIG. 2, the broad carbon peak inGroup C having a chemical shift around 63.0490 ppm is consistent withthe —CH₂— carbon connected to the oxygen of the carbamate group(—NH—C(═O)—O—CH₂—) of the MDI-HENB mono adduct as shown above herein,where the broadness of the peak indicates overlapping of the exo andendo isomers. In FIG. 2, the carbon peak in Group D having a chemicalshift around 62.5340 ppm is consistent with the —CH₂— carbon connectedto the oxygen of the ester group (—CH₂—O—C(═O)—) of the MDI-HENB monoadduct as shown above herein, exo isomer. In FIG. 2, the carbon peak inGroup D having a chemical shift around 62.2901 ppm is consistent withthe —CH₂— carbon connected to the oxygen of the ester group(—CH₂—O—C(═O)—) of the MDI-HENB mono adduct as shown above herein, endoisomer.

Examples 1(a-c)-5(a-c) ILSS of Glass and Carbon Composites Prepared byVARTM

The modified DCPD (containing 20-25% tricyclopentadiene) was formulatedwith 0.6 phr TPP, 2 phr Ethanox® 4702 antioxidant, and 0 phr, 2 phr, or4 phr liquid MDI (Mondur® MLQ). The resin was catalyzed by the additionof C827 (monomer to catalyst ratio 45,000:1) in a suspension of mineraloil. VARTM samples were prepared using commercial glass fabrics andcommercial carbon fabrics as described above herein. The compositelaminates were cured as described above herein. The ILSS of theresulting composites are shown in (Table 1).

TABLE 1 ILSS Example Adhesion 1 2 3 4 5 Promoter Vectorply ZoltekVectorply Saertex CPIC (Mondur ® Carbon Carbon Glass Glass Glass MLQ)Fabric Fabric Fabric Fabric Fabric a None 3120 1715 1756 1253 1692 b 2phr 9154 3734 8628 6048 8628 c 4 phr 9786 3607 8865 6073 8637

Examples (6a,6b) ILSS of Glass Composites Prepared by VARTM

On Day 1, modified DCPD (containing 20-25% tricyclopentadiene) wasformulated with 20 ppm CHP, 2 phr Ethanox® 4702 antioxidant, and 2 phrliquid MDI (Mondur® MLQ) to give Resin Formulation (A1). Also on Day 1,modified DCPD (containing 20-25% tricyclopentadiene) was formulated with20 ppm CHP, 2 phr Ethanox® 4702 antioxidant, 2 phr MDI (Mondur® MLQ),and 2 phr HENB to give Resin Formulation (B1). The liquid MDI (Mondur®MLQ) and HENB were independently added to Resin Formulation (B1) asseparate additives. Resin Formulation (A1) and Resin Formulation (B1)were sparged with argon and stored in separate air-tight containers atambient temperature (20-25° C.).

On Day 1, Day 7, Day 28, Day 58, and Day 105 a portion of Formulation(A1) was catalyzed by the addition of C827 (monomer to catalyst ratio30,000:1) in a suspension of mineral oil and a VARTM sample was preparedas described above herein using commercial glass fabric SGL Kumpers(HPT970E0) based on PPG Hybon® 2002 (“SGL Glass Fabric”). The compositelaminates were cured as described above herein. The ILSS of theresulting composites are shown below in Table 2.

On Day 1, Day 7, and Day 28 a portion of Formulation (B1) was catalyzedby the addition of C827 (monomer to catalyst ratio 30,000:1) in asuspension of mineral oil and a VARTM sample was prepared as describedabove herein using commercial glass fabric SGL Kumpers (HPT970E0) basedon PPG Hybon® 2002 (“SGL Glass Fabric”). The composite laminates werecured as described above herein. The ILSS of the resulting compositesare shown below in Table 2.

TABLE 2 ILSS Resin Example Formulation Day 1 Day 7 Day 28 Day 58 Day 1056a A1 7564 7561 7596 7224 7417 6b B1 8070 6783 4916 Not Not measuredmeasured

Examples 7(a)-7(f) ILSS of Glass Composites Prepared by VARTM

On Day 1, modified DCPD (containing 20-25% tricyclopentadiene) wasformulated with 0.4 phr TPP, 2 phr Ethanox® 4702 antioxidant, and 2 phradhesion promoter composition (A) to give Resin Formulation (C₁). ResinFormulation (C₁) was sparged with argon and stored in an air-tightcontainer at ambient temperature (20-25° C.). The adhesion promotercomposition (A) was prepared as described above herein.

On Day 1, Day 69, Day 104, Day 151, and Day 201, and Day 326 a portionof Formulation (C1) was catalyzed by the addition of C827 (monomer tocatalyst ratio 30,000:1) in a suspension of mineral oil and a VARTMsample was prepared as described above herein using commercial glassfabric SGL Kumpers (HPT970E0) based on PPG Hybon® 2002 (“SGL GlassFabric”). The composite laminates were cured as described above herein.The ILSS of the resulting composites are shown below in Table 3.

TABLE 3 ILSS Example Day ILSS 7a 1 7945 7b 69 8016 7c 104 8063 7d 1517984 7e 201 7895 7f 326 8162

Examples 8(a)-8(d) ILSS of Glass Composites Prepared by VARTM

On Day 1, modified DCPD (containing 20-25% tricyclopentadiene) wasformulated with 0.4 phr TPP, 2 phr Ethanox® 4702 antioxidant, and 2 phradhesion promoter composition (A) to give Resin Formulation (D1). ResinFormulation (D1) was sparged with argon and stored in an air-tightcontainer at ambient temperature (40° C.). The adhesion promotercomposition (A) was prepared as described above herein.

On Day 1, Day 72, Day 151, and Day 202, a portion of Formulation (D1)was catalyzed by the addition of C827 (monomer to catalyst ratio30,000:1) in a suspension of mineral oil and a VARTM sample was preparedas described above herein using commercial glass fabric SGL Kumpers(HPT970E0) based on PPG Hybon® 2002 (“SGL Glass Fabric”). The compositelaminates were cured as described above herein. The ILSS of theresulting composites are shown below in Table 4.

TABLE 4 ILSS Example Day ILSS 8a 1 7945 8b 72 7512 8c 151 7811 8d 2027687

Examples 9(a-h)-13(a-h) ILSS of Glass and Carbon Composites Prepared byVARTM

The modified DCPD (containing 20-25% tricyclopentadiene) was formulatedwith 0.6 phr TPP, 2 phr Ethanox® 4702 antioxidant, and 4 phr of theappropriate adhesion promoter composition. The resin was catalyzed bythe addition of C827 (monomer to catalyst ratio 45,000:1) in asuspension of mineral oil. VARTM samples were prepared using commercialglass fabrics and commercial carbon fabrics as described above herein.The composite laminates were cured as described above herein. Theadhesion promoter compositions were prepared as described above herein.The ILSS of the resulting composites are shown in below in Table 5.

TABLE 5 ILSS Example 9 10 11 12 13 Adhesion Vectorply Zoltek VectorplySaertex CPIC Promoter Carbon Carbon Glass Glass Glass Composition FabricFabric Fabric Fabric Fabric a (B) 9269 4462 9330 6797 8639 b (C) 92326865 9370 8184 8877 c (D) 9769 9390 9294 8605 9027 d (E) 10622 9252 92758832 9425 e (F) 9976 9423 9694 8924 9248 f (G) 8921 9276 9094 8715 8957g (H) 7759 8838 8806 8112 8487 h (I) 6865 6787 7413 7803 7742

Examples 14(a)-18(a) ILSS of Glass and Carbon Composites Prepared byVARTM

The modified DCPD (containing 20-25% tricyclopentadiene) was formulatedwith 0.6 phr TPP, 2 phr Ethanox® 4702 antioxidant, and 4 phr of adhesionpromoter composition (J). The resin was catalyzed by the addition ofC827 (monomer to catalyst ratio 45,000:1) in a suspension of mineraloil. VARTM samples were prepared using commercial glass fabrics andcommercial carbon fabrics as described above herein. The compositelaminates were cured as described above herein. The adhesion promotercomposition (J) was prepared as described above herein. The ILSS of theresulting composites are shown below in Table 6.

TABLE 6 ILSS Example 14 15 16 17 18 Adhesion Vectorply Zoltek VectorplySaertex CPIC Promoter Carbon Carbon Glass Glass Glass Composition FabricFabric Fabric Fabric Fabric a (J) 9845 9126 9188 8769 9532

Examples 19(a)-23(a) ILSS of Glass and Carbon Composites Prepared byVARTM

The modified DCPD (containing 20-25% tricyclopentadiene) was formulatedwith 0.6 phr TPP, 2 phr Ethanox® 4702 antioxidant, and 0.6 phr of theMDI-HENB mono adduct. The resin was catalyzed by the addition of C827(monomer to catalyst ratio 45,000:1) in a suspension of mineral oil.VARTM samples were prepared using commercial glass fabrics andcommercial carbon fabrics as described above herein. The compositelaminates were cured as described above herein. The MDI-HENB mono adductwas prepared as described above herein. The ILSS of the resultingcomposites are shown below in Table 7.

TABLE 7 ILSS Example 19 20 21 22 23 Vectorply Zoltek Vectorply SaertexCPIC Carbon Carbon Glass Glass Glass Fabric Fabric Fabric Fabric Fabrica 2563 2051 2580 1881 1762

Examples 24(a)-28(a) ILSS of Glass and Carbon Composites Prepared byVARTM

The modified DCPD (containing 20-25% tricyclopentadiene) was formulatedwith 0.6 phr TPP, 2 phr Ethanox® 4702 antioxidant, 3.4 phr liquid MDI(Mondur® MLQ), and 0.6 phr of the MDI-HENB mono adduct. The liquid MDI(Mondur® MLQ and the mono MDI-HENB mono adduct were independently addedto the modified DCPD as separate additives. The resin was catalyzed bythe addition of C827 (monomer to catalyst ratio 45,000:1) in asuspension of mineral oil. VARTM samples were prepared using commercialglass fabrics and commercial carbon fabrics as described above herein.The composite laminates were cured as described above herein. TheMDI-HENB mono adduct was prepared as described above herein. The ILSS ofthe resulting composites are shown below in Table 8.

TABLE 8 ILSS Example 24 25 26 27 28 Vectorply Zoltek Vectorply SaertexCPIC Carbon Carbon Glass Glass Glass Fabric Fabric Fabric Fabric Fabrica 9150 5173 9450 7431 8402

Examples 29(a-d) ILSS of Glass Composites Prepared by VARTM

The modified DCPD (containing 20-25% tricyclopentadiene) was formulatedwith 20 ppm CHP, 2 phr Ethanox® 4702 antioxidant, 2 phr liquid MDI(Mondur® MLQ), and 2 phr of 9-decen-1-ol to form Resin Formulation (E1).The liquid MDI (Mondur® MLQ) and 9-decen-1-ol were independently addedto Resin Formulation (E1) as separate additives. The modified DCPD(containing 20-25% tricyclopentadiene) was formulated with 20 ppm CHP, 2phr Ethanox® 4702 antioxidant, 2 phr liquid MDI (Mondur® MLQ), and 2 phrof oleyl alcohol to form Resin Formulation (F1). The liquid MDI (Mondur®MLQ) and oleyl alcohol were independently added to Resin Formulation(F1) as separate additives. The modified DCPD (containing 20-25%tricyclopentadiene) was formulated with 20 ppm CHP, 2 phr Ethanox® 4702antioxidant, 2 phr of adhesion promoter composition (K) to form ResinFormulation (G1). The modified DCPD (containing 20-25%tricyclopentadiene) was formulated with 20 ppm CHP, 2 phr Ethanox® 4702antioxidant, 2 phr of adhesion promoter composition (L) to form ResinFormulation (H1). The resin formulations (E1-H1) were catalyzed by theaddition of C₈₂₇ (monomer to catalyst ratio 30,000:1) in a suspension ofmineral oil. VARTM samples was prepared as described above herein usingcommercial glass fabric SGL Kumpers (HPT970E0) based on PPG Hybon® 2002(“SGL Glass Fabric”). The composite laminates were cured as describedabove herein. The ILSS of the resulting composites are shown below inTable 9.

TABLE 9 ILSS Resin Example Formulation ILSS 29a E1 6109 29b F1 7865 29cG1 8680 29d H1 8203

Examples 30(a-f) ILSS of Glass Composites Prepared by VARTM

DCPD (containing 6-8% tricyclopentadiene) was formulated with 2 phrEthanox® 4702 antioxidant, 4 phr adhesion promoter composition (D), andwith the inhibitor described in Table 10. The resin was catalyzed by theaddition of the catalyst listed in Table 10 (monomer to catalyst ratiobetween 5,000:1 and 60,000:1 as listed in Table 10) in a suspension ofmineral oil. VARTM samples were prepared using commercial glass fabricVectorply (E-LT 3500-10) based on PPG Hybon® 2026 (“Vectorply GlassFabric”). The composite laminates were cured as described above herein.The adhesion promoter composition was prepared as described aboveherein. The ILSS of the resulting composites are shown below in Table10.

TABLE 10 ILSS Monomer to ILSS Example Catalyst Catalyst Ratio Inhibitor(psi) 30a C771 45,000:1 None 8028 30b C801  5,000:1 TPP (0.1 phr) 883030c C627 60,000:1 TPP (1.0 phr) 8533 30d C827 30,000:1 CHP 8166 (20 ppm)30e C835 29,040:1 None 8106 30f C747 60,000:1 TPP (0.4 phr) 8029

Examples 31(a-f) ILSS of Carbon Composites Prepared by VARTM

DCPD (containing 6-8% tricyclopentadiene) was formulated with 2 phrEthanox® 4702 antioxidant, 4 phr adhesion promoter composition (D), andwith the inhibitor described in Table 11. The resin was catalyzed by theaddition of the catalyst listed in Table 11 (monomer to catalyst ratiobetween 5,000:1 and 60,000:1 as listed in Table 11) in a suspension ofmineral oil. VARTM samples were prepared using commercial carbon fabricVectorply (C-L 1800) (“Vectorply Carbon Fabric”). The compositelaminates were cured as described above herein. The adhesion promotercomposition was prepared as described above herein. The ILSS of theresulting composites are shown in below in Table 11.

TABLE 11 ILSS Monomer to ILSS Example Catalyst Catalyst Ratio Inhibitor(psi) 31a C771 45,000:1 None 9119 31b C801  5,000:1 TPP (0.1 phr) 917231c C627 60,000:1 TPP (1.0 phr) 8765 31d C827 30,000:1 CHP 9295 (20 ppm)31e C835 29,040:1 None 8943 31f C747 60,000:1 TPP (0.4 phr) 8831

Example 32(a)-33(a) ILSS of Glass Composites Prepared by VARTM

DCPD (containing 6-8% tricyclopentadiene) was formulated with 2 phrEthanox® 4702 antioxidant, 0.6 phr TPP, and 4 phr adhesion promotercomposition (D). The adhesion promoter composition (D) was prepared asdescribed above herein. The adhesion promoter composition (D) had beenprepared 156 days before being formulated into (added to) the resincomposition as described above. The adhesion promoter composition (D)was stored in a sealed container under a dry, inert atmosphere (e.g.,under argon or nitrogen) at normal storage temperatures as definedherein (e.g., 5° C.-50° C.) before being formulated into (added to) theresin composition as described above. The resin was catalyzed by theaddition of C827 (monomer to catalyst ratio 45,000:1) in a suspension ofmineral oil. VARTM samples were prepared using commercial glass fabricand commercial carbon fabric as described above herein. The compositelaminates were cured as described above herein. The ILSS of theresulting composites are shown in below in Table 12.

TABLE 12 ILSS Example 32 33 Vectorply Vectorply Carbon Glass FabricFabric a 9752 8417

It is to be understood that while the invention has been described inconjunction with specific embodiments thereof, that the descriptionabove as well as the examples that follow are intended to illustrate andnot limit the scope of the invention. Other aspects, advantages, andmodifications within the scope of the invention will be apparent tothose skilled in the art to which the invention pertains.

1. A resin composition, comprising: at least one cyclic olefin; at leastone olefin metathesis catalyst; and at least one adhesion promotercomposition, where the at least one adhesion promoter compositioncomprises a pre-reacted mixture of at least one compound containing atleast two isocyanate groups and at least one compound comprising atleast one heteroatom-containing functional group and at least onemetathesis active olefin, wherein the at least one compound comprisingat least one heteroatom-containing functional group and at least onemetathesis active olefin have the following structure:(O^(M))-(Q*)n-(X*)—H wherein O^(M), Q*, and X* are as follows: O^(M) isa metathesis active olefin fragment selected from cyclic olefins andacyclic olefins, where the carbon-carbon double bond is nottetra-substituted; Q* is an optional linker group selected from thegroup consisting of a hydrocarbylene, substituted hydrocarbylene,heteroatom-containing hydrocarbylene, and substitutedheteroatom-containing hydrocarbylene; n=0 or 1; and X* is oxygen,sulfur, or a heteroatom-containing fragment selected from the groupconsisting of N(R^(X)), P(R^(X)), OP(R^(X)), OP(R^(X))O, OP(OR^(X))O,P(═O)(R^(X)), OP(═O)(R^(X)), OP(═O)(R^(X))O, OP(═O)(OR^(X))O,Si(R^(X))₂, Si(R^(X))₂O, Si(OR^(X))₂O, and Si(R^(X))(OR^(X))O, whereineach R^(X) is, independent of one another, a hydrogen, an aryl, and alower alkyl group, wherein the mol ratio of the at least one compoundcomprising at least one heteroatom-containing functional group and atleast one metathesis active olefin relative to the at least one compoundcontaining at least two isocyanate groups ranges from 0.01:1 to 0.5:1.2. The resin composition of claim 1, wherein the at least one compoundcontaining at least two isocyanate groups is selected from the groupconsisting of methylene diphenyl diisocyanate and hexamethylenediisocyanate and the at least one compound comprising at least oneheteroatom containing functional group and at least one metathesisactive olefin is selected from the group consisting of 2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate (HENB), 2-hydroxyethyl acrylate(HEA), oleyl alcohol, and 9-decen-1-ol.
 3. The resin composition ofclaim 2, wherein the pre-reacted mixture of 2-hydroxyethylbicyclo[2.2.1]hept-2-ene-5-carboxylate (HENB) and methylene diphenyldiisocyanate comprises


4. The resin composition of claim 1, wherein the adhesion promoter ispresent in an amount ranging from 0.001-50 phr.
 5. The resin compositionof claim 1, wherein the at least one adhesion promoter composition isstorage stable.
 6. The resin composition of claim 1, wherein the atleast one adhesion promoter composition is in-resin storage stable. 7.The resin composition of claim 1, further comprising: at least onesubstrate material.
 8. The resin composition of claim 7, wherein thesubstrate material is a glass substrate or a carbon substrate.
 9. Theresin composition of claim 1, wherein the at least one olefin metathesiscatalyst is a Group 8 transition metal complex having the structure ofFormula (I):

wherein M is a Group 8 transition metal selected from ruthenium andosmium; L¹, L², and L³ are neutral electron donor ligands; n is 0 or 1,such that L³ may or may not be present; m is 0, 1, or 2; k is 0 or 1; X¹and X² are anionic ligands; and R¹ and R² are independently selectedfrom hydrogen, hydrocarbyl, substituted hydrocarbyl,heteroatom-containing hydrocarbyl, substituted heteroatom-containinghydrocarbyl, and functional groups, wherein any two or more of X¹, X²,L¹, L², L³, R¹, and R² can be taken together to form one or more cyclicgroups.
 10. The resin composition of claim 9, wherein the at least oneof 12, L², and L³ is an N-heterocyclic carbene ligand.
 11. The resincomposition of claim 10, wherein the N-heterocyclic carbene ligand hasthe structure

wherein, Q is —CR¹¹R¹²—CR¹³R¹⁴— or —CR¹¹═CR¹³—, wherein R¹¹, R¹², R¹³,and R¹⁴ are independently selected from hydrogen, hydrocarbyl,substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substitutedheteroatom-containing hydrocarbyl, and functional groups, or wherein anytwo of R¹¹, R¹², R¹³, and R¹⁴ may be linked together to form asubstituted or unsubstituted, saturated or unsaturated ring; and R³ andR⁴ are unsubstituted phenyl or phenyl substituted with one or moresubstituents selected from C₁-C₂₀ alkyl, substituted C₁-C₂₀ alkyl,C₁-C₂₀ heteroalkyl, substituted C₁-C₂₀ heteroalkyl, C₅-C₂₄ aryl,substituted C₅-C₂₄ aryl, C₅-C₂₄ heteroaryl, C₆-C₂₄ aralkyl, C₆-C₂₄alkaryl, or halide.
 12. The resin composition of claim 1, wherein the atleast one olefin metathesis catalyst is a Group 8 transition metalcomplex having the structure of Formula (VII), wherein:

M is ruthenium; X¹ and X² are anionic ligands; L¹ is a neutral electrondonor ligand; Y is a heteroatom selected from N, O, S, and P; R⁵, R⁶,R⁷, and R⁸ are each, independently, selected from the group consistingof hydrogen, halogen, alkyl, alkenyl, alkynyl, aryl, heteroalkyl,heteroatom containing alkenyl, heteroalkenyl, heteroaryl, alkoxy,alkenyloxy, aryloxy, alkoxycarbonyl, carbonyl, alkylamino, alkylthio,aminosulfonyl, monoalkylaminosulfonyl, dialkylaminosulfonyl,alkylsulfonyl, nitrile, nitro, alkylsulfinyl, trihaloalkyl,perfluoroalkyl, carboxylic acid, ketone, aldehyde, nitrate, cyano,isocyanate, hydroxyl, ester, ether, amine, imine, amide,halogen-substituted amide, trifluoroamide, sulfide, disulfide,sulfonate, carbamate, silane, siloxane, phosphine, phosphate, andborate; n is 0, 1, or 2, such that n is 1 for the divalent heteroatoms Oor S, and n is 2 for the trivalent heteroatoms N or P; and Z is a groupselected from hydrogen, alkyl, aryl, functionalized alkyl,functionalized aryl where the functional group(s) may independently beone or more or the following: alkoxy, aryloxy, halogen, carboxylic acid,ketone, aldehyde, nitrate, cyano, isocyanate, hydroxyl, ester, ether,amine, imine, amide, trifluoroamide, sulfide, disulfide, carbamate,silane, siloxane, phosphine, phosphate, or borate; methyl, isopropyl,sec-butyl, t-butyl, neopentyl, benzyl, phenyl and trimethylsilyl. 13.The resin composition of claim 1, wherein the at least one olefinmetathesis catalyst has the structure of Formula (I):

wherein: M is ruthenium; n is 0; m is 0; k is 1; L¹ and L² aretrisubstituted phosphines independently selected from the groupconsisting of tri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine(PCp₃), tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);or L¹ is an N-heterocyclic carbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene,1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene,1,3-bis(2,6-di-isopropylphenyl)-2-imidazolidinylidene, and1,3-bis(2,6-di-isopropylphenyl)imidazol-2-ylidene and L² is atrisubstituted phosphine selected from the group consisting oftri-n-butylphosphine (Pn-Bu₃), tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);L³ is not present; X¹ and X² are chloride; and R¹ is hydrogen and R² isphenyl or —CH═C(CH₃)₂ or thienyl; or R¹ and R⁷ are taken together toform phenylindenylidene.
 14. The resin composition of claim 1, whereinthe at least one olefin metathesis catalyst has the structure of Formula(I):

wherein: M is ruthenium; n is 0; m is 0; k is 1; L¹ is an N-heterocycliccarbene selected from the group consisting of1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene and1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene; L² is a trisubstitutedphosphine independently selected from the group consisting oftri-n-butylphosphine (Pn-Bus); tricyclopentylphosphine (PCp₃),tricyclohexylphosphine (PCy₃), triisopropylphosphine (P-i-Pr₃),triphenylphosphine (PPh₃), methyldiphenylphosphine (PMePh₂),dimethylphenylphosphine (PMe₂Ph), and diethylphenylphosphine (PEt₂Ph);L³ is not present; X¹ and X² are chloride; and R¹ is hydrogen and R² isphenyl or —CH═C(CH₃)₂ or thienyl; or R¹ and R² are taken together toform phenylindenylidene.
 15. The resin composition of claim 1, whereinthe cyclic olefin is selected from the group consisting ofdicyclopentadiene; tricyclopentadiene; cyclopentadiene tetramer;cyclopentadiene pentamer; dicyclohexadiene; norbornene;5-methyl-2-norbornene; 5-ethyl-2-norbornene; 5-isobutyl-2-norbornene;5,6-dimethyl-2-norbornene; 5-phenyl norbornene; 5-benzylnorbornene;5-acetylnorbornene; 5-methoxycarbonylnorbornene;5-ethoxycarbonyl-1-norbornene; 5-methyl-5-methoxy-carbonylnorbornene;5-cyanonorbornene; 5,5,6-trimethyl-2-norbornene;cyclo-hexenylnorbornene; endo, exo-5,6-dimethoxynorbornene; endo,endo-5,6-dimethoxynorbornene; endo, exo-5-6-dimethoxycarbonylnorbornene;endo, endo-5,6-dimethoxycarbonylnorbornene; 2,3-dimethoxynorbornene;norbornadiene; tricycloundecene; tetracyclododecene;8-methyltetracyclododecene; 8-ethyl-tetracyclododecene;8-methoxycarbonyltetracyclododecene; 8-methyl-8-tetracyclo-dodecene;8-cyanotetracyclododecene; pentacyclopentadecene; pentacyclohexadecene;5-butyl-2-norbornene; 5-hexyl-2-norbornene; 5-octyl-2-norbornene;5-decyl-2-norbornene; 5-dodecyl-2-norbornene; 5-vinyl-2-norbornene;5-ethylidene-2-norbornene; 5-isopropenyl-2-norbornene;5-propenyl-2-norbornene; and 5-butenyl-2-norbornene.
 16. The resincomposition of claim 1, wherein the cyclic olefin is selected from thegroup consisting of dicyclopentadiene; tricyclopentadiene;cyclopentadiene tetramer; cyclopentadiene pentamer; tetracyclododecene;norbornene; 5-butyl-2-norbornene; 5-hexyl-2-norbornene;5-octyl-2-norbornene; 5-decyl-2-norbornene; 5-dodecyl-2-norbornene;5-vinyl-2-norbornene; 5-ethylidene-2-norbornene;5-isopropenyl-2-norbornene; 5-propenyl-2-norbornene; and5-butenyl-2-norbornene.
 17. The resin composition of claim 1, whereinthe resin composition further comprises at least one additive.
 18. Theresin composition of claim 1, wherein the resin composition furthercomprises at least one crosslinker.
 19. The resin composition of claim18, wherein the at least one crosslinker is selected from the groupconsisting of dialkyl peroxides, diacyl peroxides, peroxyacids, andmixtures thereof.
 20. An article of manufacture comprising at least oneresin composition of claim
 1. 21. A method for improving the adhesion ofa resin composition to a substrate material, comprising: combining atleast one cyclic olefin, at least one olefin metathesis catalyst, andthe at least one adhesion promoter composition of claim 1 to form aresin composition, contacting the resin composition with the substratematerial, and subjecting the resin composition to conditions effectiveto promote an olefin metathesis reaction of the cyclic olefin.